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Abstract
The roles of early signalling intermediates in insulin-stimulated GLUT4 trafficking were 
investigated in insulin-resistant adipocytes. Chronic-insulin treatment of rat adipocytes 
reduced insulin receptor tyrosine phosphorylation, PI 3-kinase activation and PKB activation. 
Despite significant reductions in the activation of early signalling intermediates, GLUT4 
exocytosis was calculated to have remained unaffected. However, reduced plasma membrane 
GLUT4 in chronic-insulin treated adipocytes, was accounted for by an increase in the rate of 
GLUT4 endocytosis. The chronic-insulin treatment on GLUT4 was reversed by the anti- 
hyperglycaemic drug metformin, which appeared to act at the level of insulin receptor 
phosphorylation.
Using periodate-oxidised GTP, it was shown that both Ras-like and heterotrimeric GTP- 
binding proteins are activated by insulin, downstream of PI 3-kinase. Furthermore, the 
GTPase ARF was shown to associate direcdy with GLUT4 vesicles. Since ARF1 recruits 
adaptor proteins onto vesicles, it is likely to facilitate the trafficking of GLUT4 from the 
plasma membrane back to the insulin-responsive GLUT4 storage pool.
The possibility of a role of PKB in insulin-stimulated GLUT4 trafficking to the plasma 
membrane in adipocytes was examined. PKB was not required for contraction-stimulated 
GLUT4 translocation to the plasma membrane in muscle. A study of PKB and the 
phosphatase inhibitor, okadaic acid, suggested that okadaic acid may stimulate the exocytosis 
of recycling endosomes by a PKB-independent route, or may act downstream of PKB.
It is postulated that the lipid products of PI 3-kinase are involved in downstream processes 
leading to GLUT4 translocation. Heparin and Ins(l,3,4,5)P4 chromatography were used to 
isolate PI(3,4)P2-/PIP3-binding proteins from adipocytes. Identification of PI(3,4)P2-/PIP3- 
binding proteins from adipocytes isolated aldolase. Aldolase has been reported to bind 
phosphoinositides, actin, and the C-terminus of GLUT4. Whether PI 3-kinase regulates 
aldolase binding to GLUT4, and hence the cytoskeleton, remains to be determined. Other 
PIP3 binding proteins that were labelled currendy remain unidentified but might include 
centaurin-a and Gaplm.
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Glucose plays a pivotal role in cellular homeostasis and metabolism. Hormones such as 
glucagon and insulin tighdy regulate the level of blood glucose. Of central importance in the 
control of glucose homeostasis is insulin’s ability to lower the blood glucose concentrations by 
promoting glucose uptake into muscle and adipose tissues. A defect in insulin’s ability to 
promote glucose uptake seems to underlie conditions such as non-insulin dependent diabetes 
mellitus (NIDDM).
Glucose uptake into most mammalian cells occurs via facilitative glucose transporters 
(GLUTs), which are integral membrane proteins. Several GLUT isoforms are known to exist, 
which are variably expressed in different tissues (reviewed by Gould & Holman, 1993). It is 
the unique regulation of glucose transporter 4 (GLUT4) in insulin-sensitive tissues (muscle, 
heart and adipose tissue) which primarily allows insulin to lower blood glucose levels. In the 
presence of insulin, specialised intracellular GLUT4 storage vesicles (GSVs) rapidly translocate 
and fuse with the plasma membrane (PM), thereby increasing the cell surface levels of 
GLUT4. Since the discovery of insulin-regulated GLUT4 trafficking, much research has been 
undertaken to understand the mechanisms regulating the trafficking process. Research has 
concentrated primarily on the signalling mechanisms that follows insulin’s binding to the 
insulin receptor, and the subsequent generation of intracellular signalling cascades leading to 
GLUT4 vesicle translocation. Whilst significant progress has been made in discerning the 
signalling molecules involved in regulating GLUT4 trafficking in adipose, and more recently, 
in muscle tissues, many aspects of the proposed signalling cascade require clarification and 
further molecules still need to be identified.
The thesis has therefore focussed on the role of insulin-regulated signalling molecules 
implicated in GLUT4 trafficking. Furthermore, research has been aimed at identifying new 
signalling molecules that may be involved in insulin-regulated GLUT4 trafficking.
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Glucose Transporter 4
Following the cloning of GLUTl/2 and 3, there appeared in 1989 five separate reports of the 
cloning and sequencing of the GLUT4 isoform, (fames et al., 1989; Birnbaum, 1989; Charron 
etal., 1989; Kaestner etal., 1989; Fukumoto et al., 1989).
Out
Figure i. Hypothetical model for the structure of glucose transporters (Gould & 
Holman, 1993). Conserved amino acids are indicated by the appropriate single letter code. 
Filled circles indicate conservative substitutions. Both the N- and C-terminus of GLUT4 
appear to be important in the trafficking and sequestration of GLUT4 to an intracellular 
location.
Analysis of the predicted amino acid sequences of the mammalian glucose transporters shows 
that they are highly homologous with one another. Hydropathic analysis predicts 12 
amphipathic helices arranged so that both the N- and C-termini are at the cytoplasmic surface 
(figure i). There is a large loop between helices 1 and 2 which can be glycosylated, and a large 
loop between helices 6 and 7. The loops between the remainder of the helices of the 
cytoplasmic surface are very short which places severe constraints on the possible tertiary 
structures and suggests very close packing of the helices at the inner surface of the membrane 
in each half of the protein (Gould & Holman, 1993).
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Unique to GLUT4 is its intracellular sequestration in unstimulated (basal) adipose, cardiac and 
muscle tissues. In an attempt to define the relevant targeting domains that direct the 
intracellular sequestration of GLUT4, studies were performed in which reciprocal domains 
were exchanged between GLUT4 and GLUTl and the subcellular distributions of these 
chimeras analysed in a variety of cellular systems. The chimera studies together with specific 
amino acid mutations have identified two important domains in the N- and C-termini (F5QQI 
and L489L490 respectively) involved in GLUT4 intracellular localisation (reviewed by Gould, 
1997). Whilst the FQQI and di-leucine motifs appear to be important for GLUT4 
internalisation from the plasma membrane, and for trafficking between intracellular 
compartments, neither of these two domains are entirely sufficient for targeting GLUT4 to 
the GSV compartment and other targeting domains remain to be discovered (Melvin et al., 
1999).
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PART A - GLUT4 vesicle biogenesis and trafficking
Insulin-stimulated glucose transporter translocation was first described by two independent 
groups, Suzuki & Kono (1980) and Cushman & Wardzala (1980). The former group isolated 
rat adipose cells and stimulated cells with insulin. Cell populations were then homogenised, 
and a crude microsomal fraction was generated by differential and density gradient 
centrifugation. Protein fractions taken from sucrose density gradients were then reconstituted 
into liposomes, and the liposomes assayed for D-[3H]glucose uptake. Glucose uptake into the 
liposomes was calculated by subtracting cytochalasin B-insensitive uptake (cytochalasin B will 
inhibit glucose uptake by binding to glucose transporters) from the total glucose uptake 
activity. The glucose uptake studies identified two glucose transport peaks on the sucrose 
gradients. One of the two peaks coincided with a marker for the PM, whereas the other peak 
coincided with a marker for the Golgi apparatus. Insulin-stimulation of the adipose cells 
decreased the glucose transport peak corresponding to the internal membrane site, with a 
concomitant increase in the glucose transport peak corresponding to the PM. Since the 
values for the two glucose transport peaks were roughly similar, it was concluded that insulin 
facilitates translocation of the transport activity from an intracellular storage site to the PM.
The same conclusion derived by Suzuki & Kono (1980) was obtained by Cushman & 
Wardzala (1980). The latter authors showed that the number of cytochalasin B binding sites in 
plasma membranes, isolated from insulin-stimulated cells, increased to 24.4 pmol/mg of 
membrane protein, compared to 7.8 pmol/mg of membrane protein in basal cells. In contrast, 
the average number of D-glucose-inhibitable cytochalasin B-binding sites in a microsomal 
membrane fraction decreased from 37.8 to 21.2 pmol/mg microsomal membrane upon 
insulin treatment.
Whilst both Suzuki & Kono (1980) and Cushman & Wardzala (1980) determined the 
translocation of a glucose transporter to the PM in insulin-stimulated rat adipose cells, the 
intracellular glucose transporter compartment and the trafficking of the glucose transporter 
remained ill-defined. Part A of this introduction primarily describes the research undertaken 
since 1980 to address these issues.
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1.1 Quantification of GLUT1 and GLUT4
Differential ultracentrifugation of adipocyte homogenates was shown to fractionate adipose 
cell membranes into four distinct subcellular components (Simpson et al., 1983; Weber et al., 
1988). Using marker proteins, the isolated membrane fractions were characterised as the 
plasma membrane (PM), high-density microsomes (HDM), low-density microsomes (LDM) 
and a mitochondria and nuclei enriched fraction. Simpson et al. (1983) determined that 
following fractionation of basal rat adipose cells, the levels of D-glucose-inhibitable 
cytochalasin B-binding sites per mg protein was greatest in the LDM fraction. Insulin- 
stimulation of the adipose cells decreased the levels of cytochalasin B-binding sites in the 
LDM enriched fraction, with a concomitant increase in cytochalasin B binding sites in the PM.
Using the fractionation procedure developed by Simpson and colleagues, Zorzano et al. (1989) 
showed that using agarose conjugated to an anti-GLUT4 monoclonal antibody (1F8), ~80% 
of the GLUT4-containing vesicles in the LDM fraction could be immunoprecipitated. Whilst 
the GLUT4 vesicles were retained by the agarose pellet, >90% of GLUT1 (unlike GLUT4 
which is expressed in adipose, cardiac and muscle tissues, GLUT1 is ubiquitously expressed) 
was found in the non-adsorbed supernatant. This result suggested that GLUT4 and GLUT1 
resided in two (or more) distinct intracellular compartments. Zorzano et al. then set out to 
determine whether both GLUT4 and GLUT1 translocate to the PM in response to insulin. 
Immunoblotting data showed a 2-fold and 8-fold increase in PM GLUT1 and GLUT4 
respectively in adipose cells stimulated by insulin. The insulin-stimulated glucose transporter 
increase in the PM was consistent with decreases observed in both GLUT1 and GLUT4 from 
the LDM fraction. To quantitate the relative contributions of GLUT4 and GLUT1 to glucose 
transport, Zorzano et al. photolabelled adipose LDM fractions with [3H] cytochalasin B. 
Solubilisation of the photolabelled-LDM fraction and immunoadsorption using the 1F8- 
agarose conjugate, resulted in the retention of ~90% of the radiolabel into the agarose pellet. 
This result suggested that GLUT4 was the predominant glucose transporter in rat adipose 
cells. Furthermore, photolabelling of PM glucose transporters (the photolabel used was 3- 
[125I]iodo-4-azidophenethylamido-7-0-succinyldeacetyl-forskolin) resulted in 75% of the 
photolabel being retained by the lF8-agarose conjugate. Together the results suggested that 
GLUT4 is the major glucose transporter in rat adipose cells and can account for the majority 
of the increase in insulin-stimulated glucose transport.
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Further studies (described below), using a novel glucose transporter photolabel, namely 2-N- 
[4-(l -azi-2,2,2-trifluoroethyl)benzoyl]-l ,3-bis(D-mannos-4-yloxy)-2-propylamine (ATB-
BMPA) (Clark & Holman, 1990) (figure 1), agreed with the data by Zorzano et al (1989).
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Figure 1. ATB-BMPA. ATB-BMPA consists of two mannose groups linked by a p ro p y l­
amine bridge. The diazirine generating photolabel is then attached to the bridge between the 
two sugars. Upon irradiation with 300 nm light, the diazirine loses nitrogen and generates a 
short-lived carbene that can form a covalent bond with any adjacent proteins. Hence, only the 
ligand that is bound to an active site is cross-linked to the protein. Tritium incorporation into 
the photolabel allows the detection of the ATP-BMPA.
ATB-BMPA was used to quantitate cell surface GLUT1 and GLUT4 in 3T3-L1 adipocytes (a 
differentiated fibroblast with properties similar to adipocytes) (Calderhead et al, 1990). 
Western blotting of 3T3-L1 adipocyte lysates revealed that GLUT1 was expressed at a higher 
level than GLUT4, however, ATB-BMPA photolabelling of insulin-stimulated 3T3-L1 
adipocytes showed 6.5- and 17.1-fold increases in PM GLUT1 and GLUT4, respectively. The 
increases in glucose transporters in the PM corresponded to a 21-fold increase in 2- 
deoxyglucose uptake. It was assumed that if GLUT4 has a higher intrinsic activity compared 
to GLUT1, then the translocation of GLUT4 could account for the insulin effect on hexose 
transport.
While 3T3-L1 adipocytes have a higher level of expression of GLUT1 than GLUT4, 
photolabelling in rat adipocytes revealed that the GLUT4 levels were 9 times higher than the 
GLUT1 levels (Holman et al, 1990). Photolabelling studies also revealed that insulin 
stimulated a 15-20-fold increase in PM GLUT4 levels, whilst GLUT1 increased by 
approximately 3-5-fold. Again, glucose transport activity corresponded to the appearance of 
GLUT4 on the cell surface (Holman et al, 1990). Studies by Nishimura et al (1993) using 
ATB-BMPA, in rat adipocytes, demonstrated that GLUT4 has a 6-fold higher intrinsic activity 
(turnover number/K^) than that of GLUT1 (turnover for both transporters were found to be
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20,000 min'1, and the K^s for GLUT1 and GLUT4 were 26.2 mM and 4.3 mM, respectively). 
Studies in 3T3-L1 adipocytes, using ATB-BMPA, also determined that GLUT4 has a higher 
intrinsic activity than GLUT1 (Palfreyman et al., 1992). Hence, ATB-BMPA photolabelling in 
rat and 3T3-L1 adipocytes determined that GLUT4 is generally the major contributor to 
insulin-stimulated glucose transport activity in these cells.
1.2 Kinetic studies of GLUT4 trafficking
ATB-BMPA photolabelling was used by Satoh et al. (1993) to dissect the trafficking of 
GLUT4 between the PM and LDM fractions in rat adipocytes. This study involved a 
combination of Western blotting of adipocyte sub-cellular fractions for GLUT4, ATB-[2- 
3H]BMPA photolabelling, and measurements of the rates of glucose uptake into adipocytes. 
The trafficking kinetic studies were carried out on adipocytes under three conditions, which 
were as follows: cells were stimulated by the continuous presence of insulin, or cells were 
stimulated with insulin and then treated with collagenase to remove insulin from the cell 
surface, or finally insulin-stimulated cells were treated with collagenase and then subsequently 
re-challenged with insulin. Cells maintained in the continuous presence of insulin retained 
high levels of PM GLUT4. In this latter condition, the levels of GLUT4 protein in the PM as 
determined by Western blotting remained constant in the continuous presence of insulin. 
However, there was a slight loss of ATB-BMPA-photolabelled GLUT4 (a decrease of 55% 
from maximal levels, to a 45% steady state) from the PM. The t/} for the decrease in ATB- 
BMPA labelled GLUT4 from the PM was similar to cells where the insulin stimulation was 
removed by collagenase treatment. This indicated that GLUT4 undergoes a constant rapid re­
cycling between the PM and intracellular membranes even in the continuous presence of 
insulin.
After ATB-BMPA photolabelling of insulin-stimulated rat adipocytes, removal of the insulin 
by collagenase treatment showed a decrease in the amount of ATB-BMPA-tagged GLUT4 in 
the PM fraction (tV] — 9.4 ± 0.8 min). The decrease in PM ATB-BMPA-labelled GLUT4 was 
fully accounted for by reciprocal changes in the LDM levels of ATB-BMPA-labelled GLUT4. 
These results correlated with both the rates of glucose uptake, and Western blotting of the 
levels of GLUT4, in both the PM and LDM fractions.
Finally, the third treatment showed that a subsequent re-challenge by insulin following 
collagenase treatment increased the ATB-BMPA labelled GLUT4 levels in the PM to a steady
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state of 45% of the initial fully insulin-stimulated level. This latter process occurred with a t/2 —
2.7 ± 0.3 min, which correlated with immunodetectable PM GLUT4, but was slighdy faster 
than the increase in glucose transporter activity. Together the results were consistent with the 
possibility that in the presence of insulin the entire complement of GLUT4 in adipocytes is 
involved in a recycling process between the PM and microsomal fraction.
The study by Satoh et al (1993) showed that at 37°C the tVi for GLUT4 translocation to the 
PM as measured by Western blotting and photolabelling with ATB-BMPA was slightly faster 
than the increase in glucose transport activity. These differences between immunodetectable 
PM GLUT4 and glucose transport were more noticeable at 20°C. The lower temperature 
studies showed that the rates of appearance of GLUT4 detected by ATB-BMPA 
photolabelling (t,A — 9 min) and by Western blotting (tVi = 5 min), were both faster than the 
rates of increase in glucose transport activity, which occurred with a UA of 12 min. These data 
are similar to studies by Yang et al (1992), using 3T3-L1 adipocytes. The discrepancies 
between the rates of increase in GLUT4 in the PM and the increase in glucose transport were 
interpreted as being due to the presence of occluded GLUT4 vesicles docked at the PM, and 
partially occluded GLUT4 vesicles existing as a consequence of membrane fusion (Satoh et al, 
1993). Indeed this is consistent with the idea that GLUT4 vesicles fuse with plasma 
membranes via SNARE complexes (section 1.4) which would involve both docking and fusion 
events.
If GLUT4 is undergoing constant recycling between the PM and a single intracellular 
compartment, then the distribution between these two compartments will depend upon the 
relative balance of the rate constant for internalisation (endocytosis) and that of the re- 
extemalisation (exocytosis), the rate constants ken and kex, respectively. Using the redistribution 
of ATB-BMPA-labelled GLUT4 (and Western blotting for GLUT4) under steady state and 
non-steady state conditions, the effects of insulin on ken and kex can be calculated. The 
calculation of ken and kex using adipose cells under the three conditions described above, 
showed that insulin has little effect on ken, but increases kex by approximately 10 fold (Satoh et 
al, 1993).
Similar trafficking kinetic studies were also undertaken in 3T3-L1 adipocytes (Yang & 
Holman, 1993). Following the redistribution of ATB-BMPA-labelled GLUT1 and GLUT4 in 
basal and insulin-stimulated steady states, insulin reduced the endocytosis of the two glucose 
transporters by approximately 30% compared to the basal state. In the insulin-stimulated state,
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the rate constants for GLUT4 and GLUT1 exocytosis (0.086 and 0.096 min1 respectively) 
were similar to those of endocytosis. In contrast, the kex of GLUT4 and GLUT1 in the basal 
state were found to be 0.01 and 0.035 min'1. It was therefore concluded that the main effect of 
insulin in 3T3-L1 adipocytes is to increase GLUT4 and GLUT1 kex by approximately 9- and 3- 
fold, respectively. Hence, the unique feature of the GLUT4 isoform is the very slow rate of 
exocytosis in the basal state.
In a two-pool model, of GLUT4 trafficking, this protein is assumed to be localised to the PM 
and only one intracellular vesicular site. The half time (which is only dependent upon kex and 
ken) for both insulin-stimulated GLUT4 translocation to the cell surface and internalisation, in 
the continuous presence of insulin, should be the same. However, this is not observed 
experimentally (Satoh et al., 1993): insulin-stimulated GLUT4 translocation to the PM has a 
faster half-time (2.7 min) than internalisation of GLUT4 in the continuous presence of insulin 
(10.6 min). These data were found to be better explained by the computer simulation of a 
three-pool model (Holman et al., 1994). Here, there are two intracellular pools: the tubulo- 
vesicular system and the early endosomes (consistent with morphological data, section 1.3). It is 
therefore conceivable that GLUT4 is rapidly internalised from the PM to the early endosomes 
without a major contribution from kcx to the half time for this process. The early endosomes 
may represent a site for sorting and recycling back to the tubulo-vesicular system, which could 
markedly slow the half time for internalisation back to the insulin-stimulated GLUT4-vesicle 
pool.
Hence, use of ATB-BMPA photolabelling has determined that the major-insulin responsive 
glucose transporter isoform in adipocytes is GLUT4 and that the main effect of insulin on 
GLUT4 is to increase the rate of exocytosis of GLUT4 from a reservoir compartment with 
only small changes in endocytosis.
1.3 Subcellular localisation of GLUT4
The idea that GLUT4 vesicles may represent a specialised compartment was derived from the 
observation that the GLUT4 vesicle compartment comprises ~3% or less of the LDM, has a 
limited protein composition, and does not contain the bulk of the insulin-like growth factor II 
receptor (Zorzano etal., 1989).
The characteristics of the specialised GLUT4 vesicle population are still not clearly defined. 
By using immunoelectron microscopic analysis of GLUT4 in rat brown adipose tissue, Slot et 
al. (1991) made significant progress in forwarding the understanding of the intracellular 
compartments involved in GSV biogenesis. Cathepsin D was used as a marker of late 
endosomes/pre-lysosomes and internalised rat albumin (which is not synthesised in brown 
adipose tissue) was used as a marker for the endosome to lysosome pathway. The changes in 
the immunolocalisation of GLUT4 in brown adipose tissue from basal and insulin-stimulated 
cells were compared with these markers. Under basal conditions, 99% of GLUT4 was located 
intracellularly. The intracellular structures consisted of tubulo-vesicular structures (both near 
the PM and in areas close to the trans-Golgi network (TGN)) and small vesicular structures 
distributed throughout the cytoplasm. Only the outermost /ra^j-cisterna of the TGN 
contained a small amount of GLUT4. A small proportion of GLUT4 (<3%) was observed in 
clathrin-coated pits at the PM and in early endosomes, under basal conditions. Upon insulin 
treatment, 50% of the GLUT4 was found associated with the PM. GLUT4 levels also 
increased within coated pits at the PM and early endosomes. The early endosomes were often 
observed to be continuous with tubular extensions (distinct from the tubulo-vesicular 
structures mentioned above) in which GLUT4 and albumin were enriched in the tubular 
extensions. The tubular extensions arising from early endosomes, enriched in GLUT4, 
suggested a sorting of GLUT4 from other endosomal proteins. The insulin-stimulated 
increase in GLUT4 localisation at the PM was consistent with a re-distribution of the GLUT4 
from the tubulo-vesicular structures to the cell surface. No significant level of GLUT4 was 
found to be localised to late endosomes, under either basal or insulin-stimulated conditions. A 
model was therefore postulated for GLUT4 trafficking between intracellular compartments 
and the PM in basal and insulin-stimulated brown adipose tissue (figure 2)(Slot et al., 1991).
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Insu lin
Figure 2. Model for GLUT4 trafficking between intracellular compartments (modified 
from Slot et a l 1991). In the presence of insulin, GLUT4 is targeted from intracellular- 
vesicular structures (blue structures; trans-Go\^ network (TGN), tubulovesicular-vesicles 
(TV), small vesicular structures (V)) to the plasma membrane (PM). The GLUT4 can then 
recycle between the PM and the endosomal system (purple structures). GLUT4 is primarily 
endocytosed via clathrin-coated pits (CCP) which fuse with early endosomal (EE) vesicles. 
GLUT4 is extruded from these vacuoles at an early step via tubular extensions. GLUT4 
positive tubulo-vesicular structures may originate directly from the early endosomes or via the 
TGN/secretory route.
The model of GLUT4 trafficking between intracellular compartments proposed by Slot et aL 
(1991), has essentially held true, with refinements to the model being proposed as a result of 
further research by others (discussed below). As discussed previously (section 1.2), it is clear 
that GLUT4 continuously recycles between the PM and intracellular vesicle compartments, 
both under basal and insulin-stimulated conditions. To further define the GLUT4 storage 
compartment a technique referred to as compartment ablation analysis (Livingstone et aL,
1996) was employed. This method loads the recycling pathway of the transferrin-receptor with 
transferrin conjugated to horseradish peroxidase (HRP). In the presence of hydrogen peroxide 
and 3,3’-diaminobenzidine (DAB), the HRP converts DAB into a dense polymer. Integral 
membrane and soluble proteins present in the transferrin-HRP containing endosomes become 
cross-linked by the DAB polymerisation reaction and are subsequently ablated. Using 
endosomal ablation in conjunction with vesicle immunoisolation in 3T3-L1 adipocytes, 
Livingstone et al (1996) showed that ~40% of the GLUT4 could be ablated in the recycling- 
endosomal pool. However, a larger proportion of GLUT4 (~60%) resides in a distinct ‘non-
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ablatable’ pool which is devoid of transferrin receptors and other endosomal recycling 
proteins. In rat adipocytes however, only 10% of the cellular GLUT4 appears to co-localise 
with transferrin receptors, as analysed by glycerol gradient density centrifugation (Gillingham 
et al., 1999). Furthermore, wortmannin (a fungal metabolite which inhibits PI 3-kinase (section 
1.9)) treatment of basal adipocytes, induces the appearance of large vacuolar structures 
containing endosomal markers such as the transferrin receptor, and blocks GLUT4 trafficking 
to the PM, without affecting the morphology of GLUT4 tubulo-vesicular structures (Malide & 
Cushman, 1997). Treatment of adipocytes initially with insulin and then by wortmannin, 
induced the formation of large vacuolar structures containing both early endosomal markers 
and GLUT4. This suggested that internalisation of GLUT4 involves early endosomes and 
wortmannin treatment traps these proteins in this location. These latter studies are in contrast 
to results published by Kandror & Pilch (1998). Using rat adipocytes, Kandror & Pilch used 
sucrose velocity gradients in an attempt to separate GLUT4 compartments from endosomal 
systems containing transferrin receptors. However, transferrin-receptor containing 
compartments and GLUT4 vesicles were found to co-sediment in the sucrose velocity 
gradient system. Based on these in vitro data, Kandror and Pilch suggested that in unstimulated 
adipocytes, GLUT4 is inseparable from the recycling endosomal system and that insulin’s 
effects on GLUT4 trafficking is entirely accounted for by a proposed reduction of retention 
within this endosome system. To date however, the majority of research tends to support the 
hypothesis that the localisation of insulin-responsive GLUT4 vesicles in basal adipocytes is 
distinct from that of the recycling-endosomal pool. However, GLUT4 molecules traffic 
through this compartment upon insulin stimulation and subsequent internalisation from the 
PM. The recycling endosomal pool is also subject to regulation by insulin. Insulin can increase, 
by 2- to 4-fold, the cell surface levels of many recycling receptors including the transferrin 
receptor. Ablation studies in 3T3-L1 adipocytes have shown that GLUT1 and the transferrin 
receptor can be ablated to a similar extent (Livingstone et al., 1996). Hence, a hypothesis has 
been proposed whereby insulin promotes the exocytosis of proteins from the recycling 
endosomal pool, where GLUT1 and a proportion of GLUT4 is localised (Livingstone et al.,
1996), in addition to the exocytosis of GLUT4 from the specialised GSV compartment.
It is not clear whether the insulin-responsive GSV compartment may bud directly from the 
early/recycling endosomal compartment or whether GLUT4 may traffic back to the trans- 
Golgi network (TGN), with the subsequent budding of the storage compartment from this 
organelle. Evidence for the latter is derived from the observation that 13% of immunoreactive
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GLUT4 is found in the TGN in basal adipocytes (Slot et al., 1991). Additionally, confocal 
microscopy has shown that GLUT4 partially co-localises with y-adaptin, a subunit of the 
adaptor complex, AP-1 (Malide et al. 1997), found associated with clathrin-coated vesicles 
budding from the TGN (Hirst & Robinson, 1998). Moreover, Gillingham et al. (1999) have 
found that AP-1 can co-sediment with GLUT4 on glycerol density gradients, and can 
associate direcdy with immunoisolated GLUT4 vesicles. As only 10% of GLUT4 has been 
found to co-localise with TGN38 (a marker of the trans-Glogi network) (Martin et al., 1994), 
this pool probably does not represent the major steady-state localisation of intracellular 
GLUT4 pool within adipocytes. However, these data suggest that the GSV may be derived 
from the TGN. In cultured skeletal myotubes, GLUT4 has also been found associated with 
the TGN (Ralston & Ploug, 1996). GLUT4 is also targeted in atrial cardiomyocytes to the 
TGN and subsequently to atrial natriuretic factor (ANF) secretory granules, which only 
become GLUT4 positive in the TGN (Slot et al., 1997). Cyclohexamide treatment does not 
prevent colocalisation of GLUT4 with the ANF-containing secretory granules in the TGN. 
Therefore GLUT4 enters the ANF secretory granules at the TGN via the recycling pathway 
and not via the biosynthetic pathway. Whether the insulin-responsive GLUT4 storage pool is 
derived direcdy from both early/recycling endosomes and the TGN still requires further 
investigation.
The subcellular trafficking of GLUT4 is likely to require signalling motifs to regulate the 
internalisation of GLUT4 via clathrin-coated pits, sorting at the TGN and sorting and/or 
retention into the storage compartment. Indeed, by studying GLUT4/GLUT1 chimeric, 
truncated, or point-mutated transporters, two discrete motifs have been identified (reviewed 
by Rea & James, 1997). These motifs include an aromatic-based motif found in the GLUT4 
N-terminus (FQQI), and a di-leucine motif in the cytoplasmic C-terminus. Interestingly, 
vpl65 (which is also found in GLUT4 vesicles; Keller et al. 1995), contains two di-leucine 
motifs and several acidic regions in its N-terminus cytoplasmic domain, similar to those which 
occur in the extreme GLUT4 C-terminus. Furthermore, the introduction of a glutathione S- 
fusion protein containing the cytosolic portion of vpl65. results in GLUT4 translocation to 
the PM in basal 3T3-L1 adipocytes (Waters et al., 1997). This suggests that the N-terminus of 
vpl65 interacts with a retention/sorting protein that also regulates the distribution of GLUT4. 
However, current evidence suggests that neither the di-leucine and FQQI motifs of GLUT4 
are entirely sufficient for targeting GLUT4 to the GSV compartment and other targeting 
signals remain to be identified (Haney et al., 1995; Melvin et al., 1999).
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1.4 GLUT4 vesicle fusion with the plasma membrane
By 1993, the JV-ethylmaleimide-sensitive factor (NSF) protein and soluble NSF attachment 
proteins (SNAPs) were shown to be essential components for various intracellular membrane 
fusion events. The discovery of SNAP receptors (SNAREs) by Sollner et al. (1993) led to the 
SNARE hypothesis for vesicle targeting and fusion. The SNARE hypothesis suggested that 
SNAP receptors are contained on both donor/vesicular membranes (v-SNAREs) and on 
target membranes (t-SNAREs). The SNARE hypothesis suggested that selective v- and t- 
SNARE interactions leads to membrane fusion mediated by the binding of NSF and SNAPs 
to the SNAREs.
Recently it has been suggested that SNAREs be reclassified as R-SNAREs or Q-SNAREs 
based on structural data which suggests that SNAREs either contribute an arginine (R- 
SNARE) or glutamine (Q-SNARE) to the SNARE complex (Fasshauer et al., 1998). In the 
neuron, Sollner et al. (1993) identified the v-SNARE on synaptic vesicles as the vesicle 
associated membrane protein-2 (VAMP2), and t-SNARES on target membranes, now 
identified as SNAP25 and syntaxinla. The SNARE hypothesis, also predicted that a family of 
v- and t-SNAREs should exist to account for targeting of vesicles to their correct location 
within a cell, and that particular v- and t-SNAREs would be localised to particular membranes. 
Whilst structural homologues of SNAP25, syntaxin and VAMP have been identified, it is still 
not yet known whether every transport step involves a set of three proteins that functionally 
correspond to the synaptic VAMP2, syntaxinla and SNAP25. Furthermore, whilst NSF and 
a-SNAP appear to be necessary for synaptic fusion, the point at which NSF and a-SNAP act 
in this fusion process remains to be clearly defined. The original SNARE hypothesis suggested 
that NSF and a-SNAP assemble onto the docked SNARE complex and lead to 
rearrangements of protein-protein interactions to allow membrane fusion. However more 
recent data suggests that NSF and a-SNAP may also be required for priming of SNARE 
docking and SNARE-complex dissociation (reviewed by Hay & Scheller, 1997).
The discovery in 1992 by Cain et al. (1992) that GLUT4 vesicles from rat adipocytes contained 
VAMPs suggested that the genesis and/or the exocytosis of GLUT4 vesicles might be similar 
to that found for synaptic vesicles. In 3T3-L1 adipocytes, the v-SNAREs VAMP2 and the 
endosomal protein cellubrevin/VAMP3 were found to be associated with GLUT4 vesicles 
and showed a redistribution from the LDM fraction to the PM upon insulin treatment
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(Volchuk et al, 1995). However, antibodies to VAMP3 immunoprecipitated vesicles 
containing GLUT4 but not VAMP2. This suggests that VAMP2 and VAMP3, may be present 
in different subsets of GLUT4 containing vesicles. The differences in VAMP2 and VAMP3 
localisation in adipocytes and their role in targeting of GLUT4 to the PM has been further 
studied by Martin et al (1998). In this study by Martin and colleagues, 3T3-L1 adipocytes were 
permeabilised using streptolysin—O, and GST-fusion proteins encompassing the cytoplasmic 
tails of VAMP 1, VAMP2 and VAMP3 were then introduced into the permeabilised cells. Out 
of the three GST-fusion proteins tested, only the VAMP2 fusion protein inhibited insulin- 
stimulated GLUT4 translocation (35% inhibition). Interestingly, the GST-VAMP2 fusion 
protein had no effect on insulin-stimulated GLUT1 translocation. Additionally, ablation of the 
recycling endosomal system using a transferrin-horseradish peroxidase conjugate with 
hydrogen peroxide and DAB (Livingstone et al, 1996), inhibited insulin-stimulated GLUT1 
trafficking but had no effect on insulin-stimulated GLUT4 translocation to the PM (Martin et 
al, 1998). Overall, the experiments indicated that VAMP2 plays a part in regulating insulin- 
stimulated GLUT4 vesicle translocation to the PM, whilst VAMP3 is more likely to be 
involved in a constitutive GLUT4 trafficking pathway. Furthermore, the ablation studies and 
the use of the GST-v-SNARE fusion proteins substantiated the idea that GLUT1 and GLUT4 
undergo insulin-stimulated translocation to the PM from different intracellular compartments.
The SNARE hypothesis suggests that fusion between vesicles and target membranes involves 
both v-SNAREs such as VAMP2 and t-SNAREs. Since VAMP2 appears to play a role in 
GLUT4 trafficking to the PM in adipocytes, it was not unexpected to find t-SNAREs in the 
PM. Indeed, antisera against t-SNAREs in rat adipocyte plasma membranes identified 
syntaxins 2 and 4 as the predominant t-SNAREs, with a small amount of syntaxin3 (Timmers 
et al, 1996). To determine which of the adipocyte PM t-SNAREs might interact with GLUT4 
vesicles and the corresponding v-SNAREs, solubilised membranes from low density 
microsomes or immunoisolated GLUT4 vesicles were added to solubilised plasma membranes 
in the presence of myc-epitope-tagged NSF and recombinant a-SNAP. Immunopecipitation 
of the myc-epitope using anti-myc antibodies and analysis of bound proteins showed that NSF 
complexes contained VAMPs 2 and 3 and syntaxin4, but not syntaxins 2 or 3. Furthermore, a
4- to 6-fold increase in v- and t-SNARE complex formation was observed when membranes 
were generated from insulin-stimulated cells, indicating that insulin can regulate SNARE 
complex formation. Whilst the latter study by Timmers et al (1996) showed that syntaxin4, 
and VAMP 2/3 from GLUT4 vesicles can form a complex, the data did not indicate whether
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syntaxin4 was necessary for GLUT4 vesicle fusion with the PM. The question of whether 
syntaxin4 is involved in GLUT4 vesicle fusion with the PM was further assessed by two 
subsequent studies. The first study used microinjection of a syntaxin4 peptide into 3T3-L1 
adipocytes (Macaulay et al, 1997), which resulted in a 40% inhibition of insulin-stimulated 
GLUT4 translocation. Microinjection of a VAMP2 peptide inhibited insulin-stimulated 
GLUT4 translocation by 54%, whereas a syntaxinlc peptide had no effect. These data 
suggested that syntaxin4 and VAMP2 are important for GLUT4 trafficking. In a second study, 
a recombinant GST-fusion protein encoding the cytoplasmic tail of syntaxin4 (Cheatham et al.,
1996), was added to streptolysin O permeabilised 3T3-L1 adipocytes, and was found to inhibit 
insulin-stimulated GLUT4 translocation.
Data therefore suggests that both VAMP2 and syntaxin4 are necessary for GLUT4 vesicle 
fusion with the PM, and that VAMP2 and syntaxin4 can bind to each other to form a stable 
complex (Timmers et al., 1996). More recently, Rea et al. (1998) have shown that 
syndet/SNAP23 (a murine homologue of SNAP25) from 3T3-L1 adipocytes can form a SDS- 
resistant SNARE complex with VAMP2 and syntaxin4. Additionally, microinjection of anti- 
syndet peptides into 3T3-L1 adipocytes inhibited insulin-stimulated GLUT4 translocation by 
40% (Rea et al., 1998). These results therefore suggest that the t-SNAREs necessary for 
GLUT4 vesicle fusion include both syndet and syntaxin4.
Whilst it is likely that VAMP2/syndet/syntaxin4 complexes are important for GLUT4 vesicle 
fusion with the PM, further proteins involved in this complex may provide the acute insulin- 
regulation of GLUT4 vesicle translocation and fusion with membranes. For instance, the 
homologues of the yeast Seel-like family, namely Munc-18 proteins, have been identified in 
3T3-L1 adipocytes (Tellam et al., 1995). In particular, Munc-18c was shown to bind to 
syntaxin4 in 3T3-L1 adipocytes and prevent VAMP2/syntaxin4 interactions (Tellam et al.,
1997). It has been subsequently shown that adenovirus mediated overexpression of Munc-18c 
in 3T3-L1 adipocytes inhibited insulin-stimulated glucose transport by 50% (Tamori et al,
1998). A role for Munc-18 isoforms in regulating SNARE complexes is further implied by the 
observations that Munc-18a binding to syntaxinla is inhibited by protein kinase C 
phosphorylation of Munc 18a (Fujita et al., 1996), and that the DOC2 protein regulates the 
formation of Munc-18a-syntaxinl complexes by binding to the Munc protein (Verhage et al,
1997). Furthermore, recent studies have shown that a protein called synip can bind to 
syntaxin4 (Min et al, 1999). The synip/syntaxin4 complex was found to dissociate in insulin-
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stimulated adipocytes. In addition, the C-terminus of synip can bind to syntaxin4 and inhibit 
insulin-stimulated GLUT4 translocation. Evidence for the masking of SNAREs by regulatory 
proteins is further provided by the observations that in yeast, the Rab-like GTPase Yptlp 
transiently interacts with the t-SNARE Sed5p, displacing the Munc-18 homologue Sly-1 
(Lupashin & Waters, 1997). This also suggests that small GTP binding-proteins may be 
involved in SNARE complex formation (section 1.14).
The current view now emerging is that the targeting of vesicles to the correct membrane 
destination involves more than just SNAREs (reviewed by Pfeffer, 1999). Briefly, vesicle 
targeting is thought to require molecular motors and the actin and/or microtubule-based 
cytoskeleton to bring a vesicle from one part of the cell to another. ‘Tethering/docking’ 
proteins collect and restrain vesicles at or near their cognate target membranes. Finally, the 
SNAREs can bring vesicle membranes in close apposition with their cognate target 
membranes, thereby driving membrane fusion. Each of these processes may be subject to 
regulation by other proteins which enhance the degree of specificity to the membrane 
trafficking processes. Using models of synaptic vesicle fusion with the PM, and including 
vesicle and target SNAREs in adipocytes, a model for GLUT4 vesicle fusion with the PM can 
be postulated (figure 3).
Legend for figure 3. (A) GLUT4 vesicles may bud from the insulin-responsive GLUT4 
storage pool. This process of budding may require the activation of small molecular weight 
GTP-binding proteins such as Rab4 (cyan) {section 1.14). The budding to form vesicles that can 
fuse with the PM is likely to be subject to regulation by insulin, via activation/inhibition of 
signalling intermediates such as phosphatidylinositol 3-kinase (section 1.9). The vesicles thus 
formed are likely to contain the SNARE protein VAMP2 that gives a degree of selectivity to 
the fusion process. (B) The movement of ‘fusion competent’ GLUT4 vesicles to the PM is 
likely to require the cytoskeleton. Unidentified proteins are likely to regulate the ‘loose 
tethering’ of the GTUT4 vesicles with the PM. Insulin regulation of proteins such as synip 
(not shown) and Munc-18c allows SNAREs to form complexes. SNARE complexes involve a 
complex of four a-helices provided by the syntaxin4, VAMP2 and syndet (which provides 
two a-helices). (C) SNARE complex formation and possibly the involvement of a- 
SNAP/NSF and/or a GTP-binding protein might drive membrane fusion. Membrane fusion 
exposes GLUT4 on the cell surface allowing increased glucose uptake into the cell, a- 
SNAP/NSF may then participate in separating SNAREs to allow recycling of the SNARE 
proteins.
Key: Undefined accessory proteins are unlabelled, GDP-dissociation inhibitor (GDI), GDI 
dissociation factor (GDF), guanidine nucleotide exchange factor (GEF), guanosine 
ttisphosphate (GTP), guanosine diphosphate (GTP).
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Figure 3. Model of GLUT4 vesicle fusion with the plasma membrane.
See previous page for figure legend (figure adapted from Gonzalez & Scheller, 1999).
17
PART B - Insulin signalling
The binding of insulin to plasma membrane insulin receptors represents the initial signalling 
event which ultimately leads to translocation of GLUT4 vesicles to the plasma membrane. 
Intracellular signalling events downstream of the insulin receptor which are linked to GLUT4 
trafficking have been intensely researched for over a decade. It is the insulin-regulated 
signalling molecules and their roles in GLUT4 trafficking which constitutes the remaining text 
of the introduction.
1.5 The Insulin receptor
The insulin receptor is a heterotetrameric transmembrane glycoprotein composed of two 
extracellular a-subunits and two transmembrane P-subunits (White, 1997) (figure 4). The a- 
subunits contain the insulin-binding domains. The transmembrane p-subunits function as 
tyrosine-specific protein kinases which mediate both //mr-autophosphorylation between the 
P-subunits (Lee et al., 1993), and tyrosine phosphorylation of receptor substrates. a-Subunit 
crosslinking by insulin induces a conformational change in the intracellular P-subunits which 
leads to the activation of the kinase (Lemmon & Schlessinger, 1994).
Insulin receptor kinase activity is crucial for glucose uptake, since a site-directed point 
mutation in the ATP binding domain (lysine1018 to alanine) destroys receptor kinase activity, 
insulin-receptor substrate-1 (IRS-1) phosphorylation (sections 1.6.1 & 1.7) and 2-deoxyglucose 
(2-DOG) uptake (Chou et al., 1987; McClain et al., 1987).
18
a-Subunits












— Juxta membrane NPEY-Motif
—  ATP Bnding






Figure 4. Schematic structure of the insulin receptor, White (1997). De Meyts (1994) 
describes a model for a-subunit crosslinking by insulin. Each a-subunit contains two distinct 
insulin-binding domains, designated as site-la and site-2a, both of which can contribute 
independendy to insulin binding. The insulin molecule itself has two distinct receptor binding 
domains. It is hypothesised that a-subunit crosslinking is achieved by insulin binding to site- 
la  on one a-subunit, with the other binding site of the insulin molecule binding to site-2a on 
the other a-subunit. The transmembrane spanning region is postulated to be important for 
stabilising the insulin-induced conformational change, since a single mutation in the 
transmembrane spanning domain of the insulin receptor has been shown to increase both (3- 
subunit autophosphorylation and glucose transport (Longo et al., 1992). The importance of 
Tyr and Lys residues of the P-subunits for insulin signalling (indicated above) is discussed in 
the body of the text.
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A lack of (3-subunit kinase activity results in decreased receptor /ra»j-autophosphorylation. 
Insulin-induced tyrosine (Tyr) phosphorylation on the receptor P-subunits occurs on a well 
defined set of Tyr residues. These include Tyr%0 in the juxtamembrane region, residues Tyr1146, 
Tyrn50 and Tyr1151 in the P-subunit regulatory loop and residues Tyr1316 and Tyr1322 in the C- 
terminus (White & Kahn, 1994) (figure 4). The importance of these tyrosine residues in insulin 
signalling has been investigated by using various insulin receptor mutations. For example, the 
combined mutation of tyrosine residues 1146, 1150 and 1151 (the autophosphorylation sites) 
to phenylalanine results in an inactive receptor tyrosine kinase, which reduces both thymidine 
incorporation and 2-DOG uptake (Murakami & Rosen, 1991). However, Tyr to Phe 
mutations of residue 953, or both the C-terminal residues 1316 and 1322, does not effect 
either insulin-stimulated receptor P-subunit phosphorylation, thymidine incorporation, or 2- 
DOG uptake. Furthermore, a truncated insulin receptor (lacking the last 82 amino acids of the 
P-subunit C-terminus) exhibiting reduced autophosphorylation gave normal IRS-1 
phosphorylation and 2-DOG uptake (Yamamoto-Honda et al, 1993). Together these data 
suggests that autophosphorylation of the receptor within the kinase domain is required for 
normal insulin receptor kinase activity, and that kinase activity is necessary for 
phosphorylation of endogenous substrates. The aforementioned studies by Yamamoto-Honda 
et al (1993) indicate that it is the phosphorylation of endogenous substrates which correlates 
more closely with the biological effects of insulin, rather than the phosphorylation state of the 
insulin receptor itself.
Insulin receptor substrate binding is an important process for mediating the effects of insulin. 
Disruption of substrate targeting to the receptor has been shown to reduce insulin action. 
Substrate targeting to the insulin receptor is thought to be mediated in part via the 
phosphotyrosine binding (PTB) domains of substrates like She and IRS-1 which associate with 
Tyr960 in the juxtamembrane region of the receptor (3-subunit. Mutations of the insulin 
receptor at Tyr960 leads to the failure of receptor phosphorylation of IRS-1 and She (White et 
al, 1988; Kaburagi et al, 1993; Chen et al, 1995). Overexpression of IRS-1 with these mutant 
receptors rescues the insulin response, suggesting that the juxtamembrane region plays a role 
in sensitising substrate targeting (Chen et al, 1995).
The insulin receptor undergoes endocytosis following binding to insulin (Marshall et al, 1981). 
Studies by Kublaoui et al (1995) have shown that endosome associated insulin receptors 
exhibit increased autophosphorylation and exogenous substrate tyrosine kinase activity
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compared to PM associated receptors. It was therefore hypothesised that the endosome 
associated insulin receptor population is responsible for the activation of intracellular 
signalling pathways. However, incubation of both 3T3-L1 adipocytes and Chinese hamster 
ovary cells (transfected with the human insulin receptor) at 4°C, prevents insulin receptor 
internalisation, despite IRS-1 phosphorylation remaining comparable to cells incubated at 
37°C (Heller-Harrison et al, 1995). A dominant-interfering mutant of dynamin also inhibits 
receptor internalisation but is without effect on insulin-stimulated glucose (Ceresa et al, 1998). 
The effects of insulin are therefore not wholly dependent upon insulin receptor 
internalisation. This suggests that receptor substrates can associate with plasma membrane- 
located receptors. These data however do not rule out the possibility that internalised 
receptors can still phosphorylate substrates. Whilst IRS-1 is generally not found associated 
with either plasma membranes or the insulin receptor (Kelly & Rudeman, 1993), IRS-1 must 
be allowed access to the insulin receptor for IRS-1 phosphorylation to occur. Recent research 
suggests that IRS-1 may be associated with the membrane cytoskeleton in close proximity to 
the insulin receptor (Clark et al., 1998).
Endocytosis of the insulin receptor downregulates insulin signalling since insulin becomes 
dissociated from the receptor following fusion of the internalised receptor compartment with 
an acidic endosome. The insulin receptor is then free to recycle back to the plasma membrane. 
Additionally, downregulation of the insulin signal is achieved by dephosphorylation of 
receptor phosphotyrosine residues by phosphatases. At least two phosphatases are known to 
interact with the insulin receptor. These include the protein tyrosine phosphatase IB (PTP1B) 
(Seely et al, 1996), and the transmembrane leukocyte common antigen-related (LAR) protein 
tyrosine phosphatase (Ahmad & Goldstein, 1997). The interaction of phosphatases with the 
insulin receptor may also be of importance in cases of insulin resistance, since increased 
phosphatase expression may reduce the insulin receptor signal. In obese individuals, reduced 
insulin receptor kinase activity and increased expression of LAR have been observed (Ahmad 
et al., 1995). Conversely, antisense inhibition of LAR expression augments the insulin signal 
(Kulas et al., 1995), and reduces receptor dephosphorylation (Mooney et al., 1997).
Unlike the insulin receptor, most other receptor tyrosine kinases interact directly with Src- 
homology-2 (SH2) domain-containing signalling molecules (Pawson, 1995). It is the tyrosine 
phosphorylation of IRS proteins which allows the subsequent activation and/or localisation of
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SH2-containing signalling molecules such as phosphatidylinositol 3-kinase (PI 3-kinase) (section
1.9).
Overall then, the kinase activity of the insulin receptor (which is the initial event in insulin 
signalling) is crucial for mediating phosphorylation of substrates that mediate the plethora of 
effects of insulin.
1.6 Insulin receptor substrates
1.6.1 Insulin receptor substrate-1 (IRS-1)
The open reading frame for the IRS-1 gene, predicts that IRS-1 has a molecular weight of 131 
kDa and the potential for multiple phosphorylation on serine, threonine and tyrosine residues 
(White, 1997). IRS-1 analysis has shown that at least eight tyrosine residues undergo tyrosine 
phosphorylation by the activated insulin receptor, including tyrosine residues contained within 
motifs (YXXM and YMXM) which are predicted to bind to SH2 containing proteins (Sun et 
al., 1993). In addition to phosphorylation sites, IRS-1 also contains a pleckstrin homology 
(PH) domain (section 1.11) and a phosphotyrosine-binding (PTB) domain.
1.6.2 Insulin receptor substrate-2 (IRS-2)
Mice lacking IRS-1 (section 1.8) only exhibit mild insulin resistance. Therefore it was thought 
that another IRS-signalling protein might exist. The concept of another IRS signalling protein 
existing led to the cloning of IRS-2 (Sun et al., 1995). Amino acid sequence alignment between 
murine IRS-1 and IRS-2 revealed a highly conserved amino terminus containing PH and PTB 
domains (69% and 75% identical to IRS-1), with a less conserved C-terminus (35% identical 
to IRS-1). Like IRS-1, IRS-2 contains about 20 putative tyrosine phosphorylation motifs, nine 
of which are YXXM motifs and four that are YMXM motifs.
The homology between IRS-1 and IRS-2 at the amino terminus is likely to indicate a 
conserved mechanism whereby the substrates recognise the insulin receptor. Whilst the PTB 
domain appears to be important for recognition of the NPXY960 of the insulin receptor 
(Sawke-Verhelle et al., 1996), it is likely that more than one site on the insulin receptor is 
involved in receptor/substrate recognition. Indeed, deletion of the PH domain of IRS-1 
reduces the level of IRS-1 tyrosine phosphorylation and signal propagation (Myers et al., 1995). 
Thus, the PH domain possibly plays a role in coupling IRS-1 to the insulin receptor. However 
direct interactions between the PH domain of IRS-1 and the insulin receptor have not been
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observed (Voliovitch et al, 1995). It is therefore postulated that perhaps other domains within 
IRS or even other proteins are involved in the recognition between the insulin receptor and its 
substrates. Evidence for other proteins mediating interaction between IRS proteins and the 
insulin receptor is more recendy shown by Burks et al (1998). This study has indicated that 
IRS PH domains bind to acidic motifs in proteins. However, it was found that IRS-1 and IRS- 
2 PH domains bound acidic motifs of various proteins to different extents, indicating 
differences in selectivity between IRS-1 and IRS-2. Direct interactions between IRS-2 and the 
insulin receptor may occur through a region corresponding to residues 591 to 786 (the kinase 
regulatory loop binding (KRLB) domain) which binds the regulatory loop of the insulin 
receptor (Sawke-Verhelle et al, 1996). This interaction between IRS-2 and the insulin receptor 
requires all three tyrosine residues of the regulatory loop of the receptor to be phosphorylated. 
Since this KRLB domain is not present in IRS-1 this region may be important for receptor 
substrate discrimination.
1.6.3 Insulin receptor substrate-3 (IRS-3)
A 60 kDa protein (pp60) that binds to PI 3-kinase (via phosphotyrosine residues) following 
insulin stimulation was identified by Lavan & Lienhard (1993). The purification of pp60 and 
the cloning of its cDNA from a rat adipocyte cDNA library were subsequently described 
Lavan et al (1997). The sequence of pp60 revealed a polypeptide of 494 residues, and like IRS- 
1 and —2 it has an amino terminal PH domain (50% and 45% identical respectively), a PTB 
domain (48% and 53% identical respectively), followed by putative tyrosine phosphorylation 
sites (four with YXXM motifs). Thus based on its similarity to IRS-1 and —2, pp60 was 
designated as IRS-3. Immunoprecipitation of p85 (the regulatory subunit of PI 3-kinase) from 
rat adipocyte membrane fractions followed by immunoblotting with anti-phosphotyrosine 
revealed a 60 kDa band located predominantly in the PM (Kelly & Ruderman, 1993). It has 
subsequently been shown that IRS-3 is localised primarily to the PM (Anai et al, 1998). This is 
in contrast to IRS-1 and IRS-2 which tend to localise to intracellular membranes (Anai et al, 
1998; Inoue et al, 1998). The significance of the different localisation of IRS-1/2 compared to 
IRS-3 are not clear since IRS-1/2 also need to be in close proximity to plasma membrane 
insulin receptors to be phosphorylated. Anai and colleagues (1998) and Inoue et al (1998) do 
suggest however that differences in the subcellular compartments of IRS-1, -2 and-3 and their 
downstream utilisation can contribute to the diversity of the insulin response.
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1.6.4 Insulin receptor substrate-4 (IRS-4)
The IRS-4 sequence was obtained following purification of a 160 kDa protein using anti- 
phosphotyrosine immunoaffinity chromatography of lysates from human embryonic kidney 
(HEK) 293 cells (Lavan et al, 1997). Cloning revealed that like other IRS proteins, IRS-4 
contains both N-terminus PH and PTB domains (~ 40% identical to other IRS proteins), and 
12 potential tyrosine phosphorylation sites, 7 of which are in YXXM motifs. As with the other 
IRS proteins, IRS-4 was found to bind to both Grb2 and PI 3-kinase, but not Syp (Fantin et 
al., 1998). Like IRS-3, IRS-4 appears to be mainly plasma membrane associated in HEK cells 
and with no apparent re-distribution upon cell stimulation by insulin. Currendy, the mRNA 
for IRS-4 has been found in tissue culture cells but not in human tissues. Therefore it appears 
to be expressed only in certain specific cell types. IRS-1 and —2 and to a certain extent IRS-3 
appear to be expressed with more widespread tissue distributions.
1.6.5 She
Another protein phosphorylated by the insulin receptor is She. The she gene was originally 
identified by Pelicci et al. (1992) and was cloned because of its homology with SH2 containing 
gene sequences. The gene was also found to have stretches of homology to a glycine/proline- 
rich coding region of the a l  chain of the collagen gene, hence the gene was called she (derived 
from SH2 and collagen). Pelicci et al. (1992) also showed that the she gene codes for three 
proteins of about 46, 52 and 66 kDa, and are expressed in a wide range of mammalian cell 
lines. These authors also showed that She was tyrosine phosphorylated by the activated EGF 
receptor. Pronk et al. (1993) subsequently showed that the insulin receptor could 
phosphorylate both the 46 and 52 kDa She proteins. Like IRS-1, She is found to bind growth 
factor receptor-bound protein 2 (Grb2), which leads to activation of the mitogen activated 
protein kinase (MAPK) pathway.
1.6.6 Grb2-associated binder-1 (Gabl)
The ability of IRS proteins such as IRS-1 to bind to the SH2-domain containing protein Grb2 
is discussed later in relation to the activation of the mitogen activated protein kinase (MAPK) 
pathway (via Sos). Using a 32P-labelled Grb2-fusion protein to screen an expression cDNA 
library, Holgado-Madruga et al. (1996) isolated a protein termed Grb2-associated binder-1 
(Gabl) which shared homology and structural features to IRS-1. Gabl was found to contain 
an N-terminal PH domain, two SH3 binding domains and several tyrosine phosphorylation
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sites (Gabl contains no PTB domain). Like other IRS proteins, Gabl was found to be 
phosphorylated on tyrosine by both the epidermal growth factor (EGF) and insulin receptors, 
and to bind Syp, phospholipase C-y (PLC-y) and PI 3-kinase. Whilst Gabl binds many of the 
same molecules as the EGF receptor, Gabl is not membrane bound and could potentially 
target signalling molecules to specific intracellular sites.
1.7 Insulin signalling via IRS proteins
It is the tyrosine phosphorylation of insulin receptor substrates which allows SH2 containing 
proteins to bind to the receptor substrates. SH2-domain containing proteins that have thus far 
been found to bind to IRS-1 include the p21ras activator complex - Grb2/Sos (Skolnik et al.,
1993), the protein tyrosine phosphatase SHPTP2 (Syp)(Sun et al., 1993), the regulatory subunit 
of the serine/threonine/lipid kinase PI 3-kinase (Sun et al., 1991) (class IA regulatory subunits, 
section 1.9), the C-terminal Src kinase (Csk) (Tobe et al., 1996), the Src-like kinase Fyn (Sun et 
al., 1996) and the adaptor protein Nek (Lee et al., 1993). The binding of numerous signalling 
molecules extends the notion made by Sun et al. (1991), that IRS-1 acts as a multisite ‘docking 
protein’ to engage various downstream regulatory elements during insulin signal transmission.
Grb2 can bind to phosphotyrosine residues on both She and IRS-1. Upon insulin-stimulation, 
Grb2 is recruited to IRS proteins and activates the cellular proto-oncogene p21ras via Sos. 
Hence, p21ras can be activated by an IRS-1 dependent and independent pathway. Whilst 
activation of p21ras has been shown to activate the mitogen-activated protein kinase (MAPK) 
pathway, the activation of p21ras via IRS-1 warranted investigation to see if p21ras activation 
was necessary for GLUT4 translocation. Activated p21ras was shown to have no effect on 
insulin-stimulated GLUT4 translocation when microinjected into 3T3-L1 adipocytes (Haruta 
et al., 1995; Quon et al., 1995). Furthermore, a dominant-negative mutant Ras also failed to 
affect insulin-stimulated GLUT4 translocation, but blocked the MAPK cascade (Quon et al.,
1995). These data therefore indicate that Ras is not likely to be involved in insulin-stimulated 
GLUT4 translocation.
Amongst the IRS-1 binding proteins is the protein tyrosine phosphatase Syp (SHPTP2, 
PTP1D) (Sun et al., 1993). Microinjection of SH2 domains of Syp or anti-Syp antibodies into 
mammalian fibroblasts inhibits insulin-induced DNA synthesis (Xiao et al., 1994). These 
results indicate that Syp acts as a regulator of mitogenic signals. Similarly, microinjection of 
fusion proteins encoding the N- and C-terminal SH2 domains of Syp, or anti-Syp antibodies
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into 3T3-L1 adipocytes blocks insulin-induced DNA synthesis (including GLUT1 expression). 
However, translocation of GLUT4 to the cell surface is unaffected. These data therefore 
indicated that Syp appears to be necessary for mitogenic signals but not for the activation of 
the metabolic pathway leading to GLUT4 translocation (Hausdorff et al, 1995).
Figure 5 shows a simplified diagrammatic representation of the binding of various signalling 
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Figure 5. The role of IRS-1 as a multisite docking protein for SH2-domain containing 
proteins (Yenush & White, 1997). PI 3-kinase activation appears to be necessary for 
GLUT4 translocation (section 1.9), however the precise mechanism of this process is still 
largely unclear. PI 3-kinase is thought to regulate Akt (protein kinase B (PKB)), PKC£, and 
the 70 kDa ribosomal S6 kinase ^ O 561*). Whilst p70s6 kinase does not appear to be involved in 
GLUT4 translocation (Fingar et al, 1993), roles for PKB and PKC£ in the regulation of 
GLUT4 translocation are implicated, and discussed later (sections 1.12 & /. 13 respectively).
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1.8 The role of insulin receptor substrates in GLUT4 trafficking
As will become apparent (section 1.9), PI 3-kinase activity appears to be necessary for insulin- 
stimulated GLUT4 translocation to the plasma membrane. Receptor substrates IRS-1, -2 and - 
3 have all been shown to bind PI 3-kinase but a definitive role of these insulin receptor 
substrates in insulin-stimulated GLUT4 translocation remains unclear. For example, 
microinjection of a fusion protein containing amino acid residues 108-516 of IRS-1 (residues 
important for IRS-1 binding to the insulin receptor) had no effect on GLUT4 translocation 
but inhibited membrane ruffling and mitogenesis (Morris et al 1996). Microinjection of IRS-1 
antibodies and tyrosine phosphorylated peptides corresponding to the NPXY960 motif of the 
insulin receptor (section 1.5) produced similar results. Together, these data suggested that IRS-1 
is not an essential component for insulin-stimulated GLUT4 translocation. Disruption of IRS- 
1 binding to the insulin receptor was also investigated by Sharma et al. (1997) who 
overexpressed IRS-1 protein domains in 3T3-L1 adipocytes. The overexpression of these IRS- 
1 protein domains resulted in a reduced IRS-1 phosphorylation, IRS-1 associated PI 3-kinase 
activity and insulin-stimulated mitogenesis, but had no effect on PKB activation (section 1.12) 
or GLUT4 translocation and glucose transport.
IRS-1 null mice have been generated by inserting a neomycin phosphotransferase gene (neo) 
cassette into the first exon of the IRS-1 gene (Tamemoto et al., 1994; Araki et al, 1994). The 
IRS-1 null mice show intra-uterine and postnatal growth retardation but only a mild degree of 
peripheral insulin resistance is observed. This indicates that there are IRS-1-independent 
signalling pathways. The IRS-1-independent pathways were postulated to occur via alternative 
substrates to IRS-1, since phosphotyrosine immunoprecipitates still show a significant insulin- 
induced phoshotyrosyl-associated PI 3-kinase activity. Furthermore, Araki et al (1994) 
observed the phosphorylation of IRS-2 in IRS-1 null mice which suggested that IRS-2 may act 
as an alternative substrate to IRS-1. Studies in NIDDM patients observe a 70% decrease in 
IRS-1 expression in NIDDM patients, with IRS-2 becoming the main docking protein for PI 
3-kinase (Rondinone et al, 1997). However, a more recent study using IRS-1 null mice showed 
that IRS-1 deficiency leads to only a 50% reduction in glucose transport, and that IRS-3 is the 
major tyrosine phosphorylated protein associated with PI 3-kinase in fat tissue (Kaburagi et al, 
1997). Tyrosine phosphorylation of IRS-2 and association with PI 3-kinase in the adipose 
tissue was almost undetectable. The latter authors therefore suggested that IRS-3 plays a major 
role in insulin-induced glucose uptake in the absence of IRS-1.
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The aforementioned studies suggest that the ability to retain insulin-sensitivity for glucose 
uptake may be mediated by alternative substrates such as IRS-2 and IRS-3. Whilst disruption 
of IRS-1 gene expression leads to only to a 50% reduction in glucose uptake, IRS-2 null mice 
show a progressive decline in glucose homeostasis (Withers et al., 1998). The eventual 
hyperglycaemia is due to insulin resistance in both the liver and skeletal muscle, which is not 
compensated for by the P-cells of the pancreas (Withers et al., 1998). Withers et al. (1998) 
therefore suggests that IRS-2 is more important for insulin-stimulated metabolic events such 
as glucose uptake, whilst other studies indicate IRS-1 is more important for mitogenic effects. 
Bruning et al. (1997) have shown that in IRS-1-deficient fibroblasts (derived from IRS-1 null 
mice), overexpression of IRS-2 cannot compensate for the lack of mitogenic responses (cell 
cycle progression) but can reconstitute immediate-early gene expression (c-fos and erg-1). It is 
therefore suggested that IRS-1 and IRS-2 are not functionally interchangeable signalling 
intermediates for stimulation of mitogenesis, but may mediate some common functions. 
Hence, whilst IRS-2 deficiency appears to be most important for glucose transport and IRS-1 
in mitogenic responses, the role in metabolic signalling served by IRS-2 may, in part also be 
provided by alternative substrates such as IRS-1. The roles of IRS-3 and IRS-4 in insulin and 
growth factor signalling still remain to be determined.
1.9 Phosphatidylinositol 3-kinases
Phosphatidylinositol 3-kinases (PI 3-kinases) represent a family of kinases capable of 
phosphorylating phosphatidylinositides at the D-3 position of the inositol ring. Hence 
phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PI(4)P) and phosphatidylinositol 
4,5-bisphosphate (PIP2) are converted to phosphatidylinositol 3-phosphate (PI(3)P), 
phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) and phosphatidylinositol 3,4,5-P3 (PIP3) 
respectively. The family of PI 3-kinases all share significant homology within the catalytic 
domain but can be divided into three main classes based upon their in vitro lipid substrate 















Figure 6. Schematic representation of the domain structure of the various classes of PI 
3-kinase catalytic subunits (Shepherd et al.> 1998). Class I PI 3-kinases form 
heterodimeric complexes which consist of an adaptor/regulatory subunit tightly associated 
with the catalytic subunit. Depending upon the associated adaptor subunit, the class I PI 3- 
kinases are further subdivided into two subclasses (A and B). Class IA PI 3-kinases are 110-130 
kDa proteins that interact with adaptor subunits containing SH2 domains (linking class IA PI 
3-kinases to tyrosine kinase signalling pathways). Three highly homologous mammalian 
isoforms of the class IA catalytic subunits have been cloned, and designated as pi 10a, pll0(3 
and pi 105. All contain the kinase domain at the C-terminus with adaptor-binding and Ras- 
binding domains towards the N-terminus. There is a phosphatidylinositide kinase (PIK) 
homology domain that is also found in phosphatidylinositide 4-kinases, but yet no role has 
been assigned to this domain. Class IB PI 3-kinase catalytic subunits are similar in structure to 
class IA PI 3-kinase catalytic subunits, but they lack the p85 binding domain and associate with 
a distinct family of adaptor subunits. The activity of class IB PI 3-kinases are therefore 
regulated by (3y subunits of heterotrimeric G-proteins, although there is no current evidence 
to suggest that class IB PI 3-kinases can be activated by insulin.
Further complexity is added by the occurrence of several splice variants of the class IA PI 3- 
kinase adaptor subunits (reviewed by Shepherd et a l, 1998). Briefly, the class IA PI 3-kinase 
adaptor subunits contain two SH2 domains and an inter-SH2 pi 10-binding domain. One 
adaptor gene generates five adaptor subunits termed as p85a, p55a/AS53, p50a and the 
splice variants of p85a and p55a termed p85a, and p55a; (an 8 amino acids insertion into the 
inter-SH2 domain). The p85a subunit contains an SH3 domain, a Bcr/Rac GTPase-activating 
protein (GAP) homology (BH) domain, as well as two proline-rich regions (PI and P2) N- 
terminal to the SH2 domains. The p55a and p50a subunits are truncated versions of p85a 
and lack the SH3, BH and PI domains. The second adaptor subunit gene generates p85P that 
differs only slightly in molecular mass to the p85a subunit. The third PI 3-kinase adaptor
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differs only slighdy in molecular mass to the p85a subunit. The third PI 3-kinase adaptor 
subunit gene product generates a 55 kDa protein, designated as p55y, which is highly 
homologous in sequence and has an identical domain structure to the p55a splice variant of 
p85a.
It is unlikely that class II PI 3-kinases are involved in insulin-stimulated GLUT4-vesicle 
translocation to the plasma membrane, for two reasons. Firstly, class II PI 3-kinases are 
unable to use PIP2 as a substrate (Domin et al., 1996; Virbasius et al., 1996), but insulin 
activates PI 3-kinase in rat adipocytes (Kelly et al., 1992) causing a rapid increase in PIP3 (also 
PI(3,4)P2). Secondly, class II PI 3-kinases are relatively resistant to the PI 3-kinase inhibitor 
wortmannin (Domin et al., 1996; Virbasius et al., 1996) at concentrations that inhibits insulin- 
stimulated GLUT4 translocation to plasma membranes (Okada et al., 1994; Clarke et al., 1994). 
PI(3,4)P2 and PIP3 production, which are thought to be necessary for further downstream 
signalling of PI 3-kinase, also rules out class III PI 3-kinases as being involved in insulin- 
stimulated GLUT4 trafficking, since class III PI 3-kinases are found to only use PI as a 
substrate. Whilst class II and III PI 3-kinases do not appear to be involved in insulin- 
stimulated GLUT4 trafficking, there is compelling evidence to suggest an involvement of class 
IA PI 3-kinases (discussed below). Class III PI 3-kinases are homologous to Vps34p, the only 
PI 3-kinase present in yeast. Vps34p is important in yeast for trafficking of newly formed 
proteins from the Golgi to the vacuole (Rameh & Cantley, 1999), and the PI(3)P lipid product 
is hypothesised to regulate membrane trafficking and vesicle morphogenesis. It is possible that 
the lipid products of class IA enzymes perform a similar role in membrane trafficking events in 
mammalian cells.
The PI 3-kinase inhibitor, wortmannin, has been shown to block glucose uptake and GLUT4 
translocation in both rat adipocytes and 3T3-L1 adipocytes (Okada et al., 1994; Clarke et al.,
1994). Furthermore, Hara et al. (1994) developed a p85 mutant which lacked the binding site 
for the catalytic pi 10 subunit. When expressed in CHO cells overexpressing the insulin 
receptor, these constructs led to attenuation in glucose transport, but not in p21ras activation. 
More recently introduction of the dominant negative p85a construct to 3T3-L1 adipocytes 
was shown to reduce PI 3-kinase activity, glucose transport and GLUT4 translocation 
(Katagiri et al, 1997). Together these results suggest that PI 3-kinase is important for insulin- 
stimulated GLUT4 translocation to the plasma membrane, and that a class IA PI 3-kinase
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would appear to be the most likely isoform necessary for insulin-stimulated GLUT4 
translocation.
Although PI 3-kinase activity is necessary for insulin-stimulated GLUT4 translocation to the 
plasma membrane, it is controversial as to whether the PI 3-kinase activity alone is sufficient 
to stimulate GLUT4 translocation. Evidence suggesting that endogenous PI 3-kinase activity 
alone is not sufficient for GLUT4 translocation is derived from two studies. Wiese et al. (1995) 
have shown that PDGF treatment of 3T3-L1 cells can activate PI 3-kinase activity to an extent 
that is comparable to insulin stimulation but does not produce a corresponding increase in 
glucose transport. Moreover, Herbst et al. (1994) introduced phosphopeptides corresponding 
to the sites of PI 3-kinase binding to IRS-1 into permeabilised 3T3-L1 adipocytes. The 
phosphopeptides activated PI 3-kinase to a similar extent as insulin stimulation without the 
normal increase in glucose transport.
Three groups have expressed constitutively active forms of pi 10 in 3T3-L1 adipocytes (Martin 
et al!, 1996a; Katagiri et al., 1996; Tanti et a l 1996). In each case, the extent of GLUT4 
translocation to plasma membranes in cells expressing the constitutively active kinase was 
comparable to that occuring in cells stimulated by insulin. This contradictory result may be 
explained by the idea that PI 3-kinase should be targeted to a particular membrane 
compartment to stimulate GLUT4 translocation. This may not have been achieved by cell 
stimulation with either PDGF or phosphopeptides, however constitutively active over­
expression of PI 3-kinase is likely to saturate any membranes with kinase activity and its lipid 
products. The idea of localisation of PI 3-kinase to a particular membrane compartment is 
discussed in section 1.10.
1.10 Localisation of IRS proteins and PI 3-kinase
Kelly & Rudeman (1993) have shown that in rat adipocytes the majority of the insulin- 
stimulated PI 3-kinase activity was localised to an intracellular LDM fraction, associated with 
tyrosine-phosphorylated IRS-1. A similar study by Yang et al. (1996) in 3T3-L1 adipocytes 
showed a similar subcellular distribution of insulin-activated PI 3-kinase activity. An increase 
in insulin-stimulated PI 3-kinase activity in the LDM fraction is also supported by the data of 
Kublaoui et al. (1995) and Inoue et al. (1998). However, analysis of the LDM fraction from 
3T3-L1 adipocytes by hypertonic sucrose gradients, has suggested that IRS-1 and PI 3-kinase 
are not associated with an internal membrane structure or with GLUT4 vesicles (Clark et al.,
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1998). Although PI 3-kinase-associated IRS-1 did not appear to be bound to any internal 
membrane, the signalling complex was found to be associated with fractions enriched in 
elements proposed to resemble cytoskeletal filaments (Clark et al., 1998). One additional study 
to address the precise location of PI 3-kinase suggested that a small proportion of the 
adipocyte PI 3-kinase activity could associate with GLUT4 vesicles (Heller-Harrison et al.,
1996). However, unpublished data from our lab, suggests that this is less than 1% of the total 
insulin-stimulated PI 3-kinase activity in 3T3-L1 adipocytes. Furthermore, targeting of PI 3- 
kinase to GLUT4 vesicles by fusing the inter-SH2 domain of the p85a adaptor subunit to the 
N- and C-terminal cytoplasmic regions of GLUT4 failed to alter insulin-stimulated GLUT4 
translocation, despite 11-13-fold increases in PI 3-kinase activity on the GLUT4 vesicles 
(Frevert et al., 1998).
Whilst the majority of studies looked at PI 3-kinase activity associated with IRS-1 it may be 
more relevant to look at IRS-2 cell distribution and association with PI 3-kinase (section 1.8). 
IRS-2 compartmentalisation in 3T3-L1 adipocytes was studied by Inoue et al. (1998). Whilst 
IRS-1 was found to be mainly concentrated in a LDM fraction, IRS-2 was found to be mainly 
cytosolic. Upon insulin stimulation, IRS-2 was found to associate with the LDM fraction and 
with PI 3-kinase. The differences between IRS-1 and IRS-2 are potentially very important, and 
more work is required to define which IRS protein is important for insulin-stimulated GLUT4 
translocation, and where the relevant PI 3-kinase activity resides.
1.11 Phosphatidylinositide-binding proteins
PI 3-kinase appears to be necessary for GLUT4 translocation, however the subsequent 
signalling events downstream of PI 3-kinase leading to GLUT4 translocation remain largely 
unclear. The most likely route for the generation of subsequent signalling processes is via the 
lipid products formed by the activated PI 3-kinase. Evidence for PI 3-kinase lipid products as 
mediators of signalling processes is provided by the observation that the transient production 
of PI(3,4)P2 and PIP3 in many cell types tends to correlate with the transient activation of 
downstream signalling processes. Further evidence for D-3-phosphatidylinositide signalling is 
shown by the ability of phosphatidylinositides to interact with signalling molecules. The PI 3- 
kinase lipid products can either act as an allosteric effector of the phosphatidylinositide- 
binding protein e.g. protein kinase C (PKC) (see below), change the conformation of 
phosphatidylinositide-binding proteins thereby revealing sites for phosphorylation e.g. PKB
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(section 1.12), or regulate co-localisation with other phosphatidylinositide-binding proteins to 
form specific signalling complexes at membranes e.g. PKB and PDK1 (section 1.12).
The atypical PKC (aPKC) isoform PKC^ (which is not activated by either phorbol esters or 
diacylglycerol) was shown to be activated by 0.1 |_lM PIP3 (Nakanishi et al., 1993), but not by 
PIP2 (only 11% of the PIP3 response). PI(3,4)P2 was only half as effective as PIP3 in 
stimulating PKC^, and no significant effects of any lipid were seen on conventional PKC 
(cPKC) isoforms (a, (3, and y)(Nakanishi et al., 1993). These results suggested that PKC^ 
might be a target for PIP3 and thus downstream of PI 3-kinase. Other isoforms additional to 
PKC£, have also been shown to be activated by PIP3 (Palmer et al, 1995). In this study by 
Palmer et al., the novel PKC (nPKC) isoforms PKCr| and PKCs were activated to the same 
extent by both PIP3 and PIP2. aPKC isoforms, such as PKC^, may therefore be potential 
targets for downstream signalling of PI 3-kinase, and their role in insulin stimulated GLUT4 
translocation is discussed (section 1.13). The study by Palmer et al. emphasises an important 
point: to study a pathway that utilises PI 3-kinase, the downstream lipid-binding proteins need 
to be shown to have specificity for either PI(3,4)P2 and/or PIP3 relative to PIP2.
The PIP3 binding of PKC^ is unknown. Various PIP3 binding proteins are found to contain a 
PIP3 binding domain that has homology to pleckstrin (termed the PH domain; Tyers et al., 
1988). The PH domain consists of approximately 120 amino acids and was originally identified 
as an internal repeat present at the amino and C-termini of pleckstrin (the major substrate for 
PKC in platelets). Proteins that are found to contain PH domains include amongst others the 
serine/threonine kinase PKB (section 1.12), dynamin, and regulators of small molecular weight 
G-proteins (GEFs and GAPs; section 1.14). Despite a low similarity in sequence, the PH 
domains all share a similar core structure. This core structure consists of an antiparallel 13- 
sheet of seven strands and a C-terminal amphiphilic a-helix (Harlan et al., 1995). The (3- 
strands form a cleft around a region of positive potential (provided by conserved lysine 
residues) which is critical for interaction with the negatively charged headgroup of 
phospholipids (Harlan et al., 1995).
Early studies examined the interaction between PH domains and PIP2, however a subsequent 
study by Rameh et al. (1997) studied the interaction of PH domains with the products of PI 3- 
kinase activity. Rameh and colleagues compared the PH domains from six different proteins,
33
including Bruton’s tyrosine kinase (Btk), the ammo-terminal PH domain of T lymphoma 
invasion and metastasis protein (Tiam-1), Son-of-sevenless (Sos), (3-adrenergic receptor kinase 
(Park), oxysterol binding protein (OSBP) and P-spectrin. The relative affinities of PIP2, 
PI(3,4)P2 and PIP3 for the various protein PH domains were determined by displacement of 
radiolabelled-C8-PI(3,4)P2 and —PIP3 bound to PH domains using unlabelled lipids. These 
binding studies demonstrated that the PH domain of Btk bound PIP3 with a higher affinity 
(Kd < 1 pM) than to PIP2 (Kd = 8 pM), PI(3,4)P2 or inositol 1,3,4,5-tetrakisphosphate 
(Ins(l,3,4,5)P4). Similar results were also obtained for Sos, Tiam-1 and Park, although these 
proteins showed less selectivity for PIP3 than the Btk PH domain. The PH domains of P- 
spectrin and OSBP bound PIP2 and PIP3 with similar affinities and with greater affinity that 
PI(3,4)P2. The PH domain of dynamin, the C-terminal PH domain of Tiam-1 and the 
phosphotyrosine binding (PTB) domain of IRS-1 (which has similarities to a PH domain) 
were found to bind the phosphatidylinositides poorly (Rameh et al., 1997). A general 
hypothesis was therefore proposed for determining the phosphatidylinositide binding affinity 
of a PH domain. In general those PH domains with clusters of basic residues in the P1-P2 
region (of the PH domain) tend to have higher affinity for PIP3 compared to PI(3,4)P2 (Btk, 
Tiam-1 N-terminal have 8 and 11 residues respectively). The PH domains with less than 5 
basic residues in the pi-p2 loop tend to have a low affinity for PIP3. Hence, the results from 
Rameh et al. (1997) indicate that distinct PH domains might have evolved selectively for 
different phosphatidylinositides to provide discriminatory regulation.
The idea that PH domains might have evolved to provide discriminatory regulation is taken 
further by a more recent study by Kavran et al. (1998). Kavran et al. used a ‘dot blot’ approach 
to screen PH domain-containing proteins for specificity to particular phosphatidylinositides. 
The dot blot analysis used phosphatidylinositides spotted onto nitrocellulose that were 
subsequendy incubated with 32P-labelled GST-PH domain fusion proteins. The results of the 
dot blot analysis revealed a classification of PH-domain containing proteins that was similar to 
that obtained by Rameh et al. (1997). In the more recent classification by Kavran et al. (1998) 
the PH domain containing proteins were divided into three groups. These groups of proteins 
consist of proteins that specifically bind PIP3 relative to other phosphatidylinositides, proteins 
which bind PI(3,4)P2 and PIP3 with a higher affinity to PIP2 and finally proteins that have no 
particular specificity for a phosphatidylinositide relative to PIP2. The dot blot screening by 
Kavran et al. (1998) also revealed that of the 10 PH domain containing proteins analysed, only 
two proteins (Grpl (see below and section 1.14.2) and phospholipase C-5t) showed clear
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specificity for a single phosphatidylinositide. It was therefore suggested that many PH 
domain-containing proteins are likely to be regulated in vivo by the most abundant 
phosphatidylinositide to which they bind. Hence, Kavran et al. (1998) suggested that highly 
specific phosphatidylinositide binding may be a characteristic of relatively few proteins.
As indicated previously in consideration of PKC^, not all proteins that bind PIP3 contain a 
PH domain. Proteins which bind PIP3 (in vitro) and which do not contain a PH domain 
include the adaptor proteins (APs) which are involved in vesicle trafficking. The dissociation 
constants for PIP3 binding to the adaptor proteins AP-2 and AP-3 are 350 nM and 5.8 pM 
respectively (Gaidarov & Keen, 1995; Falck et al., 1997). Similarly, synaptotagmin, which is 
also involved in vesicle trafficking, regulates neurotransmitter release by a regulatory process 
involving the calcium induced exchange of PIP3 for PIP2 (Schiavo et al., 1996). It is therefore 
interesting to speculate that PIP3-binding proteins may represent, in part, a family of proteins 
that are involved in regulating vesicle trafficking processes.
A link between PIP3-binding proteins and vesicle trafficking may also be provided by the 
observation that various PIP3-binding proteins (GRP-1, cytohesin-1, ARF nucleotide binding 
site opener (ARNO), SOS, tiam-1, neurogranin, centaurin-a) are found to be regulators of 
small GTP binding-proteins (section 1.14) (table 1). Small GTP binding-proteins include 
members of the Ras-related superfamily, consisting of Ras, Rho, Rab and ARF (sections 1.14.1 
& 1.14.2) subfamilies (each family exhibits 30-50% similarity with Ras p21). As discussed in 
section 1.14, it is likely that small GTP binding-proteins are involved in insulin-stimulated 
GLUT4 translocation in insulin-sensitive tissues. Therefore, regulators of small GTP binding- 
proteins (GTPase activating proteins (GAPs) and GTP exchange factors (GEFs)) may play an 
important part in regulating the translocation of GLUT4.
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PIP3-Binding Protein________Protein Function____________ Reference
Cytohesin-1 ARF GEF Meacci et al., 1997
GRP1 ARF GEF Klarlund et al., 1997
ARNO ARF GEF Peyroche et al., 1996
Tiam-1 Rac GEF Michiels et al., 1995
Neurogranin ARF GAP Lu & Chen, 1997
Centaurin-a ARF GAP Hammonds-Odie et al., 1996
SOS Ras GEF McCollam et al., 1995
Table 1. PIP3-binding proteins with homology to small GTP binding-protein GAPs 
and GEFs.
In yeast, constitutive membrane trafficking into the vacuole and the sorting of newly 
synthesised proteins is dependent upon PI 3-kinase (reviewed by Rameh & Candey, 1999). 
Additionally, the early-endosomal autoantigen (EEA1) is found to bind to PI(3)P (Patki et al., 
1997), and to Rab5 (Simonsen et al., 1998), thereby linking small GTP binding-proteins and PI 
3-kinase. Yeast trafficking processes are inhibited by the addition of wortmannin but may be 
overcome by activating Rab5 (Simonsen et al., 1998). In a similar scenario, inhibition of 
GLUT4 translocation by wortmannin may be partially overcome by the addition of GTPyS (a 
non-hydrolysable analogue of GTP, which activates both small GTP-binding proteins and 
heterotrimeric G-proteins) in adipocytes (Clarke et al., 1994). It is therefore interesting to 
speculate that a conserved mechanism may exist in which small GTP binding-proteins 
involved in vesicle trafficking processes such as GLUT4 translocation are linked to GTP 
binding-protein regulators which are also regulated by upstream PI 3-kinase.
Ultimately, identification of proteins which specifically bind the lipid products of PI 3-kinase 
activity, and which can be shown to be necessary for insulin-stimulated GLUT4 translocation 
may help to clarify subsequent downstream signalling processes that lead to the fusion of 
GLUT4 vesicles with the plasma membrane. Currendy, PIP3 proteins identified in adipocytes 
include PKC isoforms (section 1.13), adaptor proteins, PKB (section 1.12), PDK1 (section 1.12), 
dynamin and proteins with Sec 7 homology domains (GRP1, ARNO) (section 1.14.2). The roles 
of some these proteins and their relationship to GLUT4 translocation are discussed further.
36
1.12 Protein kinase B
The serine/threonine kinase protein kinase B (PKB) (Coffer & Woodgett, 1991) is so named 
because of its similarity in its catalytic domain to the kinases PKA and PKC. This similarity 
has also given rise to the alternative name RAC-kinase (‘related’ to protein kinases ‘A’ and ‘C’) 
(Jones et al., 1991). Additionally PKB is also known as c-Akt-kinase, since it is the cellular 
homologue of the viral oncogene v-Akt (Bellacosa et al., 1991).
Three PKB isoforms have been identified, PKBa, PKBp (Cheng et al., 1992) and PKBy 
(Konishi et al., 1995). Each PKB isoform has >80% sequence identity between each isoform 
and contains a PH domain amino-terminal to the catalytic domain. The major difference 
between the three PKB isoforms is that PKBy is truncated at the C-terminus and hence lacks 
a serine phosphorylation site (present in the other two isoforms). PK B a and PKBp are found 
to be ubiquitously expressed whereas PKBy expression is generally found in greater amounts 
in brain and testicular tissue (Alessi & Cohen, 1998). PKBp activation by insulin has been 
shown to be twice that of PK B a in adipocytes (Walker et al., 1998), but surprisingly in skeletal 
muscle PK B a is the dominant isoform activated by insulin, and litde activation of PKBp is 
observed (Walker et al., 1998). For glucose disposal, skeletal muscle is more relevant than 
adipose tissue since it represents 90% of the insulin-stimulated glucose uptake from the blood. 
Research is therefore still required to assess the roles of individual PKB isoforms in particular 
tissues and their relevance to GLUT4 translocation.
The current interest in PKB and glucose transport arises from the observations that PKB is 
activated by various growth factors, including insulin (Burgering & Coffer, 1995; Kohn et al.,
1995). Furthermore, PKB activity was shown to be blocked by PI 3-kinase inhibitors 
(Burgering & Coffer, 1995; Kohn et al., 1995), implying that PKB activation is a downstream 
event of PI 3-kinase activity. Further evidence for PKB activity occurring downstream of PI 
3-kinase was derived from the observations that overexpression of a constitutively active 
mutant of PI 3-kinase activated PKB (Didichenko et al., 1996), whereas a dominant negative 
form of PI 3-kinase inhibited PKB activation (Burgering & Coffer, 1995). Although PI 3- 
kinase- independent mechanisms for PKB activation do exist (Sable et al., 1997), the activation 
of PI 3-kinase appears to be the major factor regulating PKB activation. Early PKB research 
showed that both PI(3,4)P2 and PIP3 could activate PKB (Freeh et al., 1997; Klippel et al.,
1997). However, it has now been shown that PKB is not direcdy activated by PI(3,4)P2 and 
PIP3 (James et al., 1996), but activation is mediated by phosphorylation (Kohn et al., 1996a).
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Indeed, early studies with PKB showed that PKB activation by growth factors (including 
insulin) was paralleled by phosphorylation of the kinase itself (Kohn et al., 1995). PKB 
phosphorylation appears to be critical for PKB kinase activity as treatment of active PKB 
immune complexes with phosphatases abolishes the ability of the kinase to phosphorylate in 
vitro substrates (Kohn et al., 1995). Insulin-induced phosphorylation of PKBa on residues 
Thr308 and Ser473 (both residues act synergistically to activate PKB) was shown to be blocked 
by wortmannin (Alessi et al., 1996). The realisation that PKB activation is dependent upon 
phosphorylation led to the discovery of a kinase which phosphorylated PKB on Thr308 (Alessi 
et al., 1997). This kinase was found to be dependent upon PI(3,4)P2 or PIP3 for activity and 
was therefore termed as PIP3-dependent protein kinase-1 (PDK1). Like PKB, PDK1 was 
shown to have a PH domain (C-terminal to its kinase domain) (Stephens et al., 1998). 
Overexpression of PDK1 enhanced PKB activation (Anderson et al., 1998) whereas mutation 
of the PH domain of PDK1 significantly reduced PKB activation (Anderson et al., 1998). 
Inhibitors of PI 3-kinase had no direct effect on PDK1 activity, suggesting that PDK1 is 
constitutively active and its activity and function is regulated by its subcellular localisation and 
substrate availability. The importance of the PH domains of both PKB and PDK1 appears to 
localise the two kinases to a membrane and thereby bring them together to allow PKB 
phosphorylation and activation. This model has been proposed for PKB activation by 
Downward (1998) and Alessi & Cohen (1998) (figure 7).
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Figure 7. Mechanism of activation of PKB 
(Downward, 1998). PKBa is activated by 
phosphorylation of two residues by kinases PDK1 
and PDK2. The initial event is the generation of 
either PI(3,4)P2 or PIP3, by PI 3-kinase, which 
allows targeting of both PKB and PDK1 to a 
particular membrane via their PH domains. PKB 
targeting to a membrane induces a conformational 
change in PKB, which allows PKB to become 
phosphorylated by PDK1 on Thr308 or the 
equivalent residue for PKB (3 and PKBy. The 
phosphorylation of Ser473 on PKBa (or Ser474 on 
PKBP) is thought to be mediated by a kinase 
similar to PDK1, but remains unidentified and is 
simply termed as PDK2. A review on PKB 
(Coffer et al., 1998) has a note added in proof on 
results soon to be published, that integrin-linked 
kinase (ILK) can phosphorylate PKB on Ser473 
and that this kinase may represent PDK2. The 
phosphorylated PKB molecule is now able to 
dissociate from the membrane and translocate to 
sites such as the nucleus (Meier et al., 1997) and 
phosphorylate substrates independently of 
phosphatidylinositides.
Whilst various processes such as protein synthesis and apoptosis have been suggested to be 
downstream of PKB (reviewed by Coffer et al., 1998), direct links remain to be established. 
Similarly PKB appears to be involved in regulating glucose metabolism, via glycogen synthase 
kinase 3 (GSK3) and the cardiac isoform of 6-phosphofructo 2-kinase (PFK-2), reviewed by 
Coffer et al. (1998). Given the dependency of GLUT4 translocation on PI 3-kinase activation, 
and the activation of PKB by insulin, it was therefore not surprising that the role of PKB in 
insulin-stimulated GLUT4 translocation was also investigated. The role of PKB activation in 
relation to GLUT4 translocation was initially studied by Kohn et al. (1996b). This group 
showed that PKBa lacking a PH domain but targeted to membranes by myristoylation, leads 
to a constitutively active kinase. Transfection of this PKB mutant into basal 3T3-L1 
adipocytes increased glucose uptake to 70% of that occuring in insulin-stimulated cells. The 
increased glucose uptake was attributed to increases in GLUT1 and GLUT4 on the cell 
surface. Whilst this was evidence that PKB may be responsible for regulating GLUT4 
translocation, these latter experiments only evaluated the long-term effects of PKB activation. 
They did not directly address the issue of whether acute-insulin stimulation of PKB is 
necessary for GLUT4 translocation. Without specific inhibitors of PKB this question is
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difficult to address. However more recently, Kitamura et al. (1998) expressed a mutant PKBa  
in CHO cells and 3T3-L1 adipocytes in which the two phosphorylation sites were replaced by 
alanine. The construct produced a dominant negative effect on the endogenous PKB activity 
that was stimulated by insulin. Endogenous PKB activity was reduced by 80 to 95%, while 
p70 S6 kinase activity was reduced by 75% in CHO cells and 30% in 3T3-L1 adipocytes. 
However, there was no effect on glucose transport. The conclusion reached was that PKB  
activity is not required for glucose transport (Kitamura et al. 1998). While the double alanine 
PKB mutant was for PKBa, the polyclonal antibodies used to examine the endogenous PKB 
activity were capable of precipitating all three known PKB isoforms. Hence the data indicated 
that the PKB mutant inhibited all three of the PKB isoforms. In contrast, Calera et al. (1998) 
have shown that insulin stimulates an association of PKBP with GLUT4 vesicles in 3T3-L1 
adipocytes. This association was shown to be wortmannin sensitive. However, it is not clear 
whether GLUT4 vesicles represent a site of insulin-stimulated PI 3-kinase activation (section
1.10) and therefore the mechanism by which GLUT4 localised PKBP is activated is not 
evident. The role of PKB in GLUT4 translocation remains unresolved and more work is 
required to determine if GLUT4 vesicles from muscle are associated with an active isoform of 
PKB.
1.13 Protein kinase C
PKC involvement in the regulation of GLUT4 vesicle trafficking has primarily been 
investigated by the use of phorbol esters such as phorbol 12-myristate 13-acetate (PMA). 
PMA is known to activate cPKC (a, P, and y), nPKC (8, s, r\, 0 and p), but not aPKC (^ and 
l/X) isoforms. In rat adipocytes, PMA only partially raises cell surface levels of GLUT1 and 
GLUT4 (5.7- and 4-fold respectively) (Holman et al., 1990). Whilst the GLUT1 increase in the 
plasma membrane caused by PMA is comparable to that observed by insulin-stimulation, the 
small PMA-induced increase in GLUT4 is not comparable to that seen by insulin-stimulation 
(20-fold). In a similar study by Gibbs et al. (1991), 3T3-L1 adipocytes stimulated by PMA only 
exhibited a 10% increase in plasma membrane GLUT4 levels compared to insulin stimulation. 
Furthermore, down-regulation of PKC by chronic treatment of 3T3-L1 adipocytes with PMA 
prevents elevation of glucose transport by acute and chronic PMA stimulation but does not 
inhibit insulin-stimulated glucose transport (Gibbs et al., 1991). These data would therefore 
suggest that PMA-sensitive PKC proteins appear not to be necessary for insulin-stimulated 
GLUT4 translocation. However, a role for cPKC’s and nPKC’s cannot be entirely ruled out,
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since PMA and insulin treatment appear to activate PKC isoforms differendy (Farese et al,
1992). Farese et al. (1992) have shown that PKCP translocates to the plasma membrane in rat 
adipocytes following insulin stimulation, but not following PMA stimulation. More recently, 
Walaas et al. (1997) have shown that in Streptolysin-O (SLO)-permeabilised rat adipocytes, the 
PKC pseudosubstrate inhibitor peptide inhibited both PKC phosphorylation of an artificial 
peptide substrate, and GLUT4 translocation to the plasma membrane. Additionally, they 
showed that PKC(3 translocates to the plasma membrane in response to insulin, and that 
neutralising antibodies to PKC(3 inhibited the insulin-stimulated GLUT4 translocation to the 
plasma membrane in SLO-permeabilised rat adipocytes. This would therefore suggest that 
PKCP may play a role in GLUT4 translocation, but whether PKCP activation is sufficient to 
account for insulin-stimulated GLUT4 translocation remains to be determined.
Studies by Nave et al. (1996) have shown that PMA can stimulate PIP3 production in 3T3-L1 
adipocytes by ~2-fold, and that this correlates with the 2-fold increase seen in glucose 
transport. However, PIP3 production and glucose transport were stimulated 6- and 8-fold 
respectively by insulin. This agrees with previous observations (as above) that PMA can 
partially stimulate GLUT4 translocation, but not to the same extent as insulin. Nave et al. 
(1996) also observed that the PMA-induced increases in PIP3 and glucose transport were 
inhibited by treatment of the cells with inhibitors of PI 3-kinase (wortmannin and LY294002). 
This therefore suggested that the partial stimulation of glucose transport by PMA was 
mediated by a downstream PI 3-kinase.
aPKC’s are not activated by PMA and therefore need to be considered separately. Additionally 
the aPKC’s are not inhibited by the pseudosubstrate inhibitor peptide (see above) since their 
pseudosubstrate domain differs from that of cPKC’s and nPKC’s. The possibility that aPKC’s 
may be involved in signalling downstream of PI 3-kinase, comes from the observation that 
PKC^ can be activated in vitro by PIP3 (Nakanishi et al., 1993; section 1.2.6). Furthermore, 
Standaert et al. (1997) have shown that insulin-stimulation of rat adipocytes results in the 
phosphorylation of PKC^ and a 4-fold increase in PKC(^ activity. The insulin-induced 
activation of PKC^ is inhibited by both wortmannin and LY294002 (another inhibitor of PI 
3-kinase) suggesting that PKC<  ^ acts as a downstream effector of PI 3-kinase. Additionally, 
lOfiM PI(3,4)P2, 10 (J.M PIP3 and 1 |nM PIP2 directly stimulated PKCi^ activity and 
autophosphorylation in immunoprecipitates, to the same extent as insulin. Furthermore, in
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adipocytes transiently expressing haemagglutinin antigen-tagged GLUT4, co-transfection of 
wild-type or constitutive PKC^ stimulated haemagglutinin antigen-tagged GLUT4 
translocation to the PM (Standaert et al, 1997). Conversely, a dominant-negative PKC<^  
construct which was transiendy transfected into adipocytes inhibited insulin-stimulated 
GLUT4 translocation to the plasma membrane by ~50%. These data therefore suggested that 
PKC^ might act as a downstream effector of PI 3-kinase and contribute to the activation of 
GLUT4 translocation (Standaert et al., 1997).
Subsequent research by Kotani et al. (1998) have shown that 3T3-L1 adipocytes express the 
aPKC PKCA and not PKC^. Insulin was observed to cause a 3-fold increase in PKCA activity 
which was inhibited by wortmannin. Additionally, 3T3-L1 adipocytes transfected with mutant 
PKCA, constructs, produced inhibition of insulin stimulated PKCA. activation. The dominant 
negative PKCA, constructs produced a 50-60% inhibition of glucose uptake, however no 
inhibition of PKB was observed. Complete inhibition of PKCA, activity in immunoprecipitates 
corresponded only to 50% inhibition in glucose transport. The lack of complete inhibition of 
glucose transport was explained by the possibility of their existing an alternative signalling 
pathway which may compensate for the lack of PKCA activity. Alternatively, the discrepancy 
between PKC activity and glucose uptake may be explained if some lipid moduators that 
activate the kinase were limiting/removed from the experimental system. Indeed, Kotani et al. 
have shown that phosphatidylserine can further increase PKCA, activity in PKCA 
immunoprecipitates from insulin stimulated cells (Kotani et al., 1998). Whilst dominant- 
negative mutants of PKCA can inhibit glucose transport, a constitutively active PKCA 
construct (made by deletion of the pseudosubstrate domain) was found to activate GLUT4 
translocation to the plasma membrane. The constitutively active PKCA stimulated glucose 
transport to an extent comparable to that seen by insulin, in a wortmannin resistant manner, 
but had no effect on PKB activity (Kotani et al., 1998). Hence, the authors suggested that 
insulin signalling diverges into at least two independent pathways downstream of PI 3-kinase, 
one pathway through PKB and the other pathway through PKCA. They suggest that the latter 
pathway contributes to insulin stimulation of glucose uptake in 3T3-L1 adipocytes.
How PI 3-kinase modulates PKCA and PKC^ activity is still uncertain, and this warrants 
further investigation, as does identification of the substrate of the aPKC isoforms. Whilst the 
significance of aPKC’s activation by insulin in not known, studies by Sanchez et al. (1998) have
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shown that aPKC isoforms are targeted to late endosomes through interaction a member of 
the src-kinase family (p56lck). Furthermore, expression of a dominant negative PKCA, impaired 
the endocytic membrane transport of epidermal growth factor receptors but not the 
transferrin receptor. These results therefore suggest that aPKC’s may be important in 
membrane trafficking, and possibly GLUT4 trafficking.
1.14 GTP-binding proteins
Guanosine nucleotide binding regulatory proteins (GTP-binding proteins) play a pivotal role 
in signal transduction. Evidence that GTP-binding proteins are involved in insulin-regulated 
GLUT4 trafficking comes from the observations that non-hydrolysable analogues of 
guanosine triphosphate (GTP) such as guanosine-5’-0-(3-thiotriphosphate) (GTPyS) can 
stimulate GLUT4 translocation (Baldini et al., 1991) even in the presence of the PI 3-kinase 
inhibitor wortmannin (Clarke et al., 1994). Furthermore, a small molecular weight GTP- 
binding protein has also been found on immunoisolated GLUT4 vesicles (Cormont et al.,
1993).
There is also evidence that GTP-binding proteins are involved in SNARE complexes (section 
1.4) and in the endocytosis of plasma membrane GLUT 4 (Omata et al., 1997; Al Hasani et al., 
1998; Volchuk et al., 1998).
Discussed below is the evidence that GTP-binding proteins (heterottimeric and small 
molecular weight ras-like GTP-binding proteins) are involved in both trafficking of GLUT4, 
to and from, the plasma membrane.
1.14.1 Small Ras-like GTP-binding proteins
Studies by Cormont et al. (1991) have shown that GLUT4 enriched vesicles contained small 
molecular weight GTP-binding proteins. These GLUT4 vesicle-associated GTP-binding 
proteins are likely to represent members of the Ras-like GTP-binding proteins which include 
ARF (section 1.14.2) and Rab families, which regulate vesicle trafficking processes (reviewed by 
Pfeffer, 1992 and Novick & Zerial, 1997)(table 2). Indeed, subsequent studies by Cormont et 
al. (1993) identified one of the proteins associated with GLUT4 vesicles as Rab4. In cardiac 
muscle, experiments undertaken by Uphues et al. (1994) similarly found GTP-binding proteins 
in a GLUT4-enriched membrane fraction, but found that only a single GTP-binding protein
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(as assessed by one-dimensional gel electrophoresis), was associated with isolated GLUT4 
vesicles, and that it was unlikely to be Rab4. Despite, the conflicting evidence on whether 
Rab4 is associated with GLUT4 vesicles (which may be due to differences in tissues), there is 
now strong evidence to suggest that Rab4 is involved in GLUT4 trafficking.
Protein Localisation Function
Rab3C Synaptic vesicles Unknown
Rab4A, Rab4B Early endosomes Recycling pathway from 
endosomes to plasma membrane
Rab5A, Rab5B, 
Rab5C
Plasma membrane, clathrin- 
coated vesicles; early endosomes
Plasma membrane to early 
endosome transport and 
homotypic fusion between early 
endosomes
Rabll TGN; constitutive secretory 
vesicles; secretory granules; 
recycling endosomes
Transport through recycling 
endosomes
Table 2. Function of a variety of rab proteins involved in vesicular trafficking events in 
mammalian cells (adapted from Novick & Zerial, 1997).
Evidence for the involvement of Rab4 in GLUT4 trafficking comes from four sources. Firstly, 
studies by Cormont et al. (1996a) showed that a moderate and transient expression of Rab4 in 
rat adipocytes led to the retention of GLUT4 to intracellular membranes under basal 
conditions, with no effect on GLUT4 trafficking under insulin-stimulated conditions. 
However, overexpression of Rab4 led to a decrease in the insulin-stimulated GLUT4 
trafficking to the plasma membrane. These data would therefore imply that Rab4 is involved 
in both the biogenesis of the insulin-sensitive GLUT4 intracellular compartment and may 
direct it to the PM under insulin-stimulated conditions. Secondly, electroporation of a peptide 
corresponding to the carboxy-terminus hypervariable region of Rab4 inhibited insulin- 
stimulated GLUT4 trafficking to the plasma membrane by 50% (Shibata et al.y 1996). The 
peptide was also capable of inhibiting GTPyS-stimulation of GLUT4 trafficking. Thirdly, 
coexpression of Rab4 and GLUT4 in Xenopus oocytes led to an increased intracellular 
retention of GLUT4 (Mora et al, 1997). Fourthly, more recent studies by Shibata et al. (1997), 
have shown that insulin stimulates guanine nucleotide exchange on Rab4 in rat adipocytes. 
The increased nucleotide exchange by insulin treatment was inhibited by wortmannin. Hence,
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it would seem that Rab4 is involved in GLUT4 vesicle trafficking events. How exacdy Rab4 
contributes to GLUT4 trafficking is still unclear, although it is likely that Rab4 is regulated by 
various nucleotide exchange factors and accessory proteins and effectors, such as GTPase 
activating proteins (GAPs) (reviewed by Scheffzek et al 1998), GDP-dissociation inhibitor 
proteins (GDIs) and guanine nucleotide exchange factors (GEFs) (reviewed by Sprang & 
Coleman, 1998). The regulation of Rab activity by these various regulatory proteins is shown 
by figure 3. Briefly, Rab proteins exist in a membrane bound state regulated by GEF and GAP 
proteins, and in a cytosolic state bound to GDI proteins. The functional cycle of Rab proteins 
as shown by figure 3, can be applied to observations seen with Rab4.
Experiments involving Rab4 have shown that upon insulin stimulation, Rab4 undergoes 
nucleotide exchange (Shibata et al. 1997), hence it is possible that a GEF (figure 3-A) is 
activated by insulin which allows for ‘activation’ of Rab4 associated with GLUT4 vesicles. 
Generally, it is found that Rab4 translocates from GLUT4 vesicles to the cytosol (Cormont et 
al, 1993), and preferentially binds to GDI-1 in the cytosol (Shisheva et al 1997). However, in 
cardiac muscle, Uphues et al (1994) found that upon insulin stimulation Rab4 shifted to the 
plasma membrane. Whilst GDI proteins normally extract Rab proteins from membranes in 
the GDP bound ‘inactive state’ (figure 3-C), it is possible, that experiments by Cormont and 
colleagues have disrupted any plasma membrane/Rab4 interactions. This is plausible, since the 
GAP activity for Rab4 is found to be enriched in the plasma membrane of 3T3-L1 adipocytes 
(Bortoluzzi et al, 1996). Furthermore, if Rab4 is associated with GLUT4 it may represent a 
regulator of the SNARE complex (section 1.4). Thus, the C-terminal hypervariable region of 
Rab4 may be involved in masking VAMP2 under basal conditions, and thus regulating vesicle 
fusion.
Whilst, Rab4 is implicated in GLUT4 vesicle trafficking it is unlikely that it represents the only 
Rab protein involved in the trafficking process, although to date, no other Rab protein has 
been determined to be necessary for insulin-stimulated GLUT4 trafficking.
Other members of the Ras superfamily, which might be important for GLUT4 trafficking are 
the small GTP-binding proteins of the Rho family. The Rho family, includes Rac, Rho and 
Cdc42. Like other small-molecular weight GTP-binding proteins these cycle from GTP-bound 
active forms to GDP-bound inactive forms. Members of the Rho family can regulate the actin 
cytoskeleton (reviewed by Machesky & Hall, 1996) which has been implicated in being
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important for GLUT4 trafficking (Wang et al., 1998). Furthermore, Cdc42, has been shown in 
conjunction with the products of PI 3-kinase to regulate actin assembly in Xenopus cells (Ma et 
al., 1998). As described in section 1.11, it is possible that GTP-binding proteins may be 
regulated by PI 3-kinase mediated events. Certainly, the more recent data by Clark et al. (1998) 
suggests that the insulin-stimulated PI3-kinase activity observed in adipocytes is associated 
with structures that could possibly be represented by the cytoskeleton. The observations that 
insulin promotes the wortmannin sensitive translocation of Rho to the plasma membrane in 
rat adipocytes, suggests that Rho might be involved in processes like GLUT4 trafficking 
(Kamam et al., 1997). Furthermore, GTPyS-stimulated GLUT4 translocation in rat adipocytes 
can be inhibited by the use of Clostridium botulinum C3 transferase, an inhibitor of Rho 
(Standaert et al., 1998). However, more work is still required to determine precisely the role of 
the cytoskeleton in GLUT4 trafficking, and the role that GTP-binding proteins have in the 
regulation of the cytoskeleton.
1.14.2 ARF
The ADP-ribosylation factor (ARF) family is a group of structurally related proteins. Like the 
Rab family these form a subset of the Ras superfamily of regulatory GTP-binding proteins. Six 
mammalian ARF genes have been identified, but only five proteins have been identified in 
humans, namely that of ARF1, 3, 4, 5 and 6. The role of these various isoforms appear to be 
as diverse as the Rab proteins, and ARF proteins have been shown to act in a variety of 
processes such as targeting recycling vesicles to the plasma membrane (D’Souza-Schorey et al.,
1998), regulating phospholipase D activity (Cockcroft, 1996), Golgi membrane budding 
(Elazar et al., 1994) and targeting of adaptor proteins to membranes (West et al., 1997). 
Brefeldin A has been shown to disrupt guanine nucleotide exchange on ARF (ARF 6 is 
brefeldin A insensitive) and thereby inhibit its function. However, whilst brefeldin A has been 
reported to inhibit insulin-stimulated GLUT4 translocation in rat adipocytes (Lachaal et al.,
1994), three further independent studies have shown that despite a small effect on basal 
glucose transport brefeldin A has litde effect on the insulin-stimulated translocation of 
GLUT4 to plasma membranes in rat adipocytes (Chakrabarti et al., 1994; Bao et al., 1995; 
Kono-Sugita et al., 1996). Despite this conflicting evidence from the use of brefeldin A, recent 
research by Rapoport et al. (1998) have shown that the adaptor protein AP-1 binds the 
carboxy dileucine motif of GLUT4. Furthermore, AP-1 binding to membranes has been 
shown to be dependent on ARF (Stamnes & Rothman, 1993). Hence it is possibile that ARF 
can associate with intracellular membranes enriched with GLUT4. Furthermore, unpublished
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data from our lab (Gillingham et al., 1999) have found both AP-1 and AP-3 (reviewed by 
Odoriz2i et al., 1998) co-localised with immunoisolated GLUT4 vesicles. Interestingly, AP-1 
and plasma membrane associated AP-2 complexes have been shown to bind the products of 
PI 3-kinase (section 1.11). It is therefore plausible that both lipid products from PI 3-kinase 
together with ARF proteins can regulate assembly of AP complexes and regulate GLUT4 
vesicle trafficking.
Moreover, the PIP3 binding proteins cytohesin-1, GRP-1 and ARNO (section 1.11) contain 
Sec7 domains which catalyses the exchange of GDP to GTP on ARF, promoting ARF 
association with membranes. It is likely that one or more of these ARF GEFs are involved in 
regulating ARF activity. Indeed, both ARF and ARNO translocate from the cytosol to the PM 
upon insulin stimulation of adipocytes (Kamam et al, 1997; Venkateswarlu et al., 1998), the 
translocation of ARNO being blocked by wortmannin (Venkateswarlu et al., 1998). Therefore 
the translocation of ARNO to the PM appears to be dependent upon PIP3 production. This 
raises further questions about the localisation of insulin-stimulated PI 3-kinase activity in 
adipocytes, since the work by Venkateswarlu et al. (1998) would suggest that insulin-stimulated 
PI 3-kinase activity is at the PM. Further work is therefore still required to determine the role 
of ARF in GLUT4 trafficking events.
1.14.3 Heterotrimeric G-proteins
There is evidence that vesicle trafficking is also regulated by heterotrimeric GTP-binding 
proteins. For example, heterotrimeric GTP-binding proteins are found to be involved in the 
organisation and formation of secretory vesicles from the Golgi complex (Barr et al., 1992; 
Yamaguchi et al, 1997). Whilst adipocytes are found to express a variety of heterotrimeric 
GTP-binding proteins (Denis-Henriot et al., 1996), very few reports have implicated these 
proteins in GLUT4 trafficking. One possible candidate for regulating GLUT4 trafficking is 
Gi(X2. Antisense RNA expression of the gene encoding Gia2in mice gave characteristics of non- 
insulin-dependent diabetes mellitus (section 1.16) such as hyperinsulinaemia, impaired glucose 
tolerance, insulin-resistance and impaired insulin-stimulated GLUT4 translocation to plasma 
membranes (Moxham & Malbon, 1996). This therefore implicates GiCX2 as a positive regulator 
of insulin action. The latter study also suggested that the deficiency of GiCt2 was upstream of 
IRS-1, since IRS-1 tyrosine phosphorylation was reduced. The reduction in tyrosine 
phosphorylation of IRS-1 was explained by the observations that the lack of GiCt2 expression
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also led to increased cellular tyrosine phosphatase activities. Further experiments will 
hopefully clarify the role of GiCt2 in GLUT4 trafficking.
1.15 Phosphatases
In intracellular signalling pathways signalling events are regulated by a balance between kinase 
and phosphatase activities. As has already been mentioned in previous sections, recent reports 
on the serine/threonine kinases PKB and PKC have implicated these proteins in insulin- 
regulated GLUT4 trafficking. However earlier studies involving the use of phosphatase 
inhibitors such as okadaic acid (OA) also implied that serine/threonine kinases may be 
important for insulin-regulated GLUT4 trafficking.
OA is a potent inhibitor of protein phosphatases 1 and 2A. Initial studies in adipocytes with 
okadaic acid by Haystead et al. (1989) have shown that OA increases the phosphorylation state 
of many cellular proteins, and more importantly increases 2-deoxyglucose uptake, to an extent 
that is comparable to insulin-stimulation. However, subsequent studies have shown that OA 
only elicits a partial insulin-like response on glucose transport (approximately 20% of the 
insulin response) in rat adipocytes (Lawrence et al., 1990; Corvera et al., 1991; Rondinone et al.,
1996). The precise targets of OA targets in rat adipocytes are not clear. Although the small 
OA-stimulated increase in glucose transport is due to an increase in the rate of GLUT4 
exocytosis from intracellular vesicles to the PM (Rampal et al., 1995). Whilst, insulin 
stimulation of GLUT4 translocation to the plasma membrane appears to have a requirement 
for PI 3-kinase, OA does not stimulate PI 3-kinase in rat adipocytes (Rondinone et al., 1996). 
This would imply that okadaic acid acts either on a pathway downstream of PI 3-kinase or by 
a distinct pathway which eventually converges with a pathway downstream of the PI 3-kinase 
which is acted upon by insulin.
Inhibition of tyrosine phosphatases by pervanadate ions can also stimulate GLUT4 
translocation to the plasma membrane (Shisheva & Shechter, 1993). Pervanadate-stimulation 
of glucose transport is thought to occur by inhibition of tyrosine phosphatases that are 
associated with the insulin receptor. This causes receptor phosphorylation and initiates the 
insulin intracellular signalling cascade that leads to glucose transport. Furthermore, 
pervanadate stimulation of 2-deoxyglucose uptake in 3T3-L1 adipocytes has been shown to be 
partially both wortmannin and LY294002 resistant (Ida et al., 1996). This suggests that 
stimulation of tyrosine kinases occurs either on a pathway distinct to those activated by insulin
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or on a pathway downstream of PI 3-kinase that is normally activated by insulin which can 
lead to glucose transport. Further evidence for tyrosine kinases acting downstream of PI 3- 
kinase activity have been shown by Elmendorf et al. (1998) and Haruta et al. (1998). These 
studies have shown that in the presence of wortmannin, GTPyS can elicit tyrosine 
phosphorylation of various cellular proteins in addition to increased glucose uptake.
Overall, it would appear that serine/threonine and tyrosine phosphatases are likely to play a 
critical role in the regulation of GLUT4 trafficking.
1.16 Non-insulin-dependent diabetes mellitus (NIDDM)
Insulin’s effects on glucose metabolism is primarily due to repression of gluconeogenesis and 
glucose uptake in the liver, acceleration of the rate of glucose uptake across the cell membrane 
of adipose and muscle tissue, and enhancement of glucose incorporation into glycogen. 
However, in NIDDM patients there tends to be a loss of peripheral sensitivity to insulin 
(insulin resistance). Hence, to maintain normoglycaemia, there is an increase in insulin 
secretion from the P-cells of the pancreas, resulting in hyperinsulinaemia. Eventually the 
increased demand placed on the pancreatic P-cells to maintain normoglycaemia results in 
progressive loss of P-cell function. The eventual hyperglycemia results from both a defect in 
insulin secretion as well as from a loss of peripheral sensitivity to insulin. Whilst NIDDM 
appears to be due to both a combination of genetic and environmental factors (Kahn, 1994), it 
is likely that the insulin resistance which is associated with the onset of NIDDM is responsible 
for the subsequent hyperinsulinaemia. Since it would appear that a diminished insulin- 
stimulated glucose transport in skeletal muscle is not a consequence of reduced GLUT4 
expression (Pederson et al., 1990), it is likely that the defect in glucose transport in NIDDM is 
due to alterations in insulin signalling, insulin-stimulated targeting of GLUT4 to the PM or 
alterations in the sequestration of GLUT4 (Garvey et al., 1998). Therefore, by obtaining a 
greater understanding of the normal insulin-regulation of GLUT4 translocation in adipose and 
muscle tissues, the precise defects which result in insulin-resistance may become apparent and 
could possibly be targeted for a cure of NIDDM.
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PART C - Aims of the thesis
A model representing insulin resistance as an indicator of NIDDM was studied. The aims in 
this study were to discern whether the reduced insulin-stimulated glucose transport in insulin- 
resistant adipocytes (Kozka et al, 1993) results from alterations in the insulin signal 
transduction pathway or in trafficking processes that lead to GLUT4 translocation.
Further aims were to study the involvement of insulin-regulated signalling intermediates 
already implicated in insulin-regulated GLUT4 trafficking. Therefore the role of PKB in 
okadaic acid stimulated glucose transport in both rat and human adipocytes was examined. 
Additionally, the role of PKB in muscle was examined to determine whether insulin- and 
contraction-stimulated glucose transport utilise the same signalling pathway
Other aims of the thesis were to develop methods for identifying new signalling molecules 
involved in GLUT4 trafficking. The signal transduction pathway from the insulin receptor 
leading to GLUT4 translocation remains only partially elucidated. Given the involvement of 
PI 3-kinase, and the potential involvement of GTP-binding proteins in insulin-stimulated 
GLUT4 translocation, research was aimed at identifying both phosphatidylinositide-binding 
proteins and insulin-regulated GTP-binding proteins. The identification of new 
phosphatidylinositide-binding proteins may help clarify the site of action of insulin-stimulated 
PI 3-kinase lipid products and the subsequent downstream molecules required for insulin- 
stimulated GLUT4 translocation to the PM. Molecules downstream of PI 3-kinase are likely 
to involve GTP-binding proteins. Therefore identification of insulin-regulated GTP-binding 
proteins which are sensitive to the activation state of PI 3-kinase can hopefully also give 
further elucidation of regulation of GLUT4 trafficking processes.
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CHAPTER 2
MATERIALS & M E T H O D S
2.1 Laboratory chemicals
Unless otherwise stated general laboratory chemicals were of analytical grade and purchased 
from either Sigma-Aldrich Company Ltd., Fisons Scientific UK Ltd. or BDH Laboratory 
Supplies.
Bovine Albumin Cohn Fraction V powder, pH 5.2 (BSA), was purchased from Intergen Co. 
(Newark, NJ). A 10% (w/v) solution was prepared at 4°C and the pH adjusted with 10 M 
NaOH to pH 7.4. The BSA solution was filtered through Millipore type A (mixed cellulose 
esters) membrane filters (0.8pm pore size), aliquoted and stored at -20°C.
Monocomponent porcine insulin was a kind gift from Dr. G. Danielson, Novo Nordisk. 1 mg 
of insulin was initially dissolved in 1 ml of 30 mM HC1, then diluted to 3 ml with distilled 
H2O. 1 ml of this stock solution was then diluted to 50 ml with 1% (w/v) BSA/KRH buffer 
(section 2.2), and the resulting 1 pM solution aliquoted and stored at -20°C. 100 pM sterile 
stocks were also made in a similar fashion for adipocyte rat culture.
Tritiated phosphatidylinositide photoprobes, phosphatidylinositide lipids and 
phosphoinositide affinity resins (Ins(l,3,4)P3 and Ins(l,3,4,5)P4 linked to Bio-Rad Affi-Gel 
10) were generous gifts from Prof. G. Prestwich, University of Utah, USA (Prestwich, 1996) 
Phosphatidylinositides used in PI 3-kinase experiments were purchased from Sigma.
2-N-4-(l-azi-2,2,2-trifluoroethyl)benzoyl-l,3-pH]bis-(D-mannos-4-yloxy)-2-propylamine 
(ATB-[3H]BMPA), approximately 10 Ci/mmol was synthesised by Prof. G. D. Holman, 
University of Bath, UK (Clark & Holman, 1990).
Radiochemicals, ECL Western blotting detection reagents and Amplify were purchased from 
Amersham International pic.
Collagenase Type 1 from Clostridium histolyticum was purchased from Worthington Biochemical 
Corporation (Freehold, NJ). Before purchase of the collagenase, individual lots were tested for 
their suitability to maintain adipocyte insulin responses (as measured by glucose uptake 
studies, section 2.10). Lots used varied in their collagenase activity from 183-296 U/mg dry 
weight.
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4-(2-aminoethyl)benzenesulfonylfluoride (AEBSF) and a-toxin from Staphylococcus aureus were 
purchased from Calbiochem.
Guanosine 5’-[y-thio]triphosphate (GTPyS) and Thesit® (C12E9) were purchased from 
Boehringer Mannheim UK Ltd.
Protein G (Sepharose 4 Fast Flow) and Pharmolytes were purchased from Pharmacia Biotech. 
Okadaic acid (sodium salt) was purchased from Alexis Corporation Ltd.
2.2 Buffers
Buffers used routinely were as follows:
Kreb’s Ringer’s HEPES (KRH) buffer
TES buffer 
Adipocyte lysis buffer
Phosphate buffered saline (PBS) buffer 
TBS-T buffer
SDS-PAGE sample buffer
Protease inhibitors were added to buffers w 
leupeptin, aprotinin, pepstatin A and antipain
140 mM NaCl, 4.7 mM KC1, 2.5 mM CaCl2,
1.25 mM MgS04, 2.5 mM NaH2P 0 4, 10 
mM HEPES pH 7.4
5 mM EDTA, 255 mM Sucrose, 10 mM 
Tris-HCl pH 7.2
50 mM HEPES pH 7.0, 150 mM NaCl, 1 
mM EGTA, 100 mM NaF, 10 mM 
Na4P20 7 , 10% (v/v) glycerol, 1.5 mM 
MgCl2, 1 mM Na3V 0 4, 1% (v/v) Triton X- 
100
12.5 mM Na2H P 04.12H20  pH 7.2, 154 
mM NaCl
10 mM Tris-HCl pH 7.4, 154 mM NaCl, 
0.1% (v/v) Tween-20
Final concentrations after addition to 
samples: 62.5 mM Tris-HCl pH 6.8, 2% 
(w/v) SDS, 10% (v/v) glycerol, 0.01% 
(w/v) bromophenol blue. The reducing 
agent was 10% (v/v) 2-mercaptoethanol 
unless otherwise stated
ien appropriate, to give final concentrations of 
it 1 pg/ml, and AEBSF at 100 pM.
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2.3 Sources of antibodies
The source of antibodies used, and where appropriate the dilution’s used in Western blotting 
(section 2.29), and the amounts for immunoprecipitation (section 2.15) are given in table 3.
Anti-IRS-1 rabbit serum was a kind gift from Dr G. Murphy, SmithKline Beecham 
Pharmaceuticals, Harlow. The peptide used for immunisation corresponded to residues 652- 
666 of rat liver ppl85 (Sun et al., 1991).
Anti-dynamin II rabbit serum used for immunoprecipitation was a kind gift from Dr M. 
Kasuga, Kobe University School of Medicine, Kobe, Japan. The antibody was raised against a 
synthetic peptide corresponding to the proline-rich region of rat dynamin II.
Anti-VAMP2 rabbit serum (Timmers et al., 1996) and anti-GLUT4 rabbit serum were gifts 
from Dr S. W. Cushman (National Institutes of Health, Bethesda, USA). Anti-GLUT4 
antibodies were raised against the C-terminal 13 amino acids of GLUT4 (a cysteine was 
attached to the N-terminus for conjugation to keyhole limpet haemocyanin). The peptide for 
immunisation was produced at Bath University (Holman et al., 1990).
Anti-syntaxin4 rabbit serum was raised against recombinant syntaxin4 (construct a gift from 
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Table 3. Sources of antibodies used for Western blotting (WB) and 
immunoprecipitation (IP).
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2.4 Production of antibodies to Giai/2
A 10 amino acid peptide (KENLKDCGLF) corresponding to the C-terminal region of 
transducin, with homology to G-protein (Xi subunits (Goldsmith et al, 1987) was synthesised, 
using a Milligan 950 automatic peptide synthesiser. The synthesised peptide was cleaved from 
the resin and purified by high-performance liquid chromatography, with confirmation of the 
sequence by mass spectroscopy (S. Phillips, Bath University). The peptide was lyophilised and 
stored at -20°C.
20 mg of keyhole limpet haemocyanin (KLH; Sigma) and 6 mg of peptide (as above) were 
dissolved in 2 ml PBS, to which was added 1 ml of 21 mM glutaraldehyde in PBS (dropwise 
with stirring). The combined 3 ml was incubated for 24 h at room temperature. An equal 
volume of Freund’s complete adjuvant was added to the KLH-peptide conjugate, an emulsion 
was formed, and 1 ml injected into multiple subcutaneous sites in New Zealand White rabbits. 
Booster injections were then performed every four weeks after the initial immunisation, using 
half the amount of peptide and KLH, initially in Freund’s incomplete adjuvant, and then in 
PBS.
A 5 ml test bleed was taken in week 6, then every 4 weeks to monitor the titre of specific 
antibodies by ELISA. Bleeds were from ear veins of rabbits under anaesthetic. Rabbits were 
bled out at 12 weeks following from the first immunisation. Sera from rabbits were allowed to 
clot for 1 h at room temperature then overnight at 4°C. Sera were then removed from blood 
clots and any cells in the sera removed by centrifugation. The sera were stored at -20°C. Sera 
from rabbits were obtained prior to immunisation (pre-immune sera) for use as negative 
controls in experiments.
2.5 Affinity purification of GLUT4 antibodies
12 ml of Reacti-gel 6X (6%, cross-linked agarose, Pierce) was filtered through Whatman 
number 1 filter paper on a Buchner funnel and washed with ice-cold distilled water. The beads 
were then rotated with 66 mg of GLUT4 peptide (as used for immunisation) in 0.1 M sodium 
borate pH 8.5 for 48 h at 4°C. The mixture was then filtered and the beads added to 24 ml of 
1 M ethanolamine in borate buffer for 3 h at room temperature with rotation. The beads were 
then packed into a column and washed successively with 1 M NaCl, distilled water and PBS. 
15 ml of anti-GLUT4 rabbit serum was circulated through the column for 12 h at 4°C. The
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column was extensively washed with PBS, then with 2M NaCl in 10 mM Na2HPC>4.12 H2O, 
pH 7.2. The anti-GLUT4 antibodies were then eluted with 3.5 M NaSCN in 10 mM 
Na2HPC>4.12 H2O, pH 6.6, and immediately dialysed against PBS. The antibody solution was 
concentrated using polyethyleneglycol 20,000. The antibody was stored at -20°C in the 
presence of 40% (v/v) glycerol and 0.02% (w/v) sodium azide. Purification of antibodies was 
monitored by ELISA.
2.6 Isolation of rat adipocytes
Adipose cells were obtained from the whole epididymal fat pads of male Wistar rats (180-200 
g). The necks of the rats were broken and tissue was quickly removed and briefly washed in 
1% (w/v) BSA/KRH buffer at 37°C. Tissue was finely chopped (using scissors) in digestion 
buffer (3.5% (w/v) BSA/KRH buffer supplemented with 5 mM glucose and 700 pg/ml 
collagenase), at a ratio of 4 fat pads/5 ml. Tissue was digested with vigorous shaking for 40-50 
min at 37°C, until a fine tissue suspension was achieved. Tissue digestion was performed in 25 
ml Sterilin clear-polystyrene tubes with the maximum amount of digestion buffer in any one 
tube being 5 ml. The resulting cell suspensions in each tube were filtered through 250 pm 
nylon mesh (Lockertex) into separate 23 ml polystyrene flat-bottomed tubes (Sarstedt). 
Adipocytes were allowed to float at 37°C. The infranatant buffer was removed using a 13 
gauge x 10 cm needle attached to a syringe and then 20 ml 1% (w/v) BSA/KRH buffer was 
added to each tube. Cells were resuspended and allowed to float at 37°C. This washing 
procedure was generally repeated 4 times until the BSA/KRH buffer became clear and the 
layer of floating cells became white in appearance. Tubes of cells were pooled together and 
the cell suspension adjusted to 40% cytocrit.
2.7 Isolation of human adipocytes
Human adipocytes were prepared from human subcutaneous adipose tissue of female patients 
undergoing gynaecological surgery (Kozka et al., 1995). Briefly, 10-30 g of tissue was excised at 
the beginning of surgery and placed in 1% (w/v) BSA/KRH buffer supplemented with 5 mM 
glucose. Tissue was transported to the laboratory in a thermos flask within 30 min. Adipose 
cell preparation was essentially as described for rat adipose cells (section 2.6), with a few 
modifications. Approximately 2 g of tissue (free of clotted blood and connective tissue) was 
digested in 3.5 ml digestion buffer. The digestion buffer was the same as for the rat buffer but 
with an increase in the BSA to 4% (w/v). Tissue digestion was achieved in approximately 30
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min. The cell suspension was then filtered through nylon mesh with a pore si2e of 400 pm. 
The washing of the human cells was as described for the rat cells but using 4% (w/v) 
BSA/KRH buffer and was continued until the BSA/KRH buffer became clear and the cells 
were bright yellow in appearance. Finally, cell suspensions were adjusted to a cytocrit of 40%.
2.8 Maintenance of rat adipocytes in culture
Rat adipocytes were prepared as previously described (section 2.6) but using sterile solutions 
and techniques where possible. The isolated adipocytes were added to Dulbecco’s 
Modification of Eagle’s Medium (DMEM (with 25 mM glucose, without L-glutamine; ICN)) 
supplemented with 1% (w/v) BSA, 25 mM HEPES pH 7.6, 2 mM L-glutamine, 100 U/ml 
penicillin and 100 pg/ml streptomycin. Initially, 2 ml aliquots of cells were added to 40 ml 
culture medium in 100 ml sterile polyethylene pots (Sarstedt). Later experiments utilised 70 ml 
sterile polystyrene pots (Sarstedt), which increased the subsequent recovery of cells following 
the overnight culture. Cells were incubated at 37°C in a 5% CO2 atmosphere for 20 h in the 
absence or presence of 500 nM insulin with or without 1 mM metformin. Cells were 
subsequently recovered by removing the culture medium and washing 4 times with 1% (w/v) 
BSA/KRH buffer (section 2.2) supplemented with either 500 nM insulin with or without 1 mM 
metformin as appropriate. Cell suspensions were adjusted to a cytocrit of 40%. The recovery 
of cells was approximately 75% after the 20 h culture period. A fraction of cells cultured 
without insulin or metformin were acutely insulin-stimulated with 20 nM insulin for 30 min at 
37°C. Cells without any additions were termed basal (B). Cells treated with 20 nM insulin for 
30 min were termed insulin-acute (la). Cells with 500 nM insulin for 20 h were termed insulin- 
chronic (Ic). Cells with 500 nM insulin and 1 mM metformin for 20 h were termed as insulin- 
chronic metformin (IcM).
2.9 Stimulation tat adipocytes with insulin and isolation of cell lysates
Adipose cells were generally stimulated with 20 nM insulin at 37°C for 30 min unless 
otherwise stated. Cells treated with okadaic acid were either incubated with okadaic acid for 20 
min alone, or treated with okadaic acid for 20 min before insulin stimulation.
Cell lysates from cells at 40% cytocrit were concentrated by briefly centrifuging cell aliquots at 
1,000^ for 10 seconds and removing excess buffer. Cells were then lysed with a volume equal
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to the original cell suspension volume, with ice cold lysis buffer containing pro tease inhibitors. 
Lysates were incubated on ice for 20 min then centrifuged at 20,000^ for 10 min at 4°C. Triton 
X-l 00-soluble lysates were separated from the fat layer, and passed through 0.2 pm Minisart 
filters (Sartorius).
Soleus muscle (samples from Dr. S. Lund, Aarhus, Denmark) lysates were generated by 
homogenising samples in 1.25 ml of 10 mM Tris-HCl pH 7.2, 5 mM EDTA, 255 mM sucrose, 
10 mM NaF, 0.2 mM Na3VC>4, 1 mM sodium molybdate, plus protease inhibitors. Triton X- 
100 was added to the homogenates to give a final concentration of 1% (v/v) and then the 
samples were rotated for 30 min at 4°C. Homogenates were centrifuged at 20,000g for 10 min 
and detergent-soluble fractions were removed from the insoluble material.
2.10 3-O-Methyl-D-glucose transport assays
Glucose transport activity in both rat and human adipocytes was determined by measuring the 
uptake of 3-O-methyl-D-glucose (3-OMG). Uptake was initiated by the addition of 50 pi of a 
40 % adipocyte suspension to 10 pi of 200 pM 3-OMG containing 0.15 pCi of 3-O-methyl-D- 
[U-14C]glucose, all in KRH buffer. Uptake studies were performed in 4 ml (50 mm x 13 mm) 
polypropylene tubes (Nunc/Gibco). Uptake was terminated by the rapid addition of 3 ml of 
300 pM phloretin in KRH. The phloretin was initially dissolved in ethanol, such that the final 
concentration of ethanol on dilution in KRH was 0.5% (v/v). Uptake was measured for 3 
seconds for insulin-stimulated cells and 120 seconds in basal cells. For cells treated with 
inhibitory or stimulatory compounds of GLUT4 translocation, timings were altered 
appropriately so as to allow uptake in the 30-60% cell fractional filling range. These timings 
are given in the results section where appropriate. Uptake for each condition was measured in 
triplicate. For uptake times less than 10 seconds a metronome was used, set at 2 beats/second. 
Background values (cpmbg) corresponding to extracellular trapped radioactivity were 
determined by adding the phloretin solution to the 3-OMG before the addition of the cells. 
Infinity values (cpnioo) (indicating equilibrium distribution of the radioactivity) were 
determined by incubating insulin-treated cells with the 3-OMG for 30 min at 37°C. Cells were 
recovered by oil floatation following addition of approximately 1 ml of Dow Coming 200/100 
cs silicon oil to the tubes and centrifugation at 2,500 rpm for 45 seconds (MSA bench 
centrifuge, swing-out rotor). Cells were removed from the top of the oil by using small pieces 
of pipe-cleaner and were placed in scintillation vials. Scintillation fluid was added to the vials
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and radioactivity uptake (cpm) counted by liquid scintillation counting (Packard 1500 
scintillation counter). The rate constant of 3-OMG uptake v/s (s_1) was calculated from the 
fractional filling (f). The rate constant v/s (s'1) = -ln(l-f)/t, where t = time of uptake in 
seconds, and f = (cpm-cpmbg) /  (cpnioo-cpmbg), which assumes that filling follows a single 
exponential time function (Taylor & Holman, 1981).
2.11 3-O-Methyl-D-glucose transport in adipocytes following a 24 h maintenance in 
tissue culture
3-OMG uptake was measured in adipocytes following a 20 h maintenance in tissue culture 
(section 2.8), either directly (section 2.10) or after the addition of 1 pM wortmannin. The rate 
constant of 3-OMG uptake was measured at time points after wortmannin addition, t = 0, 3, 
6, 9,20, 30 and 60 min. To enable the amount of fractional filling to be calculated at each time 
point, the uptake times (used for estimating the rate constant for 3-OMG) varied, and are 
given in table 4.
Culture Time in seconds of measurement of 3-OMG uptake at time 
(t) following wortmannin treatment 
t = 0 & 3 t = 6 & 9 t = 20 & 30 t = 60Condition
Basal 30 40 50 60
Insulin-acute 5 7 10 30
Insulin-chronic 10 15 20 40
Insulin-chronic
/Metformin
5 7 10 30
Table 4. Time used for measuring 3-OMG uptake in cultured adipocytes following 
wortmannin treatment.
The measurements of the 3-OMG uptake rate constants following wortmannin treatment 
allowed an estimate of the rates of endocytosis and exocytosis rate constants for GLUT4 to be 
calculated as follows:
It was assumed that GLUT4 exists in only two pools, one in the low-density microsomes and 
one in the plasma membrane. The process of redistribution between these two pools can be 
described by a single exponential function (eqn. 1)
£1? = ke* .(1-Tp) - ken .TP (Eqn. 1)
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where Tp is the plasma membrane GLUT4 pool expressed as a fraction of the total cellular 
GLUT4 pool, and kcx and ken represent the exocytosis and endocytosis rate constants for 
movement between the two pools of GLUT4. Integration of equation 1, where Tp = Tpo at t 
= 0 gives
Tp = k x  . (1 e x p (  t(k e x  + k e n ) ))  + ^  e x p ( - t ( k e x  + k e n ))  (Eqn. 2)
Kex ' Ken
For the analysis of transport data, the rates of transport for all conditions were normalised to 
the unperturbed acute insulin-treatment transport rate and this ratio was multiplied by the Tpo 
value (0.5) for cell-surface GLUT4 in the acute-insulin treatment (Yang et al.y 1992). The rate 
constants kex and ken were calculated by least-squares fitting (non-weighted fit) to equation 2, 
using the PRISM software (GraphPad Software, Inc., San Diego).
2.12 Subffactionation of rat adipocytes
Adipocytes were washed twice in TES buffer (plus protease inhibitors) at 18°C, and 
resuspended to give a suspension of 1.0 ml cells at approximately 80% cytocrit. Cells were 
then homogenised with 10 strokes in a 55 ml Potter-Elvehjem homogeniser (Thomas 
Scientific). The specific clearance of the homogeniser was 150 pm. Unless otherwise stated, 
the homogenate and all subsequent fractions were centrifuged in a Beckman TL-100 benchtop 
ultracentrifuge at 4°C, using a TLA-100.3 fixed angle rotor. Centrifugation of homogenates at 
1 7 ,5 0 0 ^  for 20 min gave a crude membrane pellet, a microsomal/cytosol fraction and a 
layer of fat. The microsomal and cytosol fraction was centrifuged at 49,000<§nax for 9 min to 
pellet the high-density microsomes (HDM). The HDM pellets were resuspended in TES and 
stored at -20°C until required. The post-HDM supernatant was centrifuged at 541,000<^mx for 
17 min to pellet the low-density microsomes (LDM) containing GLUT4 vesicles. The LDM 
pellet was also resuspended in TES and stored at -20°C until required. Following the removal 
of the solid fat layer from centrifuge tubes, membrane pellets were resuspended in TES and 
homogenised with 5 strokes in a 10 ml homogeniser tube (Braun) and centrifuged at 
17,500<£nax for 20 min. Membrane pellets were resuspended in 300 pi of TES and loaded on 
top of 600 pi of a sucrose cushion (1.12 M sucrose, 10 mM Tris-HCl pH 7.2, 5 mM EDTA). 
These were then centrifuged at 105,000<^nax for 20 min in a Beckman TLS-55 swing-out rotor. 
The plasma membranes were collected at the cushion interface and resuspended in 3 ml of
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TES. The collected plasma membranes were pelleted by centrifugation at 74,000§nax, 
resuspended in TES and stored at -20°C.
2.13 Photolabelling of GLUT4 in rat adipocytes
1 ml aliquots of adipose cells at a cytocrit of 40% in KRH buffer were added to 0.5 mCi of 
ATB-[3H]BMPA in 35 mm-diameter polystyrene dishes (Nunc/Gibco) and irradiated for 1 
min using 300 nm lamps in a Ravonet RPR-100 photoreactor. Following irradiation, cells were 
washed 3 times with 1% (w/v) BSA/KRH at 18°C and lysed with 1% (w/v) Thesit in PBS 
(with protease inhibitors). Cells were solubilised for 20 min at room temperature and then 
centrifuged at 20,000^ for 20 min at 4°C. GLUT4 was immunoprecipitated from the detergent 
soluble lysate (section 2.15) and analysed by SDS-PAGE and liquid scintillation counting of 
proteins extracted from gel slices (section 2.26).
2.14 In Situ periodate-oxidised GTP labelling
Freshly isolated adipocytes (200 pi of 40% cytocrit suspension) were permeabilised with a- 
toxin (8 pg/ml) in the presence of 25 pCi [a-32P] GTP (3000 Ci/mmol). Permeabilisation was 
performed in 0.1% (w/v) BSA/KRH with 4 mM Mg-ATP and 3 mM sodium pyruvate, at 
37°C for 15 min. Appropriate aliquots of cells were then stimulated with 20 nM insulin for 5 
min followed by centrifugation through silicone oil at 1,000^ for 10 seconds. Excess buffer 
and silicon oil was removed and cells were then incubated with 1 mM NaIC>4 for 1 min, then 1 
mM NaCNBH3 for 1 min and finally 20 mM NaBH4 for 1 min (all freshly made up in KRH 
buffer). This was followed by a 10 min incubation at 4°C. Cells were then lysed in ice cold 
lysis buffer with protease inhibitors. The lysates were centrifuged at 13,400^ in a microfuge for 
5 min and detergent-soluble lysates were added to SDS-PAGE sample buffer. Samples were 
then analysed by either SDS-PAGE or two-dimensional electrophoresis, followed by 
autoradiography.
2.15 Immunoprecipitation of proteins
Dried Protein A immobilised on Sepharose CL-4B (Sigma) was rehydrated with PBS for 15 
min on ice. The rehydrated Protein A-Sepharose was resuspended to give a 50% (v/v) 
suspension. Protein G-Sepharose was supplied hydrated, and was washed 3 times with PBS to 
remove preservatives. The Protein G-Sepharose was resuspended to give a 50% (v/v)
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suspension. Rabbit and the majority of mouse antibodies were conjugated to Protein A, 
mouse IgGi and goat antibodies were coupled to Protein G.
Antibodies were coupled to 20-30 pi (50% suspension) of either Protein A-Sepahrose or 
Protein G-Sepharose in 1 ml of PBS for 2 h at 4°C with rotation. The amounts of antibody 
used are given in table 3. The antibody-Sepharose conjugates were pelleted by centrifugation 
at 13,400^ for 1 min and were washed with PBS. This washing was repeated a further 2 times. 
Cell lysates were then added to the antibody-Sepharose conjugate pellets. Generally 1 ml of 
adipocyte cell lysate (section 2.9) was added to each pellet. The lysates were rotated with the 
Sepharose conjugates for 2 h at 4°C. The Sepharose conjugates were pelleted and either 
washed 3 times with lysis buffer for SDS-PAGE, or with appropriate buffers for the kinase 
assays (section 2.17, section 2.18). Immunoprecipitation of phosphotyrosine containing proteins 
was as described above, but no antibody conjugation was required since the anti- 
phosphotyrosine antibody was covalently coupled to the agarose suspension supplied.
2.16 Immunoprecipitation of GLUT4 vesicles
GLUT4 vesicles were isolated using Staphylococcus aureus Cowan I cells (Staph cells) expressing 
Protein A on the surface membranes (Sigma). Staph cells were initially prepared by heating to 
95°C for 30 min in an extraction buffer (50 mM Tris-HCl pH 7.2, 150 mM NaCl, 104 mM 
SDS, 10% (v/v) 2-mercaptoethanol), at a ratio of 50 mg Staph cells/ml buffer. Staph cells 
were then pelleted by centrifugation at 13,400^ for 1 min, the supernatants removed, and the 
resuspended again in extraction buffer. Cells were again heated to 95°C for 30 min, pelleted 
and washed 3 times with TES buffer. Cells were finally resuspended in TES at 50 mg/ml and 
aliquots stored at -20°C until required.
Aliquots of the Staph cells (40 |lll) which were used for immunoprecipitation experiments were 
rotated (2 h at 4°C) with either rabbit serum or anti-GLUT4 rabbit serum (50 pi serum) in 1 
ml TES buffer. Staph cells were then washed 3 times with 1 ml of TES buffer and then mixed 
with adipocyte post-HDM supernatants as appropriate. The equivalent of 1 rat post-HDM 
supernatant was added to each 40 pi of Staph cell suspension. Adipocyte post-HDM 
supernatants were initially pre-cleared using Staph cells bound with rabbit IgG for 30 min at 
4°C (with rotation). Supernatants were then transferred to Staph cells bound with rabbit IgG 
(pre-immune controls) or rabbit anti-GLUT4 IgG (GLUT4 vesicle isolation) for 2 h at 4°C
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with rotation. Staph cells were washed 3 times with TES buffer and vesicle proteins 
solubilised with 1% (v/v) Thesit in TES (20 min at room temperature). Following removal of 
solubilised vesicle proteins from the Staph cell pellets, IgG and GLUT4 molecules still bound 
to the Staph cells, were recovered from the Staph cells by heating in SDS-PAGE sample 
buffer (20 mM dithiothreitol (D'l'i) as the reducing agent) to 95°C for 2-3 min.
2.17 Measurement of PI 3-kinase activity
PI 3-kinase activity was measured in immunoprecipitates isolated from adipocyte cell lysates. 
Following immunoprecipitation, Protein A-Sepharose pellets were washed twice with 12.5 mM 
Na2HP0 4 .12H2 0 , pH 7.2,154 mM NaCl, 1% (w/v) Thesit, 1 mM DTT, then twice with 0.1 M 
Tris-HCl pH 7.4, 0.5 M LiCl, 1 mM DTT, and finally twice with 10 mM Tris-HCl pH 7.4, 100 
mM NaCl, 1 mM DTT (1 ml for each wash). Immunoprecipitates were resuspended in a final 
volume of 50pl containing 20 mM HEPES pH 7.1, 0.4 mM EGTA, 0.4 mM Na2HP0 4 .12H2 0 , 
10 mM MgCl2.6H20, 40 pM ATP with 10 pCi [y-32P]ATP and 10 pg of either 
phosphatidylinositol (PI) or phosphatidylinositol 4,5-bisphosphate (PI 4,5-P2). After 20 min at 
room temperature, the assay was stopped by the addition of 30 pi 4 M HCL 130 pi of 
chloroform/methanol 1:1 (v/v) was then added to each tube. The tubes were vortexed briefly 
and centrifuged at 13,400^ for 10 min to separate the chloroform and aqueous phases.
TLC polyester plates coated with silica gel (layer thickness 250 pm, particle size 5 to 17 pm, pore 
size 60 A) were pre-treated for 10 seconds with /ra/w-l,2-diaminocyclohexane-N,N,N’,N’- 
tetraacetic acid (CDTA) in 0.6% (v/v) 10 M NaOH, 66 % (v/v) ethanol. Plates were left to air- 
dry before baking in an oven at 80°C for 1 h. 10 pi samples from the lower chloroform phase 
were spotted on to the TLC plates and lipids separated by the following solvent system: 75 ml 
methanol, 60 ml chloroform, 45 ml pyridine, 12 g dissolved boric acid, 7.5 ml distilled water, 3 
ml 88 % (v/v) formic acid, 0.375 g 2,6-di-/i?//-butyl-4-methylphenol (BHI) and 75 pi ethoxyquin. 
After separation, the plates were dried and then exposed to autoradiography film. Radiolabelled 
phosphatidylinositides were then excised from the TLC plates and counted by liquid scintillation 
counting.
2.18 Measurement of PKB activity
PKB activity was immunoprecipitated from cell lysates {section 2.9), and Sepharose pellets were 
washed 3 times with lysis buffer (with protease inhibitors) and then 3 times with kinase assay
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buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2,.6H20). Immunoprecipitates were incubated in 
50 pi kinase assay buffer containing 1 mM DTT, 100 ng protein kinase A (PKA) inhibitor 
peptide, 25 fig protamine sulphate, 5 fiM ATP and 2 fiCi [y-32P]ATP. The reaction was allowed 
to proceed for 20 min at 30°C. Supernatants were then removed and 40 fil of 2% (w/v) SDS 
was added to the pellets. After a further 10 min, this supernatant was removed. The two 
supernatants were pooled and 20 (i! of the combined mixture in duplicate samples were spotted 
onto a 2 cm x 2 cm area of phosphocellulose paper. The phosphocellulose paper was washed 
five times, each for 5 min and with a large excess of 75 mM phosphoric acid, and then once with 
distilled water and once with acetone. The dried paper was cut into squares, scintillation fluid 
was added and then the radioactivity was estimated by liquid scintillation counting.
2.19 Benzophenone-phosphatidylinositide photolabelling
Initially, subcellular protein fractions were photolabelled using the benzophenone- 
phosphatidylinositide photolabels (section 6.2). Subsequent experiments on isolated rat 
adipocyte cytosol, used the benzophenone-phosphatidylinositide photolabels either before, or 
after chromatography purification steps (section 2.20, section 2.21). Initial photolabelling 
experiments used 0.2 fiCi (42.5 Ci/mmol) of the appropriate photolabel with 50 jig of protein. 
After chromatography purification steps, the photolabelling experiments used 0.1 fiCi of the 
appropriate benzophenone-based phosphatidylinositide photolabel with 50 |ig of protein. 
Photolabelling reactions in which the competition with non-radioactive phosphatidylinositides 
was studied, contained a 1000-fold molar excess of non-radioactive phosphatidylinositide to 
radioactive phosphatidylinositide-photolabel.
Protein samples for photolabelling (50 fig) were incubated with the appropriate 
phosphatidylinositide-photolabel for 10 min on ice, in a final volume of 50 pi in either TES 
buffer or TE buffer (10 mM Tris-HCl pH 7.2, 1 mM EDTA). Following the 10 min 
incubation on ice, protein samples to be photolabelled were transferred to flat-bottomed, 
clear, polystyrene 96 well plates (Falcon), and irradiated with 350 nm light using a Rayonet 
RPR-100 photoreactor (maximum intensity 9,200 (iWatts/cm2), for 30 min at 4°C. SDS 
sample buffer was then added to the samples and the proteins were separated by SDS-PAGE 
on 10% Laemmli gels. Gels were then stained with Coomassie brilliant blue, destained, and 
were then incubated with Amplify for 30 min. The gels were then dried down and the 
radioactivity was imaged by exposure to autoradiography film for 4-60 days (section 2.26).
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2.20 Binding to heparin-agarose
Adipose cells were isolated from the epididymal fat pads from 20 rats, and the cytosol 
fractions were obtained (containing approximately 30 mg protein). These samples were diluted 
5 fold with 10 mM Tris-HCl pH 7.2. The diluted cytosol fractions were then incubated (2 h at 
4°C with rotation) with 5 ml of heparin-agarose type I (Sigma) (per 20 rats), which had been 
previously washed with 10 mM Tris-HCl pH 7.2, 1 mM EDTA. NaCl was added to the 
heparin-agarose plus cytosol fraction to give a final NaCl concentration of 50 mM. Following 
the 2 h incubation of the cytosol fractions with the heparin-agarose, the agarose resins were 
washed with 20 volumes of 10 mM Tris-HCl pH 7.2, 1 mM EDTA, at 4°C. The heparin- 
agarose was then incubated for 2 h at 4°C with 10 mM Tris-HCl pH 7.2, 1 mM EDTA 
containing 175 mM NaCl (approximately 50 ml). The heparin-agarose eluates were then 
removed and the agarose was washed as previously described but using 10 mM Tris-HCl pH 
7.2, 1 mM EDTA, with 300 mM NaCl. Eluate fractions were then repeatedly concentrated 
(using Macrosep and Microsep centrifugal concentrators (Pall Filtron), MWCO = 10K) and 
then diluted with 10 mM Tris-HCl pH 7.2, 1 mM EDTA, to remove the NaCl from the 
eluates. Concentrated heparin-agarose eluates were then either photolabelled using 
benzophenone-phosphatidylinositide photolabels (section 2.19), or were further purified by 
phosphoinositide affinity chromatography (section 2.21).
2.21 Phosphoinositide affinity columns
Phosphoinositide affinity resins (Ins(l,3,4)P3 and Ins(l,3,4,5)P4 linked to Bio-Rad Affi-Gel 
10) were washed with 10 column volumes of 10 mM Tris-HCl pH 7.2, 1 mM EDTA and 
packed into C 10/10 columns with AC 10 adapters (Pharmacia Biotech). The heparin-agarose 
eluates (300 mM NaCl elution fractions) were continuously circulated through the 
phosphoinositide affinity resin columns overnight at 4°C using a peristaltic pump. The affinity 
columns were then washed with 10 mM Tris-HCl pH 7.2, 1 mM EDTA and those proteins 
which bound to the phosphoinositide affinity resins were eluted using a NaCl gradient, (0-2 
M) with a flow rate of 0.2 ml /  min (all at 4°C). Thirty 1 ml fractions were collected. Protein 
concentrations from the fractions eluted from the affinity columns were estimated by 
measuring the absorbance at 280 nm. Fractions were concentrated using Microsep centrifugal 
concentrators (as previously described, section 2.20).
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2.22 Protein assays using BCA
Protein concentrations were determined using the Pierce bicinchoninic acid (BCA) protein 
assay. Protein samples for protein determination were diluted with 0.2 M NaOH to give a final 
concentration of 0.1 M NaOH. 10 pi of protein samples were then mixed with 200 pi aliquots 
of BCA reagent, in the wells of microplates (Labsystems). Protein concentrations were 
calculated from a standard calibration curve using 0-10 pg BSA. Colour development due to 
Cu+1 and BCA complex formation was allowed to proceed for 30 min at 37°C. This was 
followed by measurement of the absorbance at 595 nm in a microplate spectrophotometer.
2.23 Chloroform and methanol protein precipitation
Proteins were precipitated by adding 1 ml methanol and 250 pi chloroform to 250 pi of 
protein sample in polypropylene tubes. Tubes were centrifuged at 9,000^ for 10 s and then 750 
pi H2O was added to each tube. Tubes were further centrifuged at 9,000£ for 1 min. The 
upper aqueous phases were removed (being careful not to remove precipitated proteins from 
the chloroform/aqueous phase interface) and a further 750 pi methanol was added to the 
chloroform/protein samples. This was followed by centrifugation at 9,000^ for 2 min. The 
supernatants were discarded and protein pellets were dried under vacuum with centrifugation.
2.24 Enzyme linked immunosorbant assay (ELISA)
ELISA’s were performed in 96-well ELISA plates (Labsystems). For assaying anti-Giai/2 and - 
GLUT4 antibodies, wells were coated with the corresponding immunising peptide (20 
ng/well) in 100 pi of PBS overnight at 4°C. After the binding of the peptides to the wells, the 
ELISA plates were washed 3 times with 100 pi of 0.05 % (v/v) Tween-20 in PBS (PBS-T) at 
room temperature and then incubated for 30 min at 37°C with 100 pi of 5 % (w/v) BSA in 
PBS. Wells were again washed 3 times with PBS-T, then incubated for 2 h at 37°C with 100 pi 
of the appropriate antibody solution, diluted appropriately in PBS-T. Following the incubation 
with the primary antibody, ELISA plates were washed 3 times with PBS-T, then incubated 
with 100 pi of a 1:2000 dilution of goat anti-rabbit peroxidase conjugate (Sigma) in PBS-T for 
2 h at 37°C. Wells were then washed 3 times with PBS-T and 100 pi of substrate (0.1 M 
sodium acetate, pH 6.0, 100 pg/ml tetramethylbenzidine, 0.005 % (v/v) H2O2) was added to 
each of the ELISA plate wells. ELISA plates were then incubated at 37°C until a blue colour
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developed. The reaction was stopped by the addition of 25 pi of 1 M H2SO4 to each well. The 
absorbance of the resulting yellow colour was read at 450 nm in a microtitre plate reader 
(Labsystems).
2.25 SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
Protein samples to be resolved by SDS-PAGE were added to sample buffer (section 2.2) and 
heated to 95°C for 2-3 min, before loading onto Laemmli gels.
Discontinuous polyacrylamide gels (lower resolving gel and upper stacking gel) were produced 
using either the Bio-Rad minigel apparatus (Mini-PROTEAN II electrophoresis cell) or the 
Bio-Rad PROTEAN II xi slab cell system (all gels were 1.5 mm in thickness). The following 
solutions were used to make the gels: resolving gel buffer (1.5 M Tris-HCl pH 8.8, 0.4 % 
(w/v) SDS), stacking gel buffer (0.5 M Tris-HCl pH 6.8, 0.4 % (w/v) SDS), 10% (w/v) 
ammonium persulfate, N,N,N\N’-tetramethylethylenediamine (TEMED) and acrylamide/bis 
(30.8% T, 2.6% C; Protogel, National Diagnostics). For both systems resolving gels were 
made to 0.375 M Tris-HCl and 0.1 % (w/v) SDS with acrylamide concentrations in the range 
of 7 to 15 %. Stacking gels were made to 0.125 M Tris-HCl and 0.1% (w/v) SDS with 
acrylamide concentrations at 6%, or 4% when using 7% resolving gels. Acrylamide 
polymerisation was initiated by the addition of TEMED and ammonium persulfate to give 
final concentrations of both TEMED and ammonium persulfate at 0.05%. The electrode 
buffer was 25 mM Tris-HCl pH 8.3, 0.1 % (w/v) SDS, 192 mM glycine.
Minigels were run at a constant 200 mA. PROTEAN II xi gels were generally run at low 
current overnight (10-13 mA constant current), or with a maximum constant current of 25 
mA through stacking gels and 35 mA through resolving gels. Gels were run until the 
bromophenol blue dye front eluted from the bottom of the gels. Broad range molecular 
weight markers (New England Biolabs) were run on each gel for molecular weight 
determination.
2.26 Gel staining, imaging and analysis
Proteins separated by SDS-PAGE were either transferred onto nitrocellulose (section 2.28) or 
fixed within the polyacrylamide gel matrix. Gels were either stained for 30 min with 0.2 % 
(w/v) Coomassie Blue R-250 in fixative (30% (v/v) methanol, 10% (v/v) glacial acetic acid)
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and destained for a few hours in fixative only. Alternatively, more sensitive staining was 
obtained using silver staining-reagent (Bio-Rad, Silver Stain Plus kit).
Protein-fixed gels containing tritium (from [3H]BZDC-phosphatidylinositide photolabelled 
proteins) were incubated with Amplify for 30 min at room temperature with gende agitation. 
These gels were briefly rinsed in water and dried down onto 3M filter paper using a Labconco 
gel dryer attached to a vacuum pump. Drying was at 60-80°C for 2 h. The 
photolabelled/tritiated proteins were visualised by exposure to autoradiography film (BioMax 
MR film, Kodak) placed directly on the gels for 4-60 days at -80°C. 32P-labelled proteins were 
also detected by liquid scintillation counting of gel slices. In these instances, lanes from the 
gels were cut into 6.5 mm slices and dried individually in open scintillation vials at 80°C. Dried 
gel slices were then solubilised with 0.5 ml 2% (v/v) NH4OH in 30% (w/w) H2O2 in sealed 
vials at 80°C. Following solubilisation of the gel slices, scintillation fluid was added to each 
vial and the radioactivity detected by liquid scintillation counting. Gels containing 32P-labelled 
proteins were also dried down (as above) and labelled proteins visualised by exposure to 
autoradiography film at -80°C.
2.27 Two-dimensional gel electrophoresis
Two-dimensional gel electrophoresis was performed using Pharmacia Biotech Immobiline 
DryStrips and ExcelGel SDS gradient gels with the Pharmacia Multiphor II Electrophoresis 
Unit. Immobiline strip preparation and the conditions for running both the first and second 
dimension gels was as described in the manufacturer instructions.
Adipocyte cell lysates (generated following periodate-oxidised GTP-labelling, section 2.14) were 
chloroform/methanol precipitated and re-dissolved in 40 pi of lysis buffer. To each sample, 
60 pi of 2D-gel electrophoresis sample buffer was added (9 M Urea, 0.02 % (v/v) Triton X- 
100, 0.02 % (v/v) 2-mercaptoethanol, 0.02% (v/v) Pharmalyte 3-10, 100 pM AEBSF). 
Samples were then applied to 180 mm Immobiline strips, with linear pH (3-10) gradients. 
Isoelectric focusing was then achieved in two phases: 3 hr at 500 Volts then 17.5 h at 3500 
Volts. Following the isoelectric focussing, Immobiline strips were then run on ExcelGel 12-14 
% gradient polyacrylamide gels (245 x 180 mm). Gels were run stepwise at 20 mA for 45 min, 
then 40 mA for 5 min, and finally 40 mA for 160 min. Gels were then stained by Coomassie 
Blue, destained and then 32P-labelled proteins visualised using a Molecular Dynamics
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phosphorimager. Molecular weight and pi values of gel proteins were determined by 
comparison with 2D SDS-PAGE molecular weight standards (Bio-Rad).
2.28 Electrophoretic transfer of proteins to nitrocellulose
Following SDS-PAGE, polyacrylamide gels were soaked in transfer buffer (0.0375 % (w/v) 
SDS, 48 mM Tris-HCl pH 8.8, 39 mM glycine, 20 % (v/v) methanol) for 5 min at room 
temperature. Gels were then placed onto nitrocellulose (BioTrace, 0.45pm pore size, Gelman 
Sciences) wetted with transfer buffer, and sandwiched between electrode- paper soaked in 
transfer buffer. Transfers were carried out using the Pharmacia Multiphor II NovaBlot unit, 
with a field strength of 0.8 mA/cm2 membrane for 110 min. After transfer, nitrocellulose 
membranes were rinsed in distilled water and then stained with 0.1% (w/v) Ponceau S in 3% 
(w/v) trichloroacetic acid. Molecular weight markers were identified and marked on the 
nitrocellulose with pencil.
2.29 Western blotting
Nitrocellulose membranes were briefly rinsed in TBS-T (section 2.2) to remove any excess 
Ponceau S stain. These membranes were then blocked with 5% (w/v) dried skimmed milk in 
TBS-T for 30 min at room temperature. For phosphotyrosine blotting, the milk was 
exchanged for 5% (w/v) BSA. Nitrocellulose membranes were briefly rinsed in TBS-T and 
then incubated with appropriate primary antibodies in 1% (w/v) BSA in TBS-T for 1 h at 
room temperature. The dilutions used for the primary antibodies are given in table 2.1. 
Following incubation with the primary antibodies, nitrocellulose membranes were washed 
with TBS-T for 30 min with frequent changes of buffer. After washing, the nitrocellulose was 
incubated with the secondary antibody (1:4000 anti-rabbit or anti-goat (Sigma), or 1:1000 anti­
mouse (Sigma) IgG conjugated to horseradish peroxidase) in 5% (w/v) dried skimmed milk in 
TBS-T for 30 min at room temperature. Alternatively, membranes were incubated with 125I- 
Protein A (0.1 pCi/ml in TBS-T) for 90 min at room temperature. Nitrocellulose membranes 
were then washed with TBS-T for 30 min as previously described. Membranes were incubated 
for 1 min with ECL detection reagents (0.125 ml/cm2 membrane) and exposed to 
autoradiography film for 5 s - 10 min. 125I-Protein A detection was carried out using air-dried 
membranes wrapped in cellophane which were exposed to autoradiography film at -80°C, for 
2-3 days.
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2.30 N-terminal protein sequencing
For proteins to be N-terminally sequenced from membranes, modifications were made to the 
SDS-PAGE and electrophoretic transfer protocols in order to minimise N-terminal blocking 
of proteins.
Protein samples were added to sample buffer and heated to 65°C for 30 min (not 95°C for 2-3 
min). Polyacrylamide gels were made at least 12 h before use, using acrylamide deionised with 
Amberlite MB-1A (a spatula-full of Amberlite into the acrylamide stock). Additionally, 2 mM 
sodium thioglycolate was included in the cathode buffer, and SDS-PAGE gels were pre-run 
for 10 min before the loading of protein samples.
Proteins were transferred onto polyvinylidene difluoride membranes (PVDF, ProBlott, 
Applied Biosystems) and not nitrocellulose. The PVDF membrane was prepared by soaking in 
methanol for 10 seconds followed by equilibration in transfer buffer for 5 min. The transfer 
buffer was modified and was 25 mM Tris-HCl pH 8.3,190 mM glycine, 10 % (v/v) methanol. 
Following transfer, the PVDF was washed 3 times with distilled H2O containing 130 pM 
DTT (10 min per wash), then 3 times with just distilled H2O. Protein bands were visualised by 
Ponceau S staining and membranes were dried overnight in a vacuum dessicator.
Protein bands were excised from membranes and sequenced using an ABI 477A Pulsed liquid 
protein microsequencer with 120A on-line analyser (Applied Biosystems). Sequencing was 
done by J. Gilroy and R. Croy at the Department of Biological Sciences, University of 
Durham.
2.31 Protein sequencing by tryptic digestion
Proteins (as indicated in section 6.7) were sequenced by a process of tryptic digestion followed 
by MALDI-TOF (matrix assisted laser description ionisation-time of flight) mass 
spectroscopy. Masses of spectroscopy fragments were compared with the theoretical tryptic 
digestion masses of proteins held in databases. Matches between mass fragments from the 
unknown sample and the databases were confirmed by Edman degradation. Tryptic digests 
and their subsequent analysis were all done by M. Skehel, Bioinformatics, SmithKline 
Beecham Pharmaceuticals, Harlow using the following method:
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Protein bands on PVDF were excised from membranes using a razor blade, and the 
membranes were washed with distilled water for 1 h at room temperature. The water was 
removed from the PVDF membranes and the membranes were washed with 4% (w/v) 
CFIAPS for 1 h at room temperature. The PVDF membranes were further washed with 20 
mM Tris-HCl pH 8.0 for 30 min at room temperature. The Tris-HCl was removed from the 
PVDF membranes, and the membranes were then covered with a solution of 20 mM Tris- 
HCl pH 8.0, containing 10 mM DTT. The PVDF membranes were then incubated at 55°C 
for 1 h. After cooling to room temperature, the DTT solution was removed and replaced with 
a solution of 55 mM iodoacetamide in 20 mM Tris-HCl pH 8.0. The PVDF membranes were 
incubated in the iodoacetamide solution for 45 min in the dark at room temperature. The 
PVDF membranes were then washed twice with 20 mM Tris-HCl pH 8.0, then incubated 
overnight at 37°C with a solution of 20 mM Tris-HCl pH 8.0, containing 5 mM CaCh and
12.5 ng/pl sequencing grade trypsin (Boehringer). The digestion solution was removed from 
PVDF membranes and transferred to Eppendorf tubes. Peptides were then extracted from the 
PVDF membranes by covering membranes with 5.0% (v/v) formic acid for 1 h at room 
temperature with occasional vortexing. Peptides were further recovered from PVDF 
membranes by covering membranes with 60% acetonitrile in 5.0% (v/v) formic acid for 1 h at 
room temperature with occasional vortexing. The latter extraction was repeated, and then all 
extracts were combined and concentrated down in a Speed-vac to 10-20 pi.
Tryptic digests were analysed by mass spectroscopy on a Micromass TOF Spec E research 
grade spectrometer. Briefly, lpl of the peptide solution obtained from a tryptic digest was 
mixed with 0.5 pi of 1% a-cyano-4-hydroxycinnamic acid matrix solution in 70% acetonitrile 
containing 0.1% trifluoroacetic acid and 200 fimole/pl insulin P-chain as internal standard. 
The mixture was allowed to air dry and then spectra were collected.
The remaining peptide solution obtained from a tryptic digest was separated out on a 
Beckman Gold HPLC system using a reverse phase column (Brownlee Aquapore RP300 7pm 
100 x 1 mm) on a gradient of 5-65 % methylcyanide containing 0.08% trifluoroacetic acid, at a 
flow rate of 0.2 ml/min. A dual wavelength Beckman 167 detector monitoring at 215 nm and 
280 nm was used to detect cleavage products, which were collected for further analysis. The 
resulting peptide peaks were reduced in volume by drying partially in a Speed-Vac and were 
analysed by MALDI mass spectroscopy prior to Edman degradation and sequencing. Edman
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degradation and sequencing used an Applied Biosystems 477A pulsed liquid automated 
protein sequencer.
2.32 Data analysis
Data were plotted using GraphPad PRISM v 2.1 (GraphPad Software, Inc., San Diego). 
Statistical analysis was carried out using the PRISM program with unpaired t tests.
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CHAPTER 3
IN SU LIN -R ESISTA N CE IN 
RAT A D IPO C Y T E S
PART A -  Insulin signalling in insulin-resistant rat adipocytes
Large decreases in insulin-responsive glucose transport occurs in rat adipocytes maintained in 
culture for 20 h in the continuous presence of insulin (Kozka & Holman, 1993). Although the 
total cellular content of GLUT4 is unaltered, or changes very little in the chronic insulin 
condition, the cell surface levels of GLUT4 are reduced by up to 60% and the adipocytes are 
poorly responsive (measuring glucose uptake) to an additional acute-insulin treatment. This 
defect may be due to either impaired/altered signalling, impaired/altered trafficking of the 
GLUT4 or a combination of both. Hence, the roles of early signalling intermediates and the 
trafficking of GLUT4 were investigated in these insulin-resistant adipocytes. Additionally, the 
effect of the oral anti-hyperglycaemic drug metformin on both signalling and GLUT4 
trafficking was studied under these conditions.
3.1 Glucose transport in rat adipocytes chronically treated with insulin
Following a 20 h culture of rat adipocytes in the absence of insulin, a subsequent acute insulin 
stimulation (20 nM) for 30 min produced a 5.6-fold increase in 3-OMG transport (figure 8). 
However, when the cells were cultured in the presence of 500 nM insulin, the levels of glucose 
transport activity were only 3-fold above those in basal cells, a 40-50% reduction in 
comparison with acutely insulin-stimulated cells. This reduction in insulin-stimulatable glucose 
transport following chronic-insulin treatment was alleviated when cells were cultured in the 
presence of both 500 nM insulin and 1 mM metformin. In this case, the subsequently 
measured levels of 3-OMG transport were 7.4-fold higher than in basal cells.
3.2 Protein levels of intracellular signalling intermediates
To investigate whether the reduced glucose transport activity in adipose cells that have been 
chronically treated with insulin was associated with reduced levels of known insulin signalling 
proteins, Western blotting was carried out on whole cell lysates for the regulatory subunit of 
PI 3-kinase (p85), IRS-1 and the p-subunit of the insulin receptor. The blots for p85, IRS-1 
and the P-subunit of the insulin receptor are shown in figure 9(A-C) respectively. The Western 
blotting shows that the levels of these signalling molecules does not alter with the chronic- 
insulin treatment, or following chronic-insulin treatment in the presence of metformin.
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Figure 8. 3-OMG transport in rat adipocytes following a 20 h culture. Isolated rat 
adipocytes were cultured with either no additions (basal; B), in the presence of 500 nM insulin 
(chronic; Ic), or with 500 nM insulin and 1 mM metformin (chronic metformin; IcM). All cells 
were washed and adjusted to 40% cytocrit. A portion of the basal cells were acutely stimulated 
with 20 nM insulin for 30 min (acute stimulation; la). The rates of uptake of 50 pM 3-OMG 
were then determined. Data are means ± SEM from 6 separate experiments. *** P<0.001 vs. 
Ic.
B




Figure 9. Western blot analysis of the levels of signalling proteins in adipocyte whole 
cell lysates. Freshly isolated adipocytes were cultured for 20 h either with no additions (B), or 
with 500 nM insulin (Ic), or with 500 nM insulin and 1 mM metformin (IcM). Cells were 
subsequently washed and adjusted to 40% cytocrit. A portion of basal cells were stimulated 
with 20 nM insulin for 2 min (la). 0.5 ml portions of the cells from each condition were then 
direcdy lysed with sample buffer and 20 pg of lysate protein was loaded onto 8% SDS-PAGE 
minigels. Proteins were transferred onto nitrocellulose and blotted for either p85 (A), IRS-1 
(B) or the P-subunit of the insulin receptor (C). The blots shown are representative of 3 
separate experiments.
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3.3 Phosphorylation of the insulin receptor P-subunit
Since the reduced glucose transport activity following chronic-insulin treatment did not 
correlate with reduced protein levels of either the insulin receptor, IRS-1 or p85, the extents of 
activation of these intermediates were investigated. The extent of tyrosine phosphorylation of 
the insulin receptor was analysed in phosphotyrosine immunoprecipitates obtained from 
detergent lysates. Immunoprecipitated proteins were separated by SDS-PAGE, transferred 
onto nitrocellulose and blotted for phosphotyrosine (figure 10A). Scanning densitometry of 
autoradiograms (figure 10B) showed that insulin, within 2 min, produced extensive 
phosphorylation of tyrosine residues of the receptor p-subunit, the 97 kDa band on the SDS- 
PAGE gels. However chronic-insulin treatment of the cells produced a 70% decrease in the 
levels of tyrosine phosphorylation on the receptor P-subunits. This decrease was partially 
reversed when metformin was included in the chronic-insulin culture. There was then a 2-fold 
increase in p-subunit tyrosine phosphorylation compared to the response to chronic-insulin 
treatment, but to a level that was still only ~60% of the acute stimulation.
3.4 Levels of PI 3-kinase activity associated with tyrosine phosphorylated proteins
Downstream effects that may occur as a consequence of the reduced level of tyrosine 
phosphorylation of the insulin receptor include reduced coupling of PI 3-kinase to tyrosine 
phosphorylated proteins. The PI 3-kinase activity that was associated with tyrosine 
phosphorylated proteins was therefore determined in anti-phosphotyrosine agarose 
immunoprecipitates. PI 3-kinase activities were assessed direcdy in the immunoprecipitates. 
The phosphatidylinositol [32P]3-phosphate (PI [32P]3-P) generated in the assay was separated 
from reaction components by TLC. This major product was quantified by autoradiography. 
An autoradiogram image is shown in figure 11 A. The kinase activity was estimated by cutting 
out the PI [32P]3-P spots from the TLC plate, counting the radioactivity and relating this to 
the radioactivity of the ATP substrate (figure 11B). Following overnight culture of the adipose 
cells without insulin, a subsequent acute stimulation with insulin increased the kinase activity 
~20-fold (from 0.57 ± 0.13 fmol/min/ml 40% cells in the basal cells to 13.43 ± 2.18 
fmol/min/ml 40% cells following the insulin treatment). By contrast, the PI 3-kinase activity 
observed in adipose cells which were cultured in the continuous presence of insulin was only 
3.48 ± 1.082 fmol/min/ml 40% cells, a 6-fold increase over the basal levels, but only 26% of
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Figure 10. Tyrosine phosphorylation of the insuhn receptor p-subunit following 
chronic-insulin treatment. Adipocytes were cultured for 20 h either with no additions (B), 
or with 500 nM insulin (Ic) or with 500 nM insulin and 1 mM metformin (IcM). A portion of 
the cells cultured under basal conditions were acutely stimulated with 20 nM insulin for 2 min 
(la). Cells were lysed and phosphotyrosine containing proteins were immunoprecipitated with 
anti-phosphotyrosine agarose and then resolved by SDS-PAGE. The gels were then Western 
blotted using an anti-phosphotyrosine antibody. The autoradiogram shown is a typical blot 
(A). The phosphorylation of the P-subunit was quantified by scanning densitometry (B), and 
represents the mean ± SEM from 5 separate experiments. In comparison with Ic, *P<0.05, 
**P<0.01.
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the response observed in cells that were acutely treated with insulin. Treatment with both 
insulin and metformin during the culture period prevented the lowering of PI 3-kinase activity. 
The PI 3-kinase activity was 11.81 ± 3.08 fmol/min/ml 40% cells, 88% of the acute response. 
The PI 3-kinase activity measurements correspond closely with the levels of the p85 regulatory 
subunit of the enzyme that was found to be associated with phosphotyrosine 
immunoprecipitates. The Western blot analysis of the p85 is shown in figure 11C.
3.5 PI 3-kinase activity associated with IRS-1
PI 3-kinase activity associated with IRS-1 immunoprecipitates was investigated to determine 
whether IRS-1 associated PI 3-kinase activity correlated with PI 3-kinase activities observed in 
anti-phosphotyrosine immunoprecipitates. PI 3-kinase activities were assessed directly in the 
IRS-1 immunoprecipitates. As in previous experiments the PI [32P]3-P generated in the assay 
was separated from reaction components by TLC. A typical autoradiogram of the PI [32P]3-P 
spots is shown in figure 12A. The PI 3-kinase activity associated with IRS-1 is shown by figure 
12B. Following overnight culture of the adipose cells without insulin, the acute stimulation 
with insulin increased the kinase activity ~ 10-fold (from 0.11 ± 0.09 fmol/min/ml 40% cells 
in the basal cells to 1.08 ± 0.09 fmol/min/ml 40% cells following the insulin treatment). As 
observed in the anti-phosphotyrosine immunoprecipitates, the PI 3-kinase activity associated 
with IRS-1 was reduced in adipose cells cultured in the presence of insulin to only 0.42 ± 0.03 
fmol/min/ml 40% cells. This was a ~60% reduction in activity compared with acute-insulin 
treatment. However, in contrast to the results obtained with the phosphotyrosine antibody, 1 
mM metformin had no effect on the PI 3-kinase activity associated with IRS-1 in cells 
maintained in culture overnight in the presence of 500 nM. Under these latter conditions the 
PI 3-kinase activity was 0.46 ±0.11 fmol/min/ml 40% cells.
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Figure 11. PI 3-kinase activity associated with tyrosine phosphorylated proteins.
Adipocytes were cultured for 20 h either with no additions (B), or with 500 nM insulin (Ic), or 
with 500 nM insulin and 1 mM metformin (IcM). A portion of the cells cultured under basal 
conditions were acutely stimulated with 20 nM insulin for 2 min (la). 1 ml aliquots of the cells 
at 40% cytocrit were lysed, and the tyrosine phosphorylated proteins immunoprecipitated with 
anti-phosphotyrosine agarose. The pellet material was then direcdy assayed for PI 3-kinase 
activity. PI [32P]3-P produced in the assay was resolved on TLC plates and visualised by 
autoradiography. The kinase activity was assayed in duplicate for each condition, with each 
reaction mix analysed by spotting twice on the TLC plate (A). The kinase activity was 
quantified by counting of PI [32P]3-P radioactivity (B). The autoradiogram shown is 
representative of 5 separate experiments. The kinase activity measurements in (B) are the 
mean ± SEM of 5 separate experiments. **P<0.01, *P<0.05 vs. Ic. The levels of the p85 
subunit of PI 3-kinase that were associated with the anti-phosphotyrosine immunoprecipitates 
were analysed by Western blotting and detection using ECL (C).
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Figure 12. PI 3-kinase activity associated with IRS-1. Adipocytes were cultured for 20 h 
either with no additions (B), or with 500 nM insulin (Ic), or with 500 nM insulin and 1 mM 
metformin (IcM). A portion of the cells cultured under basal conditions were acutely 
stimulated with 20 nM insulin for 2 min (la). 1 ml aliquots of the cells at 40% cytocrit were 
lysed, and the IRS-1 was immunoprecipitated from lysates. The pellet material was then 
directly assayed for PI 3-kinase activity. PI [32P]3-P produced in the assay was resolved on 
TLC plates and visualised by autoradiography. The kinase activity was assayed in duplicate for 
each condition, with each reaction mix analysed by spotting twice on the TLC plate (A). The 
kinase activity was quantified by counting of PI [32P]3-P radioactivity (B). The autoradiogram 
shown is representative of 3 separate experiments. The kinase activity measurements in (B) are 
the mean ± SEM of 3 separate experiments. **P<0.01, *P<0.05 vs. Ia.
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3.6 Levels of PI 3-kinase activity associated with p85 immunoprecipitates
Studies on synthetic peptides that interact with the SH2 domains of the p85 subunit of PI 3- 
kinase suggest that an activating conformational change in p85 occurs following the binding of 
phosphotyrosine ligands (section 1.9). To determine whether chronic-insulin treatment can alter 
the PI 3-kinase through this type of mechanism, the changes that occur in PI 3-kinase activity 
in p85 immunoprecipitates have been measured (figure 13A). From the quantitation of a series 
of these experiments (figure 13B) it is evident that a relatively small, less than 2-fold, increase 
above basal levels of PI 3-kinase activity occurs in the p85 precipitates from cells acutely 
treated with insulin. This effect is likely to be due to the increased association of PI 3-kinase 
with insulin receptor substrates such as IRS-1 which enhance the activity through the 
conformational change mechanism. However, these data also suggest that the large (20-fold) 
effects of insulin on activity determined in anti-phosphotyrosine immunoprecipitates occur 
because of a large increase in the levels of tyrosine phosphorylated proteins that associate with 
PI 3-kinase rather than to extensive activation through the conformational change mechanism. 
Likewise, neither the chronic-insulin treatment nor metformin produce a significant alteration 
in PI 3-kinase activity through the latter mechanism.
3.7 Levels of PKB activity following maintenance of adipocytes in culture
To explore whether signalling changes are transmitted downstream of PI 3-kinase, PKB was 
immunoprecipitated from cell lysates and the kinase activity determined (figure 14A). A 2 min 
acute insulin stimulation of the cells produced a 4.7-fold increase in activity over that in basal 
cells. The activity was increased from 16.23 ±1.76 fmol/min/ml 40% cells in cells cultured 
without insulin to 87.75 ± 20.35 fmol/min/ml 40% cells in cells which were acutely treated 
with insulin after culture. The chronic-insulin treatment reduced this activation to 34.90 ± 2.48 
fmol/min/ml 40% cells, only 40% of the acute stimulation. This chronic effect was partially 
alleviated by inclusion of metformin in the culture medium. The PKB activity was 61.0 ± 9.28 
fmol/min/ml 40% cells. This represents 69% of the acute response and a 1.7-fold increase 
over the activity in chronically-treated cells. Western blot analysis of the levels of PKB in 
whole cell lysates (figure 14B) indicated that the protein levels of the enzyme were not reduced 














Figure 13. PI 3-kinase activity associated with p85 immunoprecipitates. Adipocytes 
were cultured for 20 h either with no additions (B), or with 500 nM insulin (Ic), or with 500 
nM insulin and 1 mM metformin (IcM). Cells were subsequendy washed and adjusted to 40% 
cytocrit. A portion of the cells cultured under basal conditions were stimulated with 20 nM 
insulin for 2 min (la). 1 ml aliquots of the cells were lysed and p85 was immunoprecipitated 
from the detergent soluble lysates. The immune pellets were then directly assayed for PI 3- 
kinase activity. PI [32P]3-P produced in the assay was resolved on TLC plates and visualised 
by autoradiography. The kinase reaction was performed in duplicate for each condition, with 
each reaction mix analysed by spotting twice on the TLC plate (A). The kinase activity was 
determined by counting the PI [32P]3-P radioactivity (B). The results are the mean ± SEM 
from 5 separate experiments.
cells, there were slight band shifts in the position of the PKB signal in the gel lanes from the 
cells that had been acutely treated with insulin and in those cells that had been chronically 
treated with insulin in the presence of metformin. The band shift was less marked in the 
samples obtained from cells that had been chronically treated with insulin. This band shift 
occurs because of a PI 3-kinase dependent phosphorylation of the enzyme that is associated 
with the activation of PKB by insulin treatment (section 1.12). Therefore, these band shift 
changes correspond to the direct measurements of enzyme activity shown in figure 14A.
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Figure 14. PKB activity following maintenance of adipocytes in culture. Adipocytes 
were cultured for 20 h either with no additions (B) or with 500 nM insulin (Ic) or with 500 nM 
insulin and 1 mM metformin (IcM). A portion of the cells cultured under basal conditions 
were stimulated with 20 nM for 2 min (la). Cells were lysed and PKB immunoprecipitated 
from the detergent soluble lysates. PKB activity was directly measured in immune pellets (A). 
The kinase activity measurements are means ± SEM from 4 separate experiments. *P<0.05 vs. 
Ic. Cell lysates were also subjected to Western blot analysis for PKB. This was detected by 
enhanced chemiluminescence (B). The Western blot is representative of 3 separate 
experiments.
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PART B -  Trafficking measurements in insulin-resistant rat adipocytes
3.8 Measurements of GLUT4 endocytosis and exocytosis in wortmannin treated 
adipocytes following a 20 h culture
As in previous experiments, adipocytes were maintained in culture for 20 h either with no 
additions to the culture medium, with 500 nM insulin, or with 500 nM insulin and 1 mM 
metformin. Cells were subsequently recovered by removing the culture medium and washing 4 
times with 1% (w/v) BSA/KRH buffer supplemented with either 500 nM insulin with or 
without 1 mM metformin as appropriate. Cell suspensions were then adjusted to a cytocrit of 
40 %. A fraction of the cells maintained in culture without insulin or metformin were then 
acutely insulin-stimulated with 20 nM insulin for 30 min. 1 pM wortmannin was then added to 
the four cell populations and the rate constants of 3-OMG uptake were measured at 0, 3, 6, 9, 
20, 30 and 60 min after the addition of the wortmannin (section 2.11). The decrease in transport 
activity (related to decreased cell surface GLUT4) as shown by figure 15A can be fitted to an 
exponential rate equation (section 2.12) to determine the trafficking rate constants (figure 15B). 
As in previous reports (Yang et al., 1996) the exocytosis rate constant (kex) was found to be 
negligible in all of the cell conditions after the addition of wortmannin (figure 15B). However, 
analysis of the endocytosis rate constant (ken) revealed that the chronic-insulin treatment 
results in a 3-fold increase in the endocytosis rate constant compared with cells cultured 
without insulin and then subsequendy acutely stimulated (0.127 ± 0.011/min for cells treated 
with 500 nM insulin for 20 h compared to 0.039 ± 0.008/min for cells acutely stimulated with 
20 nM insulin for 30 min following a 20 h maintainance in culture) (figure 15B). Addition of 
metformin to the culture medium together with insulin reversed the effects of the chronic- 
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Figure 15. Reduction in cell surface GLUT4 in rat adipocytes following a 20 h 
maintenance in culture and wortmannin treatment, and determination of GLUT4 
trafficking kinetics. Isolated rat adipocytes were cultured with either no additions (basal; B), 
in the presence of 500 nM insulin (chronic; Ic), or with 500 nM insulin and 1 mM metformin 
(chronic metformin; IcM). All cells were washed and adjusted to 40% cytocrit. A portion of 
the basal cells were acutely stimulated with 20 nM insulin for 30 min (acute stimulation; la). 
The rates of uptake of 50 pM 3-OMG were then determined at times 0, 3, 6, 9, 20, 30 & 60 
min following the addition of 1 pM wortmannin (time of 3-OMG uptake at each time point 
varied for each cell condition and time after the addition of the wortmannin -  see table 4, 
section 2.1 /). The data are plotted as the fractional reduction of the initial activity (A). A  - B, O 
- Ia, ^  - Ic, ▼ - IcM. The rate constants kex and ken were calculated by least-squares fitting 
(non-weighted fit) to equation 2 (section 2.11) (B). Data are means ± SEM from three separate 
experiments. ** P < 0.01 vs Ic.
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3.9 Chapter 3 discussion
It has previously been observed that a large decrease in insulin-responsive glucose transport 
occurs in rat adipocytes maintained in culture for 20 h in the continuous presence of insulin 
(Kozka & Holman, 1993). The reduction of glucose transport activity induced by chronic- 
insulin treatment is found to be independent upon the total cellular levels of both GLUT1 and 
GLUT4 (Kozka & Holman, 1993; Pryor et al!, 1999). It was therefore investigated to observe 
whether impairments in signalling and/or altered trafficking of the GLUT4 could account for 
the downregulation of PM GLUT4.
The oral biguanide metformin is used clinically to alleviate insulin resistance (Davidson & 
Peters, 1997). In vivo metformin treatment has been found to ameliorate insulin resistance by 
inducing transporter translocation in obese (fa/fa) Zucker rats (Matthaei et al., 1993) and 
streptozotocin diabetic rats (Rossetti et al., 1990). It has previously been observed that 
inclusion of metformin in the culture medium during the chronic-insulin treatment of rat 
adipocytes can alleviate the downregulation of glucose transport activity (Kozka & Holman,
1993). Hence, we addressed the question of whether the metformin effect is related to the 
reversal of early signalling and/or trafficking events induced by chronic insulin treatment.
The initial event in insulin intracellular signalling is the activation of the insulin receptor 
kinase. Chronic-insulin treatment of the rat adipocytes caused a significant reduction in 
receptor p-subunit tyrosine phosphorylation (figure 10). The reduction in insulin receptor 
phosphorylation is fully accountable by reduced receptor kinase activation and not by a 
reduction in the levels of receptor protein (figure 9C). Furthermore, the levels of PM insulin 
receptors did not alter with the chronic-insulin treatment (data not shown). The reduced 
receptor phosphorylation is likely to result in a reduced kinase activity towards IRS molecules, 
and therefore a reduction in the intracellular signalling pathway leading to GLUT4 
translocation to the PM. Indeed, downstream signalling of the insulin receptor was markedly 
reduced in the chronic-insulin treatment model of insulin resistance. Chronic-insulin treatment 
resulted in the reduction of IRS-1- and phosphotyrosine-associated PI 3-kinase activity 
(figures 12 and 11 respectively) and PKB phosphorylation/activation (figure 14). The results 
also suggest that chronic-insulin treatment does not alter PI 3-kinase catalytic activity directly, 
but alters the coupling of PI 3-kinase to upstream phosphotyrosine intermediates (figure 13). 
Hence, these data show that impaired signalling at the level of receptor phosphorylation,
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transmitted to downstream signalling molecules, is associated with the chronic-insulin 
treatment model of insulin resistance.
Reduced PKB and glucose transport activities have been observed in human muscle from 
NIDDM patients (Krook et al., 1998). Similarly, the activity of PKB following chronic-insulin 
treatments in vitro (in the absence and presence of metformin) correlates with the changes 
occurring at the levels of insulin receptor phosphorylation and phosphotyrosine associated PI 
3-kinase. In turn, the changes in PKB also correlate with the changes observed in glucose 
transport activity but this may occur because both of these processes are related to the same 
early signalling changes. These data suggest that alterations in PKB activity are a consequence 
of the early processes and that there are probably no additional effects of these treatments 
(insulin or metformin) on enzyme activity. This correlation does therefore not provide 
evidence either for or against the possibility that changes in transport are mediated by PKB.
Reduced insulin receptor kinase activity has also been observed in other insulin-resistant 
systems (Handgerg et al., 1993; Goodyear et al., 1995; Saad et al., 1997). Reductions in insulin 
receptor activation are possibly due to either reduced intrinsic tyrosine kinase activity or to an 
increased receptor associated phosphatase activity. Reduced receptor intrinsic kinase activity 
has not been assessed here, but it is possible that the chronic-insulin treatment has directly 
affected the receptor kinase. However, a more likely scenario is that increased expression 
and/or activity of one or more insulin receptor-tyrosine phosphatase has been altered with the 
chronic-insulin treatment. Studies with purified enzymes and recombinant catalytic domains 
have revealed several protein tyrosine phosphatases are active against the autophosphorylated 
insulin receptor (Goldstein, 1993). These phosphatases include the transmembrane 
phosphatases CD45, LAR and leukocyte common antigen-related protein tyrosine 
phosphatase (LRP), and cytosolic protein tyrosine phosphatases PTP1B and TC-PTP 
(Goldstein, 1993). The role of LAR in insulin receptor dephosphorylation has been studied by 
both overexpression in insulin-responsive CHO cells (Zhang et al., 1996), and by knocking out 
LAR expression in a rat hepatoma cell line using antisense RNA (Kulas et al., 1995). 
Overexpression of LAR, reduced insulin receptor autophosphorylation, whilst antisense 
inhibition of LAR increased both insulin receptor autophosphorylation and PI 3-kinase 
activity (150 and 350 % respectively). Furthermore, in obese human subjects with reduced 
receptor tyrosine phosphorylation, the levels of LAR expression in adipose tissue is elevated 
(Ahmad et al., 1995). However, a study of LAR expression in the major human insulin target
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tissues revealed that LAR expression in skeletal muscle is extremely low (Norris et al, 1997). 
Additionally, overexpression of LAR in insulin-responsive hamster kidney cells has no effect 
on insulin-stimulated insulin receptor autophosphorylation (Moller et al, 1995). Moreover, 
overexpression of LRP and PTPs in the hamster kidney cells significantly reduced the insulin 
responses. Whilst PTP1B overexpression in hamster kidney cells has no effect on receptor 
phosphorylation, overexpression in Rat-1 fibroblast inhibits insulin-stimulated 
autophosphorylation. These conflicting observations may reflect the use of different cell lines 
where relative levels of overexpressed protein tyrosine phosphatases and the insulin receptor 
vary. Since in vitro studies suggest that different protein tyrosine phosphatases may 
dephosphorylate specific tyrosine residues on the insulin receptor (Goldstein, 1993), it is 
possible that a complex regulatory process exists whereby receptor dephosphorylation may 
involve several phosphatases acting in tandem to regulate insulin receptor signalling (Drake & 
Posner, 1998). Further work needs to be carried out using phosphorylated insulin receptors to 
determine whether the chronic-insulin treatment of the adipose cells results in an elevation of 
insulin receptor-tyrosine phosphatase activity.
Inclusion of metformin has been found to reverse the chronic-insulin effects on receptor 
phosphorylation (figure 10). There are reports that metformin treatment of obese (fa/fa) 
Zucker rats (Matthaei et al., 1993) and a 2 h metformin treatment of rat adipocytes (Matthaei et 
al., 1991) have no effect on the insulin receptor phosphorylation. However, there is 
contradictory evidence suggesting that metformin can produce increases in the receptor 
tyrosine phosphorylation in streptozotocin diabetic rats (Rossetti et al., 1990), erythrocytes 
(Santos et al, 1995), Xenopus oocytes (Stith et al., 1996), and basal insulin receptor tyrosine 
phosphorylation in vascular smooth muscle (Dominguez et al., 1996). It is possible that 
metformin can either directly activate the receptor kinase or alternatively metformin may act 
as an insulin receptor tyrosine phosphatase inhibitor. The action of metformin on 
phosphatases can readily be tested. This may provide some evidence for the mechanism of 
action of metformin, which currently remains largely unresolved.
Not assessed in this study, is which particular insulin receptor tyrosine residues have reduced 
phosphorylation with the chronic-insulin treatment. Substrate targeting to the insulin receptor 
is thought to be mediated in part via the PTB domain of substrates like IRS-1 and She (section 
1.5), the KRLB domain of IRS-2 (sectionl.6.2) and even perhaps other proteins linking the 
substrates and receptor (Burks et al., 1998). Dephosphorylation of particular insulin receptor
89
tyrosine residues by specific phosphatases may differentially alter the binding efficacy of 
receptor substrates. Hence, IRS-2/3 may become a better substrate than IRS-1. The partial 
reversal of the chronic-insulin effect by metformin on receptor phosphorylation may be a 
result of metformin acting as a phosphatase inhibitor on one or more phosphatases. However, 
whilst metformin can reverse the chronic-effect on phosphotyrosine-associated PI 3-kinase, 
this reversal was not due to an association with IRS-1 (figure 12). This suggests that another 
phosphotyrosine protein is binding PI 3-kinase under the chronic-insulin metformin 
treatment. This further supports the hypothesis that another IRS molecule such as IRS-2 may 
be more important for glucose transport than IRS-1 (section 1.8). Obviously, it has not been 
shown here whether the tissue culturing of the adipose cells has altered the levels of the IRS 
proteins relative to each other, and more work is therefore required to determine whether this 
is the case, and whether IRS-2/3 can account for the increased PI 3-kinase activity under the 
chronic-insulin metformin treatment. Certainly, the tyrosine phosphorylation of a 60 kDa 
protein is shown to be increased by the insulin-chronic and metformin treatment (figure 10), 
and this protein is probably IRS-3. Whether IRS-3 phosphorylation can account for the 
metformin reversal of the chronic-insulin treatment on phosphotyrosine-associated PI 3- 
kinase requires further investigation.
There appears to be spare receptor and signalling capacity in the normal system leading to the 
elevation of GLUT4 translocation. The concentration of insulin required to activate glucose 
transport maximally corresponds to only 14% of the maximal receptor kinase activity (Klein et 
al, 1991). Furthermore, in 3T3-L1 adipocytes only 10% of the insulin-stimulated PI 3-kinase 
activity is required to give full glucose uptake that is comparable to maximal insulin 
stimulation (unpublished data). However, only rather moderate deficiencies in receptor 
phosphorylation and the subsequent intracellular signalling processes produces insulin 
resistance and the downregulation of PM GLUT4. This appears to apply to both in vitro model 
systems and in human NIDDM (Bjomholm et al., 1997).
Wortmannin appears to have little or no effect on endocytosis as the values for k^ derived 
here are similar to those previously obtained in cells not treated with wortmannin (Yang & 
Holman, 1993; Satoh et al., 1993; Yang et al., 1996). As in 3T3-L1 cells (Yang et al., 1996), 
GLUT4 exocytosis is inhibited by wortmannin since values for kex (figure 15B) are much 
lower than those previously obtained in cells not treated with wortmannin (Yang & Holman, 
1993; Satoh et al, 1993; Yang et al, 1996). These comparisons therefore suggest that it is the
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inhibition of exocytosis and not acceleration of endocytosis that leads to the perturbation of 
glucose transport and reduction of levels of cell-surface GLUT4 following wortmannin 
treatment. A rate constant for unperturbed GLUT4 exocytosis (kex) can be calculated if we 
assume (and as suggested above) ken is unaltered by wortmannin. To do this the steady-state 
GLUT4 distributions (k ^ /k j are used. These ratios (k ^ /k j are ~0.81 and 0.33 for acute- and 
chronic-insulin treatments respectively (Kozka & Holman, 1993; Holman et al., 1994). For 
acute- and chronic-insulin treatments, the derived exocytosis rate constants are therefore 
~0.032 min'1 and 0.042 min'1, respectively. From this analysis, it is apparent that the calculated 
rate of GLUT4 exocytosis in the absence of wortmannin is not markedly altered by chronic- 
insulin treatment, despite a reduction in insulin signalling. However, the down-regulation of 
cell surface GLUT4 is associated with a 3-fold increase in the rate of endocytosis of GLUT4 
(figure 15) and this effect is reversed by metformin. It is the increase in endocytosis of 
GLUT4 that correlates with the reductions in insulin receptor phosphorylation and PI 3- 
kinase activity. The effects on endocytosis persist under conditions in which exocytosis is 
blocked by wortmannin treatment. This suggests that, once elevated, the endocytosis rate is 
not dependent upon signalling via a wortmannin-sensitive PI 3-kinase. Therefore, an 
explanation for the apparent poor correlation between high insulin sensitivity/signalling 
capacity and insulin signalling resistance may be that the former is associated with GLUT4 
exocytosis while the latter is associated with GLUT4 endocytosis. Regulation of the 
endocytosis limb of the translocation pathway may involve a divergent signalling route or 
branch with a different insulin and PI 3-kinase dependence.
Previous studies have shown that GLUT4 exocytosis is increased over 9-fold by insulin (Satoh 
et al., 1993; Yang & Holman, 1993) while endocytosis is slightly decreased by insulin under 
normal conditions (Satoh et al., 1993; Yang & Holman, 1993; Jhun et al., 1992). It appears that 
the relatively small effect of acute-insulin treatment to reduce endocytosis is lost following 
prolonged insulin treatment. However, as the endocytosis process appears to be more 
sensitive to perturbations in signalling, an acceleration of endocytosis may be an important 
component of the pathophysiological changes leading to insulin resistance.
Shibata et al. (1995) have suggested that GLUT4 endocytosis requires the hydrolysis of GTP 
by a GTP-binding protein. It may therefore be of interest to study the effects of chronic- 
insulin treatment on the activity of GTP-binding proteins involved in the endocytosis of 
GLUT4 from the PM. One candidate GTP-binding protein might be Rab5, which has been
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shown to regulate endocytosis (Bucci et a l 1992; Li et al., 1995) and whose distribution in 
3T3-L1 adipocytes is altered upon insulin treatment (Cormont et al, 1996b). Further 
experiments are required to determine how insulin regulates the endocytosis of GLUT4 and 
whether proteins such as rab5 might be involved in this process.
We have found that metformin can reverse both signalling and the related GLUT4 trafficking 
defects associated with chronic-insulin treatment. The metformin reversal appears to be 
primarily associated with altered insulin receptor tyrosine phosphorylation. Although its 
precise mechanism of action remains to be fully elucidated, the secondary effects on GLUT4 
endocytosis provide a rationale for the therapeutic use of this compound in the treatment of 




Guanosine nucleotide binding regulatory proteins (GTP-binding proteins) play a pivotal role 
in signal transduction. Evidence for the involvement of GTP-binding proteins in insulin- 
regulated GLUT4 trafficking comes from the observations that non-hydrolysable analogues of 
guanosine triphosphate (GTP) such as guanosine-5,-0-(3-thiotriphosphate) can stimulate 
GLUT4 translocation (Baldini et al, 1991) even in the presence of the PI 3-kinase inhibitor 
wortmannin (Clarke et al., 1994). Furthermore, small molecular weight GTP-binding proteins 
have been found on immunoisolated GLUT4 vesicles (Cormont et al., 1993; Uphues et al.,
1994). Since GTPyS activation of GTP-binding proteins does not distinguish between small 
molecular weight Ras-like and heterotrimeric GTP-binding proteins, it is possible that both 
families of GTP-binding proteins are involved in the insulin-stimulated translocation of 
GLUT4 vesicles to the plasma membrane (section 1.14). Experiments were therefore 
undertaken to identify possible GTP-binding protein targets of acute insulin stimulation.
4.1 Periodate-oxidised [a-32P]GTP as a probe for identifying GTP-binding proteins
Two methods have been described which use [a-32P]GTP to detect GTP-binding proteins. 
One method involves an incubation of proteins which have been electrophoretically 
transferred onto a membrane. In this procedure the proteins are allowed to renature on the 
membrane and then [a-32P]GTP-binding to the proteins is measured. The second method 
involves photo-crosslinking of the [a-32P]GTP to cell extracts following irradiation of samples 
with an intensive ultraviolet light source. However, both of these techniques have their 
limitations (Huber & Peter, 1994). For instance, only proteins with very high binding affinities 
are detectable and proteins which do not renature on nitrocellulose after SDS-PAGE cannot 
be detected. A limitation of the GTP photo-crosslinking method is that often the levels of 
incorporation of the radionucleotide into GTP-binding proteins is found to be low. Hence, a 
technique of in situ periodate-oxidised GTP labelling has been developed by Peter et al. (1993) 
(figure 16). This technique introduces [a-32P]GTP into permeabilised cells, with the 
subsequent addition of sodium periodate to oxidise the GTP. The addition of the sodium 
periodate leads to oxidative cleavage of the nucleotide ribose and formation of a reactive 
dialdehyde. This can form an unstable condensate with an 8-amino group of a nearby lysine 
residue (a lysine residue tends to be conserved in the nucleotide binding pocket of GTP- 
binding proteins, Low etal., 1992). Subsequent addition of sodium cyanoborohydride stabilises 
the covalent bond, thereby labelling the protein. Any unbound oxidised-GTP is reduced with 
sodium borohydride. Using this technique, it has been found that stimulation of the T-cell
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receptor (TCR) in Jurkat cells leads to an increase in GTP-binding of the TCR-£, chain 
(Sancho et al, 1993). The aim of the work described here was therefore to use the technique of 
periodate-oxidised GTP labelling to tag GTP-binding proteins in basal and insulin-stimulated 
rat adipocytes.
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Figure 16. Reaction scheme for covalent linking of [a-32P]GTP to GTP-binding 
proteins. [a-32P]GTP non-covalendy bound to a protein is oxidised with N aI04 to produce a 
reactive dialdehyde. This forms an unstable imine with the S-NH2 of a nearby lysine residue. 
Reduction of the imine with NaCNBH3 gives rise to a stable covalent bond and thereby 
radiolabels the GTP-binding protein.
4.2 Retention of insulin-responsive GLUT4 translocation to the plasma membrane of 
permeabilised rat adipocytes as determined by ATB-BMPA photolabelling
Cells are impermeable to [a-32P]GTP and therefore need to be permeabilised to allow access 
of the [a-32P]GTP to the intracellular GTP-binding proteins. Since the aim of the in situ 
periodate-oxidised GTP labelling of rat adipocytes was to observe differences between GTP- 
labelling in basal and insulin-stimulated cells the rat adipocytes needed to be permeabilised 
under conditions that still maintained an insulin-stimulated GLUT4 translocation to plasma 
membranes.
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Rat adipocytes were permeabilised using a-toxin from Staphylococcus aureus cells. The 
conditions for permeabilisation were essentially as described by Baldini et al. (1991). 
Permeabilised cells were tested for a functional insulin response by stimulating with 20 nM 
insulin for 20 min and then by photolabelling the cell-surface GLUT4 with the cell 
impermeant ATB-[2-3H]BMPA photolabel. Although the photolabel is likely to gain access to 
the cell cytosol (since the cells are permeabilised) the photolabel tends only to bind to the 
exofacial side of the glucose transporter and probably does not permeate the intracellular 
vesicles. Therefore labelling of GLUT4 in permeabilised cells is mainly indicative of the levels 
of plasma membrane GLUT4. Photolabelling followed by immunoprecipitation of GLUT4 in 
intact basal and insulin-stimulated adipocytes showed a 20-fold difference in the levels of 
GLUT4 in the PM (figure 17). In permeabilised cells, the insulin-induced increase in PM 
GLUT4 was reduced to 6-fold, but the experiment indicated that the permeabilised cells were 
still partly insulin responsive (figure 17). Additionally, 600 pM GTPyS was also capable of 
stimulating the translocation of GLUT4 to the PM in permeabilised cells, to the same extent 
as permeabilised cells stimulated by insulin (figure 17). Since normally cells are not permeable 
to GTPyS, the GTPyS-induced stimulation of labelling indicated that the adipocytes had been 
permeabilised. The photolabelling experiment therefore showed that under the experimental 
conditions described, the adipose cells were permeable to small molecules such as GTP and 
were still insulin responsive.
By washing permeabilised cells after the addition of a-toxin, small molecular weight 
intracellular molecules may be removed and thereby reduce the insulin response. Hence, the 
adipose cells were left continuously in the presence of the a-toxin during the periodate- 
oxidised GTP-binding procedure. However, the adipose cells were sensitive to prolonged 
incubation with the a-toxin. This is shown in figure 17, where adipose cells which had been 
permeabilised for 35 min, instead of 15 min, showed no translocation of GLUT4 to the 
plasma membrane in response to insulin-stimulation. With cells other than adipocytes, a-toxin 
can be bound to cell membranes at 0°C thus preventing damaging effects but allowing excess 
toxin to be removed. However, this was not practical with the adipose cells due to their high 






Insulin -  + -  + -  +
GTPyS -
a-Toxin - -  + + + ++
Figure 17. ATB-BMPA photolabelling of plasma membrane GLUT4 in a-toxin 
permeabilised rat adipocytes. Intact, or permeabilised rat adipocytes (8 pg/ml a-toxin for 
15 min, or 35 min (++)) were stimulated with, or without 20 nM insulin, or with 600 pM 
GTPyS for 20 min at 37°C. Cell surface GLUT4 was then photolabelled with the glucose 
transporter photolabel ATB-[2-3H]BMPA. Cells were then lysed and total cell GLUT4 
immunoprecipitated. Immunoprecipitates were subjected to SDS-PAGE and the total 
amount of radiolabelled GLUT4 determined by liquid scintillation counting of gel slices 
corresponding to the molecular mass of GLUT4 on SDS-PAGE gels.
4.3 In situ periodate-oxidised GTP labelling of GTP-binding proteins in permeabilised 
rat adipocytes
200 pi aliquots of adipose cells at a cytocrit of 40% were permeabilised in the presence of [a- 
32P]GTP (section 2.14) and then stimulated with 20 nM insulin for 15 min at 37°C. Sodium 
periodate was then added to the cells for 1 min, followed by the subsequent additions of 
sodium cyanoborohydride for 1 min, then sodium borohydride for 10 min on ice. Cells were 
then lysed in a 1% (v/v) Triton X-100 lysis buffer (section 2.2). The lysates were briefly 
centrifuged in a microfuge and the detergent-soluble infranatant added to SDS-PAGE sample 
buffer for gel electrophoresis. Radiolabelled proteins were visualised by autoradiography of 
the gels. Initially, the radiolabelling of the proteins resulted in GTP-incorporation into 
proteins as shown by figure 18. Numerous proteins in cells treated with or without a-toxin 
were labelled by GTP. This indicates that there was some non-specific labelling. Nonetheless, 
there was more labelling in cells treated with the a-toxin, and differences between basal and 
insulin-stimulated cells could be seen. In particular, in insulin-stimulated cells there appeared
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to be an increased labelling of proteins at ~25 kDa and 50 kDa (indicated by arrows - figure 
18) than in basal permeabilised adipocytes.
In order to reduce the non-specific labelling, the protocol was modified to reduce the amount 
of free [a-32P]GTP present before the addition of the sodium periodate. This was achieved by 
centrifuging the cells through 100 pi of silicone oil and by removing the labelling solution 
before the addition of the periodate. The effect of this was to markedly reduce the labelling in 










Insulin - - +
a-Toxin - + +
Figure 18. In situ periodate-oxidised GTP labelling of proteins in a-toxin 
permeabilised rat adipocytes. Rat adipocytes in 0.1% BSA/KRH were incubated either 
with or without a-toxin for 15 min at 37°C in the presence of 25 pCi [a-32P]GTP. Cells were 
then incubated for 20 min, either with or without 20 nM insulin, at 37°C. Cells were 
subsequently incubated for 1 min each with 1 mM NalCU, 20 mM NaCNBFE and then 20 
mM NaBH4. Cells were lysed in a detergent lysis buffer and infranatants subjected to SDS- 
PAGE. Gels were dried and imaged by autoradiography.
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Specificity of GTP-labelling was determined by including 100 |iM cold GTP in the labelling 
solution. This reduced the labelling to a level that was similar to that seen in unpermeabilsed 
cells (figure 19 - lanes 5 & 6). In the development of the GTP-labelling technique, 4 mM Mg- 
ATP and 3 mM sodium pyruvate were included in the labelling solution to help maintain 
insulin responses (not shown). The inclusion of the ATP had no effect on .the extent of the 
GTP labelling, which further implies that the GTP labelling is specific for GTP-binding 
proteins. By removing excess radionucleotide before periodate addition, and with the 
inclusion of the ATP and pyruvate, a clear difference in GTP-labelling between basal and 
insulin-stimulated adipocytes could be observed (figure 19 - lanes 2 & 3). In particular proteins 
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Figure 19. In situ periodate-oxidised GTP labelling of proteins in a-toxin 
permeabilised rat adipocytes. Rat adipocytes in 0.1% BSA/KRH were incubated either 
with or without a-toxin for 15 min at 37°C in the presence of 4 mM ATP, 3 mM sodium 
pyruvate and 25 pCi [a-32P]GTP. Cells were then incubated for 20 min either with or without 
20 nM insulin at 37°C, and with or without 1 pM wortmannin. As a control for specific 
labelling, basal and insulin-stimulated permeabilised samples were incubated additionally with 
100 pM cold GTP. Cells were centrifuged through silicone oil and excess labelling solution 
removed. Cells were subsequendy incubated for 1 min each with 1 mM NaIC>4, 20 mM 
NaCNBH3 and then 20 mM NaBhU. Cells were lysed in a detergent lysis buffer and 
infranatants were subjected to SDS-PAGE. The gel was dried and imaged by autoradiography. 
Bands labelled 1-4 were quantified for radioactivity by liquid scintillation counting (figure 20). 
The differences observed between basal and insulin-stimulated samples is representative of at 
least 3 separate experiments.
The insulin-induced increase in labelling was inhibited by the inclusion of 1 pM wortmannin 
during the insulin stimulation (figure 19 - lane 4). Quantification of the extent of insulin- 
stimulation of GTP-labelling and of inhibition by wortmannin was achieved by excision of 
bands (labelled 1-4 on figure 19) and by liquid scintillation counting of the radioactivity. The 
background radioactivity for each lane, was obtained by scintillation counting of a gel slice 




Band 1 Band 2 Band 3 Band 4
Figure 20. Quantification of [a-32P]GTP labelled proteins in a-toxin permeabilised rat 
adipocytes. Protein bands corresponding to [a-32P]GTP labelled proteins (determined by 
autoradiography, figure 19) were excised from gels and the radioactivity was estimated by 
liquid scintillation counting. Background labelling has been subtracted from each value. ■  - 
Basal, □  - Insulin, ESS - Insulin + Wortmannin.
Scintillation counting of radiolabelled-protein bands showed that whilst band 1 only showed a 
slight increase (~ 1.5-fold) in labelling with insulin, band 2 (region corresponding to a-subunits 
of heterotrimeric GTP-binding protiens) showed a ~2.5-fold increase in labelling. Bands 3 and 
4 (region corresponding to small molecular weight GTP-binding proteins) showed 1.8- and 
1.6-fold increased labelling respectively.
4.4 Time-dependent increases in periodate-oxidised GTP-labelling following insulin 
treatment
To determine whether the increased GTP-labelling that followed insulin stimulation was time 
dependent, permeabilised adipocytes were stimulated with 20 nM insulin for varying times 
before the addition of the sodium periodate and the oxidation of the [a-32P]GTP. Cells were 
then treated with NaCNBEb and NaBH4 as in previous experiments, and radiolabelled- 
proteins analysed by SDS-PAGE and autoradiography (figure 21).
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Figure 21. Time course for periodate-oxidised GTP labelling in insulin-treated, rat 
adipocytes. Rat adipocytes in 0.1% BSA/KRH were incubated either with or without a-toxin 
for 15 min at 37°C in the presence of 4 mM ATP, 3 mM sodium pyruvate and 25 pCi [a- 
32P]GTP. Cells were then stimulated with 20 nM insulin for 5-30 min at 37°C. The total time 
in the presence of a-toxin was constant for each condition. Cells were then incubated for 1 
min each with 1 mM NalCU, 20 mM NaCNBIT and then 20 mM NaBH4- Cells were then 
lysed in a detergent lysis buffer and infranatants were subjected to SDS-PAGE. The gel was 
dried and radioactivity was imaged by autoradiography.
The time course of insulin-stimulation shows that the GTP labelling of the proteins at ~25 
kDa and ~45 kDa occurs rapidly within 5 minutes of insulin stimulation. Scanning 
densitometry of the autoradiogram (data not shown) revealed that maximum labelling of the 
~25 and ~45 kDa proteins was achieved 20 min after insulin stimulation.
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4.5 Analysis of GTP-labelled proteins by two-dimensional gel electrophoresis
The previously described GTP-labelling experiments have shown that insulin-stimulation of 
the permeabilised adipose cells increases the [oc-32P] GTP-labelling of at least two groups of 
proteins (25 and 45 kDa), as analysed by one-dimensional SDS-PAGE and autoradiography. 
The radiolabelling of proteins at approximately 25 kDa corresponds to the expected migration 
of small-molecular weight Ras-like GTP-binding proteins on SDS-PAGE. Moreover, the 
GTP-radiolabelling of proteins at approximately 45 kDa is in a region expected on SDS- 
PAGE gels for a-subunits of heterotrimeric G-proteins. Since one-dimensional SDS-PAGE 
only separates proteins by molecular weight, it is possible that the periodate-oxidised GTP- 
labelling of proteins at 25 and 45 kDa represents several Ras-like and a-subunit GTP-binding 
proteins. Hence, labelled GTP-binding proteins were analysed by two-dimensional 
electrophoresis.
Two-dimensional (2D) electrophoresis was performed using the Pharmacia Multiphor II 
system (section 2.27). Rat adipocytes from basal, insulin-stimulated and cells treated with 1 (iM 
wortmannin and 20 nM insulin, were covalently labelled with [a-32P]GTP as described for 
previous experiments. The cell lysates generated from labelling experiments were then 
chloroform/methanol precipitated (section 2.23) and the precipitated proteins solubilised in 40 
pi of lysis buffer and 60 pi of 2D-gel electrophoresis sample buffer (section 2.27). The 
solubilised proteins were then applied to Immobiline strips for isoelectric focusing, followed 
by SDS-PAGE (section 2.27). The 32P-labelled proteins were then visualised using a Molecular 
Dynamics phosphorimager. A typical 2D gel of periodate-oxidised GTP-labelled proteins is 
shown by figure 22. It was observed that the high degree of radiolabelling in the 20-25 kDa 
region by one dimensional SDS-PAGE was resolved into a cluster of at least 7 radiolabelled 
proteins, with pis of approximately 5.0-5.5. From examination of a map of small GTP-binding 
proteins separated by 2D-PAGE (Huber et al., 1994) it was concluded that the small molecular 
weight proteins Rab2, 8,10,17 and 18 would be expected to run in this area.
When analysing the cluster of radiolabelled proteins at 20-25 kDa, pi 5.0 — 5.5, it was difficult 
to discern whether there were any differences between basal, insulin-stimulated, or insulin and 
wortmannin treated cells (figure 23). While differences in GTP-labelling between basal, 





















Figure 22. Two dimensional electrophoresis of [a-32P]GTP-labelled proteins from insulin-stimulated rat adipocytes. Rat adipocytes were 
labelled with periodate-oxidised [a-32P]GTP, and then lysed. Infranatants were chloroform/methanol precipitated and then solubilised in lysis buffer. 









Figure 23. Analysis of small molecular weight proteins labelled by periodate-oxidised 
[a-32P]GTP from permeabilised rat adipocytes by two-dimensional electrophoresis.
GTP-binding proteins in basal, insulin-stimulated and insulin-stimulated cells in the presence 
of 1 |iM wortmannin, were labelled with [a-32P]GTP as in previously described experiments. 
Lysates were then subjected to 2D-gel electrophoresis. Areas shown are representative of the 
boxed area (figure 22) and from representative gels from two separate experiments.
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polyacrylamide gels, two-dimensional electrophoresis revealed that this difference could not 
be accounted for by any one particular protein. Differences in labelling between the various 
conditions could not be observed for any proteins in the 45 kDa region. Using the schematic 
diagram below (figure 24), which represents the small molecular weight proteins that appeared 
to be distincdy labelled, it appeared that protein spots 1 and 3 showed the highest degree of 
labelling. It was however difficult to discern whether insulin had any effect on the extent of 
labelling of protein spots 1,3,5 and 7. However, it did appear that wortmannin reduced the 
labelling of protein spots 5 and 7, and to a lesser degree spots 2 and 6.
1
Figure 24. Schematic representation of the small molecular weight proteins labelled by 
periodate-oxidised [a-32P]GTP (20-25 kDa, pi 5.0 - 5.5).
A single Coomassie stained spot was observed in the region that was represented by the GTP- 
radiolabelled proteins at 20-25 kDa, pi 5.0-5.5. The Coomassie stained protein was excised 
from 18 2D-gels and the protein digested by trypsin (section 2.31). The peptides resulting from 
the tryptic digest were analysed by mass spectroscopy (section 2.31). The mass spectroscopy 
data were compared to the theoretical mass spectroscopy peaks obtained from tryptic digests 
of sequenced proteins held in databases (mass finger printing). Unfortunately the mass finger 
printing failed to generate results that allowed identification of the protein.
4.6 Generation of antibodies to periodate-oxidised GTP
One disadvantage of the in situ periodate-oxidised GTP labelling technique is that GTP 
binding proteins that exhibit slow nucleotide exchange kinetics do not become radiolabelled. 
Hence antibodies to oxidised and reduced GTP (GTPox-red) were generated. Generation of 
antibodies to GTPox-red should therefore allow the isolation of GTP-binding proteins which 
have GTP in the nucleotide binding site, but which have a slow rate of nucleotide exchange. 
The antibodies were generated by following a protocol described Peter et al. (1993). Briefly,
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lOOpM GTP was oxidised with 20 mM sodium periodate in the presence of 5 mg keyhole 
limpet haemocyanin (KLH). The KLH and GTP mixture was then treated with 100 mM 
sodium cyanoborohydride and then 100 mM sodium borohydride. Reducing reagents and free 
nucleotides were then removed with a NAP-25 column (Pharmacia). The modified KLH was 
then injected subcutaneously into two New Zealand White rabbits in Freund’s complete 
adjuvant (amounts and booster injections as for antibodies to G ia i/2, section 2.4). 3 months 
after the initial immunisation, the sera from the two rabbits (SI88 and SI 89, and pre-immune 
sera NS188 and NS189) were used to detect GTP-binding proteins in adipocyte whole cell 
lysates, by Western blotting. The cell lysates used in the Western blotting were pre-treated 
with or without 1 mM NalCL and subsequendy with 20 mM NaCNBH3 before SDS-PAGE 
to generate GTP-labelled proteins. The results of the Western blotting are shown by figure 25.
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Figure 25. Western blotting of NaIC>4 and NaCNBH3 treated proteins from rat 
adipocytes with anti-GTPox-red antibodies. Rat adipocytes were permeabilised with a-toxin 
as previous experiments for 15 min at 37°C. Adipocytes were then treated with or without 1 
mM NaI0 4 . All samples were then treated with 20 mM NaCNBH3. Cells were then lysed with 
lysis buffer, and 20 pg aliquots of the lysates were subjected to SDS-PAGE and 
electrophoretic transfer onto nitrocellulose. Membranes were then Western blotted (1:50 
dilution in TBS-T) using antisera SI88 and SI89 (raised against G T P 0x-red) or the respective 
pre-immune sera (sera from rabbits before immunisation) NS188 and NS189.
Both of the anti-GTPox-red sera (SI 88 and SI 89) were found to detect numerous proteins by 
Western blotting. These proteins were not detected using pre-immune sera (NS188 and 
NS189). However, no significant differences could be seen by Western blotting for GTPox-red 
protein samples that had been treated with or without NaIC>4 . This result contrasts with 
results described for anti-GTP ox-red antibodies generated by Peter et al. (1993). Few bands 
were observed by Western blotting in samples which were not treated with the NaI0 4 ,
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compared with samples treated with N aI04. Additionally, Peter and co-authors reported 
significant reductions in the number of proteins that were detected by their anti-GTPox-red 
antiserum by incubating the primary antibody with 300 pM GTP. Using sera SI 88 and SI89, 
inclusion of 300 pM GTP had no effect on the number of proteins detected by the two 
antisera to the GTPox-red, (figure 26). The Western blotting also showed that ATP also had no 
effect on the number of proteins detected by the two antisera, indicating that the antibodies 
raised were not specific to any oxidised-reduced nucleotide.
Anti-Sera NS189__________ S189_________
kDa




N a I0 4 - + - + - + - +
300 pM GTP - + +  - - + +
300 pM ATP - - + + + +
Figure 26. Western blotting of N a I0 4 and NaCNBFU treated proteins from rat 
adipocytes with anti-GTPox-red serum S189 in the presence of GTP and/or ATP. Rat
adipocytes were permeabilised with a-toxin for 15 min at 37°C, as previously described. 
Adipocytes were then treated with or without 1 mM N aI04. All samples were then treated 
with 20 mM NaCNBFb. Cells were then lysed with lysis buffer and 20 pg aliquots of the cell 
lysates were subjected to SDS-PAGE and electrophoretic transfer onto nitrocellulose. 
Membranes were then Western blotted (1:50 dilution in TBS-T) using antiserum SI 89 (raised 
against GTPox-red) or the pre-immune serum (serum from the rabbit before immunisation) 
NS189, in the presence of 300 pM GTP and/or 300 pM ATP.
4.7 Generation of antibodies to Giai/2 and immunoprecipitation of periodate-oxidised 
GTP-labelled proteins
The 2D-gel electrophoresis of GTP-labelled proteins did not show any major differences 
between samples labelled with periodate-oxidised GTP, under basal and insulin-stimulated 
conditions. Nonetheless, attempts were made to immunoprecipitate GTP-binding proteins 
possibly implicated in the regulation of GLUT4 trafficking. One such GTP-binding protein
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that has been implicated in regulating G L U T 4  trafficking is G ia2, (Moxham & Malbon, 1996; 
section 1.14.3). Hence, antibodies to G ia were generated to enable G ia to be 
immunoprecipitated following periodate-oxidised [a-32P]GTP labelling.
An antibody was raised against the C-terminal region of transducin, which shares homology to 
heterotrimeric G-protein a-subunits (Goldsmith et al., 1987). Antibodies raised to this region 
of homology recognise both G ia i and G ia2- Two New Zealand White Rabbits (designated 
G182 and G183) were immunised with the C-terminal transducin peptide. An ELISA showed 
that good immune responses had been raised to the peptide by both of the rabbits, 6 weeks 
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Figure 27. ELISA for antibodies raised against Giai/2 . Sera from rabbits (G182 and G183) 
before immunisation, and after immunisation at weeks 6 and 11 were tested for antibody 
reactivity to the immunising peptide (homologous to the C-terminal region of Giai/2) by 
ELISA (section 2.24).
Using a commercially available antibody to Giai/ 2  (Serotec) it had been shown that the 
majority of Giai/ 2  is to be found localised to the plasma membranes in rat adipocytes (figure
28). Hence, using the anti-Giai/ 2  sera from the week 11 bleeds, plasma membranes obtained
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from rat adipocytes were Western blotted for Gia 2 (recombinant Gia 2 from Santa Cruz 
Biotechnology was included on the gel as a positive control) (figure 29).
CYT HDM LDM PM
B B I B I B kDa
G ial/2
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Figure 28. Western blotting of rat adipocyte subcellular fractions for Giai/2 using a 
commercially available antibody. Basal (B) and insulin-stimulated (I) rat adipocytes were 
homogenised and subcellular fractions isolated by ultracentrifugation. 20 pg aliquots of each 
sample were subjected to SDS-PAGE and electrophoretic transfer onto nitrocellulose 
membrane. The membrane was then Western blotted for Giai/2, using a commercially 
available antibody (Serotec).




Figure 29. Western blotting of adipocyte plasma membranes using anti-Giai/2 sera 
(G182 and G183). 20 pg of adipocyte plasma membranes (lanes 2, 4, 6 & 8) or recombinant 
Gia2 (lanes 1, 3, 5 & 7) were Western blotted for Gia2 using antiserum G182 (lanes 1 & 2), or 
antiserum G183 (lanes 5 & 6). Serum from rabbits before immunisation were also used as a 
negative control (pre-immune serum G182 - lanes 3 & 4, pre-immune serum G183 - lanes 7 & 
8).
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The two anti-Giai/ 2  sera confirmed the ELISA result, with antiserum G183 (used at the same 
dilution as G182) detecting more Giai/ 2  than antiserum G182 (compare lanes 2 & 6, figure
29). Antiserum G183 also detected recombinant Gia 2 to a greater extent than antiserum G182 
(lanes 1 & 5; the recombinant Gia 2 has a slightly higher molecular weight than the predicted 
molecular weight of native Gia2). In both cases the pre-immune sera did not detect any Giai/2  
(lanes 3, 4, 7 & 8).
Anti-Giai/ 2  serum G183 was then used to immunoprecipitate Giai/ 2  from rat adipocyte 
membranes (figure 30). However, as figure 30 shows, the antiserum did not 
immunoprecipitate the Giai/ 2  with high efficiency. Lane 1 represents 20 pg of plasma 
membrane protein, whereas 150 pg of plasma membrane protein was used for the 
immunoprecipitations (lanes 2 - 5 ) .  Protein samples used for immunoprecipitations were 
either solubilised in Triton X-100, lanes 4 & 5 (native conditions), or heated in a Tris-HCl 
buffer with 1% (w/v) SDS, lanes 2 & 3 (denatured conditions). Under both native and 
denatured conditions a protein band was detected specifically for the Giai/ 2  serum compared 
to the pre-immune serum (lanes 2 and 5), but only to the same extent as the positive control 
(lane 1). Increasing the amount of antiserum (and Protein A) had no effect on the amount of 
Giai/ 2  that could be detected. Similar results were produced by antiserum G182. Overall, it is 
concluded that whilst the antisera worked well in Western blotting, they were inefficient at 
immunoprecipitation.
1 2 3 4 5
Figure 30. Immunoprecipitation of Giai/2 from adipocyte plasma membranes. 150 ng
isolated plasma membranes were either denatured by heating to 95°C in a Tris-HCl buffer 
containing 1% (w/v) SDS (lanes 2 & 3) or solubilised in a 1% Triton X-100 solubilisation 
buffer (lanes 4 & 5). Giai/ 2  was then immunoprecipitated using antiserum G183 (lanes 3 & 5) 
or the respective pre-immune serum (lanes 2 & 4). Immunoprecipitates were then subjected to 
SDS-PAGE and Western blotting using G183 and Protein A-125I for detection. Lane 1 is 20 
pg of purified plasma membrane.
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In situ periodate-oxidised GTP labelling followed by immunoprecipitation of G,ai/ 2  from cell 
lysates failed to reveal any bands that could be assigned to the immunoprecipitated G-protein 
a-subunit. Similarly, immunoprecipitations of dynamin (which could be immunoprecipitated 
with a higher efficiency than Giai/2) also failed to reveal any bands that could be assigned to 
the GTPase. A typical result from an immunoprecipitation experiment which followed a 
periodate-oxidised GTP labelling is shown by figure 31. The left-hand panel shows the typical 
basal and insulin differences in labelling, whilst the right-hand panel shows the non-specific 












Figure 31. Immunoprecipitation of GTP-binding proteins following in situ periodate- 
oxidised GTP-labelling in rat adipocytes. Basal and insulin-stimulated rat adipocytes were 
permeabilised and labelled with periodate-oxidised [a-32P]GTP. The typical basal and insulin 
responses as seen previously are shown (A) (lane 1- basal, lane 2 -insulin). Detergent soluble 
samples were immunoprecipitated for various GTP-binding proteins (see text) and the 
immunoprecipitates subjected to SDS-PAGE and autoradiography (B). Lane 1 represents 
non-specific bands associated with Protein A alone, lanes 2 & 3 - immunoprecipitates using 
pre-immune serum from basal and insulin-stimulated adipocytes respectively, lanes 4 & 5- 
immunoprecipitates using anti-GTP-binding protein serum (dynamin in this case) from basal 
and insulin-stimulated adipocytes respectively. Panel A represents a 4 h exposure, panel B a 3 
day exposure.
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4.8 Periodate-oxidised GTP-labelling of isolated GLUT4 vesicles.
It has been previously reported that use of the [a-32P]GTP ligand blotting technique revealed 
that GLUT4 vesicles contain low molecular weight GTP-binding proteins (Cormont et al,, 
1991). Hence, to compare the periodate-oxidised GTP labelling method with the ligand 
blotting method, GLUT4 vesicles were isolated and subsequendy any associated GLUT4- 
vesicle GTP-binding proteins were labelled using periodate-oxidised [a-32P]GTP. However no 
labelled proteins were detected by this method. Whilst immunoglobulins bound to the 
Staphylococcus aureus cells (section 2.16) could be seen by Coomassie staining on SDS-PAGE gels, 
it is uncertain whether the GLUT4 vesicles remained intact following the oxidation with the 
sodium periodate and the subsequent reductions with the borohydride compounds.
4.9 ADP-ribosylation factor (ARF)
Given the role of ARF isoforms in membrane trafficking processes (section 1.14.2) and the 
report of ARF translocation to plasma membranes in insulin-stimulated rat adipocytes 
(Kamam et al., 1997), there is perhaps a precedence for the involvement of ARF in GLUT4 
trafficking processes. Therefore, experiments were designed to identify whether ARF truly 
does translocate to plasma membranes as reported. Additionally experiments described below 
investigated the role of an association of ARF with GLUT4 vesicles.
4.9.1 ARF cellular localisation in basal and insulin-stimulated rat adipocytes
Basal and insulin stimulated rat adipocytes were subfractionated (section 2.12), to produce PM, 
LDM, HDM and cytosol fractions. Equal amounts of plasma membranes (20 |4g) from basal 
and insulin-stimulated cells were Western blotted for GLUT4, syntaxin4 and ARF (figure 32). 
The blotting for GLUT4 clearly shows the increase of GLUT4 in the PM under insulin 
stimulated conditions. As a marker for protein loading on the SDS-PAGE gel, the plasma 
membranes were Western blotted for syntaxin4. Unlike GLUT4, syntaxin4 is found to be 
mainly localised to the plasma membrane, with plasma membrane concentrations remaining 
constant under insulin-stimulated conditions. The Western blot for syntaxin4 showed an equal 
amount of syntaxin4 in both basal and insulin-stimulated plasma membranes, under 
conditions where GLUT4 translocation to the plasma membrane can be observed. Similarly, 
using an ARF polyclonal antibody that recognises ARF isoforms 1,3,4,5 and 6 an increase in 
ARF protein levels in plasma membranes of rat adipocytes stimulated with 20 nM insulin was 
detected. Whilst ARF appeared to increase in plasma membranes of insulin-stimulated rat
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adipocytes, a concomitant decrease in ARF protein was observed in the cytosol of insulin- 
stimulated adipocytes, compared to basal cells. No differences between basal and insulin 
samples were observed for ARF in the HDM or LDM fractions. The levels of ARF protein 
observed in the LDM fraction were very small (data not shown) and may represent cytosolic 







Figure 32. Western blotting of plasma membranes and cytosol fractions for ARF. Rat
adipocytes were isolated and basal cells (B) or cells stimulated with 20 nM insulin for 20 min 
(I) were fractionated and the PM and cytosol fractions isolated. 20 pg aliquots of B and I 
samples were subjected to SDS-PAGE, followed by transfer onto nitrocellulose membrane. 
The nitrocellulose membrane was stained with Ponceau S and the nitrocellulose membrane 
cut to enable the blotting of GLUT4 at 45 kDa, syntaxin4 at 37 kDa and ARF at 20 kDa. No 
GLUT4 or syntaxin4 were found in cytosol preparations and therefore these results are not 
shown. The blots shown are from a single experiment, representative of three separate 
experiments.
4.9.2 ARF association with GLUT4 vesicles
To determine whether the translocation of ARF to plasma membranes upon insulin- 
stimulation is associated with GLUT4 vesicle translocation, GLUT4 vesicles were isolated and 
vesicle proteins Western blotted for ARF (figure 33). GLUT4 vesicles were isolated from the 
post-HDM supernatant of basal and insulin-stimulated adipocytes using Staphylococcus aureus 
cells pre-adsorbed with either rabbit serum containing anti-GLUT4 antibodies or with rabbit 
serum from non-immunised rabbits (pre-immune serum (PI)) (section 2.16). Vesicle proteins 
were solubilised in 1% Thesit. Bound immunoglobulins and GLUT4 were eluted from the 
Staphylococcus aureus cells with SDS-PAGE sample buffer heated to 95°C. To estimate the 
efficiency of GLUT4 vesicle isolation, 40 pg of the LDMs that remained after 
immunoprecipitation of the vesicles were also Western blotted for GLUT4. The various
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immunoprecipitates were also Western blotted for the known GLUT4 vesicle protein, 
VAMP2. Western blotting for VAMP2 allows the integrity of the isolated GLUT4 vesicles to 
be determined. The top panel of figure 33, shows the Western blotting of GLUT4. The 
GLUT4 remains tightly associated with the anti-GLUT4 antibody bound to the S. aureus cells. 
Hence no GLUT4 were observed in samples solubilised by Thesit. However, the GLUT4 was 
eluted by SDS-PAGE sample buffer heated to 95°C. Under these conditions, rabbit serum 
containing anti-GLUT4 antibodies immunoprecipitated GLUT4 from both basal and insulin- 
stimulated post-HDM fractions. It could also be seen that since 50% of GLUT4 vesicles 
translocate to the plasma membrane under insulin-stimulated conditions, approximately 50% 
less GLUT4 vesicles were immunoprecipitated under insulin-stimulated conditions. The 
immunoprecipitation of the GLUT4 vesicles was found to be specific, since serum from non­
immunised rabbits (pre-immune serum) failed to immunoprecipitate any GLUT4 as detected 
by Western blotting. The efficiency of the anti-GLUT4 serum compared to the pre-immune 
serum was determined by blotting a fraction of the remaining LDMs following the 
immunoprecipitations. Western blotting of these fractions showed that there was a greater 
reduction in the amount of GLUT4 in the LDM fraction following immunoprecipitation using 
specific anti-GLUT4 antibodies than using pre-immune serum. The efficiency of GLUT4 
immunoprecipitation from this and other experiments was found to be approximately 60-70% 
for basal cells, and approaching 100% for insulin-stimulated cells (as determined by Western 
blotting and scanning densitometry). GLUT4 vesicle immunoprecipitation using 12 pg 
purified GLUT4 antibodies coupled to S. aureus cells was found to be more efficient and 
results in over 90 % efficiency for immunoprecipitation of GLUT4 from the LDM of basal 
cells (data not shown).
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Figure 33. Isolation of GLUT4 vesicles and Western blotting for ARF and the known 
GLUT4 vesicle proteins GLUT4 and YAMP2. The post-HDM fraction was isolated from 
basal (B) and insulin-stimulated (I) rat adipocytes. Using Staphylococcus aureus cells pre-adsorbed 
with either pre-immune serum (PI) or rabbit serum containing anti-GLUT4 antibodies 
(GLUT4), GLUT4 vesicles were immunoprecipitated from the post-HDM fractions. Each 
immunoprecipitation used 50pl of serum conjugated to 40pl of Staphylococcus aureus cells and a 
post-HDM fraction equivalent to the post-HDM fraction obtained from one rat. Following a 
2 h immunoprecipitation, S. aureus bound vesicle proteins were solubilised using 1% (v/v) 
Thesit in TES (Thesit soluble proteins), and immunoglobulins bound to the Staphylococcus 
aureus cells eluted with SDS-PAGE sample buffer heated to 95°C (Staph, cell bound proteins). 
The LDMs not bound to the S. aureus cells following immunoprecipitation were pelleted by 
centrifugation, of which 40pg was used in Western blotting (remaining LDMs). Thesit soluble 
protein fractions, Staph, cell bound proteins and remaining LDMs were then subjected to 
SDS-PAGE, and electrophoretic transfer onto nitrocellulose membrane. Nitrocellulose 
membranes were cut and Western blotted for either GLUT4 (top panel), ARF (middle panel) 
or VAMP2 (bottom panel). Positive blotting controls were included in the experiment; 50pg 
of rat basal low density microsomes (LDM) and cytosol (CYT).
The bottom panel of figure 33, shows that GLUT4 vesicles can be isolated intact, as shown by 
the Western blotting for VAMP2. VAMP2 was found in the Thesit solubilised fractions 
following GLUT4 immunoprecipitation, but not in fractions using pre-immune serum as the 
immunoprecipitating antibody. Like GLUT4, approximately 50 % less VAMP2 was observed 
in solubilised vesicle proteins from GLUT4 vesicles derived from insulin-stimulated cells, 
compared to basal cells. The solubilisation of vesicle proteins with Thesit was found to be 
100% effective, since no VAMP2 was observed in any sample following the subsequent 
addition of sample buffer to the S. aureus cells and by heating to 95°C. Unlike GLUT4, it
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appeared that 100% of VAMP2 containing vesicles were removed by immunoprecipitation of 
GLUT4 vesicles, whereas VAMP2 could still be observed in LDM fractions after 
immunoprecipitations using pre-immune rabbit serum.
Western blotting for ARF (middle panel, figure 33) showed that unlike VAMP2 no ARF could 
be detected in the Thesit solubilised fractions. This would indicate that ARF was not 
associated with the GLUT4 vesicles. This was confirmed by Western blotting of the remaining 
LDMs which showed that there were no differences between basal or insulin-stimulated 
samples. Furthermore, removal of GLUT4 vesicles by immunoprecipitation had no effect on 
the levels of ARF found in the LDM. A protein band was observed at the predicted molecular 
weight for ARF in samples removed from the S. aureus cells using SDS-PAGE sample buffer, 
but this is representative of a non-specific band, since no differences were seen between 
samples derived from either the pre-immune serum or anti-GLUT4 serum.
Inclusion of 600 pM GTP to the post-HDM supernatant had no effect on the association of 
ARF with G LU T4 vesicles (data not shown). However, inclusion of 600 pM GTPyS to the 
post-HDM supernatant resulted in the detection of ARF on G LU T4 vesicles (figure 34). 
There was also an association of ARF with immunoprecipiates that were obtained using pre- 
immune serum in the presence of GTPyS, but to a lesser extent to that obtained with specific 
immunoprecipitation of the G LU T4 vesicles. The effect of the GTPyS on ARF association 
with G LU T4 vesicles was also observed following inclusion of 20 pM GTPyS in the TES  
homogenisation buffer (figure 35).
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Figure 34. ARF association with GLUT4 vesicles with and without the presence of 
GTPyS. Post-HDM supernatants containing the low density microsomes (LDMs) were 
isolated from basal (B) and insulin-stimulated (I) rat adipocytes. Using Staphylococcus aureus cells 
pre-adsorbed either with rabbit serum from non-immunised rabbits (pre-immune serum (PI)), 
or rabbit serum containing anti-GLUT4 antibodies (GLUT4), GLUT4 vesicles were 
immunoprecipitated from the post-HDM supernatants, either with or without 600 pM 
GTPyS. Each immunoprecipitation used 50 pi of serum bound to 40 pi of Staphylococcus aureus 
cells with a post-HDM fraction equivalent to that obtained from one rat (an average of 300 pg 
of LDM protein). Following a 2 h immunoprecipitation, S. aureus bound vesicle proteins were 
solubilised using 1% (v/v) Thesit in TES, and immunoglobulins bound to the Staphylococcus 
aureus cells were eluted with SDS-PAGE sample buffer heated to 95°C. Thesit soluble 
proteins were Western blotted for ARF (lower panel; 40 pg of adipocyte cytosol (Cyt) was 
used as a positive control for blotting), and proteins were removed from the S. aureus cells by 
SDS-PAGE sample buffer and Western blotted for GLUT4 (upper panel).
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Figure 35. Western blotting for ARF associated with GLUT4 vesicles, isolated in the 
presence of 20 pM GTPyS. GLUT4 vesicles were immunoprecipitated from basal (B) and 
insulin-stimulated (I) rat adipocytes as described in previous experiments but with the 
inclusion of 20 pM GTPyS to the homogenisation buffer. Thesit soluble proteins from 
isolated vesicles were subjected to SDS-PAGE and electrophoretic transfer onto 
nitrocellulose. Membranes were then Western blotted for ARF.
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4.10 Chapter 4 discussion
It is well established that GTP-binding proteins play important and diverse roles in membrane 
trafficking. In particular the Ras-like GTP-binding protein families, Rabs and ARFs, have been 
shown to be involved in numerous membrane trafficking events. GTP-binding proteins 
implicated in GLUT4 trafficking include Rab4 (section 1.14.1) and Gia2 (section 1.14.3), but their 
roles in GLUT4 trafficking remain unclear.
Periodate-oxidised, GTP-labelling. The method of periodate-oxidised GTP-labelling of GTP- 
binding proteins has several advantages over other methods ([a-32P]GTP ligand binding and 
photocrosslinking of [a-32P]GTP) to identify GTP-binding proteins. For instance, periodate- 
oxidised [a-32P] GTP-labelling will radiolabel high molecular weight GTP-binding proteins, 
whereas [a-32P]GTP ligand binding is restricted to the detection of low molecular weight 
GTP-binding proteins, since only small molecular weight proteins will renature upon transfer 
to nitrocellulose and form the GTP binding pocket. Additionally, periodate-oxidised GTP- 
labelling can be performed under equilibrium conditions which enables the labelling of low 
affinity nucleotide binding proteins, whereas GTP ligand binding only detects GTP-binding 
proteins that have very high binding affinities for GTP. The main advantage of periodate- 
oxidised GTP-labelling is that in addition to identifying GTP-binding proteins, under 
conditions where the exchange of GDP for GTP is stimulated i.e. GTP-binding protein 
activation, then the activation of GTP-binding proteins can be identified.
Using insulin-responsive permeabilised rat adipocytes, periodate-oxidised GTP-labelling 
revealed specific GTP-labelling of numerous proteins from ~ 20-120 kDa (figure 19). In 
particular, proteins at ~22-24 kDa and ~45 kDa showed marked increases in GTP-labelling 
upon insulin stimulation. The insulin-induced increased GTP-labelling of these latter proteins 
was reduced when the cells were treated with insulin in the presence of wortmannin. The 
GTP-labelling was consistendy observed, and implied that GTP-binding proteins are activated 
by insulin downstream of a wortmannin sensitive PI 3-kinase. The molecular weight of the 
proteins, which showed increased GTP-labelling upon insulin stimulation, suggested that both 
Ras-like, and heterotrimeric GTP-binding proteins are activated by insulin downstream of PI 
3-kinase. Whilst, insulin treatment increased GTP-labelling up to ~2.5-fold above basal GTP- 
labelling, 2D-gel electrophoresis failed to reveal any single protein that could account for the 
increased insulin-stimulated GTP-labelling. This latter result would suggest that more than one 
heterotrimeric GTP-binding protein and Ras-like protein are activated by insulin.
119
Unfortunately, the identification of these proteins was not possible using the techniques 
described.
The 2D-gel electrophoresis experiments showed that the highest degree of GTP-labelling was 
of proteins with a pi in the range ~4.0-5.5 and an apparent molecular mass of 21-25 kDa. It is 
likely that these labelled proteins are Ras-like GTP-binding proteins. However, it was difficult 
to interpret what the Ras-like GTP-binding proteins following periodate-oxidised GTP- 
labelling might be. This may be because periodate-oxidised GTP-labelling can cause a 
significant shift in the isoelectric focussing of proteins (Huber & Peter, 1994), and can shift 
the apparent molecular weight of proteins e.g. Ras on SDS-PAGE shifts from 21 to 25 kDa 
following periodate-oxidised GTP-labelling (Low et al., 1993).
Whilst numerous proteins were shown to be labelled by the periodate-oxidised GTP, there are 
some disadvantages of the technique. Firsdy, the technique relied upon the covalent 
attachment of the oxidised GTP to an amino group, such as the 8-amino group of lysine. If an 
amino group is not present within, or close to, the GTP binding site, then GTP-labelling of 
the protein is unlikely to occur. Periodate-oxidised GTP-labelling of Ras was shown to 
covalendy label two lysine residues namely K117 and K147, which are parts of the NKXD 
and SAK/L consensus elements of Ras-related proteins (Low et al> 1993). The predicted 
amino acid sequences of Rab4 and Gia2 both have the NKXD sequence in their predicted 
GTP-binding pocket (N121KKD and N268KKD respectively; protein accession numbers 
P05714 and P04696 respectively). Both Rab4 and Gia2 would therefore be expected to be 
labelled by the periodate-oxidised GTP. However, immunoprecipitation of dynamin, Rab4 
and Gitt2 following periodate-oxidised GTP-labelling failed to immunoprecipitate any of these 
proteins. These data raise a second limitation of the periodate-oxidised GTP-labelling 
technique. Whilst not assessed, it is possible that penodate-oxidation and borohydride 
reduction of proteins inflicts damage to an extent where they are no longer recognised by 
antibodies. Moreover, the excess borohydride added to samples was present on addition to 
Sepharose-conjugated antibodies that were used for immunoprecipitation reactions. Whilst 
experiments demonstrated that the antibodies remained attached to the Sepharose in the 
presence of the borohydride (25 and 50 kDa bands in Coomassie Blue stained gels) the 
reduction of the antibody by borohydride may have reduced antibody to antigen binding. 
Further experiments need to be undertaken to determine whether proteins such as Rab4 and
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Gia2 can still be immunoprecipitated under conditions which follow oxidation and reduction 
of proteins and borohydride reduction of antibodies.
The chemical crosslinking reaction probably destroys native protein structures, which can 
disrupt the association with other proteins. Hence, whilst Rab4 has been found associated 
with GLUT4 vesicles (Cormont et al.y 1993), GTP-labelling of immunoisolated GLUT4 
vesicles may result in the dissociation of any GTP-binding protein with the GLUT4 vesicles. 
Therefore, it may be necessary to precipitate any proteins from the supernatant following 
GTP-labelling of proteins initially associated with the GLUT4 vesicles.
One final limitation of the periodate-oxidised GTP-labelling method is that proteins that have 
a slow rate of nucleotide exchange (exchange of GDP for GTP) are unlikely to become 
labelled. Many Ras-like proteins fall into this latter category. The action of accessory proteins, 
GEFs and GAPs, normally increase the rate of nucleotide exchange. Additionally, the 
concentration of free Mg2+ may alter the exchange of GDP for GTP. For instance, guanine 
nucleotide exchange rates on Ras are critically dependent on the Mg2+ concentration (Hall & 
Self, 1986). In high free Mg2* nucleotide exchange rates on Ras are very slow and the half-life 
for nucleotide dissociation is around 60 min. In low free Mg2+ (0.1 flM) exchange is fast and 
the half-life is less than 1 min. The adipocytes were permeabilised in KRH buffer (containing 
1.25 mM MgSC>4) supplemented with 4 mM Mg-ATP. Under these conditions the free Mg2+ 
concentration can be calculated to be ~ 1.6 mM (free Mg2"*" was calculated using the freeware 
computer program BAD4 (v. 4.0) developed by Brooks & Storey, 1992). Hence, the relatively 
high free Mg2+ may have slowed guanine nucleotide exchange thereby reducing both insulin- 
responsiveness and periodate-oxidised GTP-labelling of GTP-binding proteins.
From the studies described here, it is difficult to know what proportion of GTP-binding 
proteins were labelled. If only a small proportion of GTP-binding proteins were labelled then 
a greater equilibrium incubation time with [a-32P]GTP may result in increased labelling. 
However, an increased equilibrium incubation time with [a-32P]GTP also means an increased 
time with a-toxin, which was shown to reduce adipocyte insulin-responsiveness.
The simplest procedure for labelling GTP-binding proteins is by u.v. irradiation of the labelled 
physiological ligand, [a-32P]GTP. However, as mentioned previously, this method gives a low 
level of covalent incorporation and hence has low sensitivity. Photoaffinity labelling is usually
121
preferred over chemical affinity labelling because the photoaffinity label is generally more 
stable in solution, photoactivation is time controlled while chemical affinity labels usually react 
only with certain amino acids (as with periodate-oxidised GTP). Zor et al (1995) describes the 
synthesis of a novel photoaffinity label, with high affinity, for GTP-binding proteins. The 
GTP-photolabel appears to have equal affinity for GTP-binding proteins compared to GTP, 
but unlike GTP the GTP-photolabel would appear not to be hydrolysed by GTP-binding 
proteins. The GTP-photolabel may therefore be a more powerful tool than periodate-oxidised 
GTP to identify GTP-binding proteins.
ADP-ribosylation factor (ARF). ARF proteins have been proposed to play several roles in the 
control of membrane traffic including endosome-endosome fusion (Lenhard et al., 1992), 
formation of Golgi coated vesicles (Ktistakis et al., 1996), adaptor protein recruitment to 
membranes (West et al., 1997) and vesicular trafficking between the ER and the or-Golgi 
compartment (Balch et al., 1992).
Guanine nucleotide exchange on ARF is disrupted by the fungal metabolite, brefeldin A 
(BFA) (ARF6 is BFA insensitive). BFA has no inhibitory effects on insulin-stimulated 
translocation of GLUT4 to the PM in adipocytes (Chakrabarti et al., 1994; Bao et al., 1995; 
Kono-Sugita et al., 1996). Although BFA treatment does not inhibit insulin-stimulated GLUT4 
trafficking to the PM, it causes a 2-fold increase in basal glucose uptake (Bao et al., 1995; 
Kono-Sugita et al., 1996). BFA also interferes with the transport of some proteins between 
the PM, endosomes and the TGN (Lippincott-Schwart2 et al., 1991). Whilst GLUT4 
internalisation from the PM does not appear to be affected by BFA treatment (Chakrabarti et 
al., 1994), BFA may prevent GLUT4 trafficking from early-endosomes to the TGN. BFA 
treatment of adipocytes may therefore increase the levels of GLUT4 in the recycling 
endosomal pool, which may account for the small increase in glucose transport in basal BFA- 
treated adipocytes.
Experiments with BFA would suggest that the TGN is not the major functional source of 
GLUT4 undergoing insulin-mediated translocation to the PM. However, these data do not 
eliminate the TGN as a compartment utilised by GLUT4 en route to the formation of the 
major insulin-responsive GSVs. If BFA does inhibit GLUT4 trafficking between the PM and 
the TGN, then this can readily be tested. If GLUT4 is trapped within the recycling endosomal 
pool in cells treated with BFA, then removal of the insulin-stimulus from insulin and BFA 
treated cells would result in an elevated basal glucose transport compared to cells treated with
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insulin alone. Furthermore, if GLUT4 is allowed to internalise following removal of the 
insulin stimulus in insulin and BFA treated cells, a subsequent insulin-stimulation may result in 
a reduced insulin-stimulated glucose transport. If reduced glucose transport occurs in this 
latter case it may be a direct result of GSVs not being regenerated, due to a lack of trafficking 
through the endocytic/TGN pathway.
Evidence for ARF being involved in GLUT4 vesicle trafficking is provided by data presented 
here, where ARF was found to associate with GLUT4 vesicles (figures 34 & 35). Smaller 
amounts of ARF were also found associated with Staph cells pre-adsorbed with non-specific 
rabbit serum. ARF loosely bound to Golgi membranes can be extracted with 
phosphatidylcholine (PC) liposomes (Helms et al., 1993). PC liposomes failed to reduce ARF 
association with GLUT4 vesicles (data not shown), suggesting a strong interaction between 
ARF and GLUT4 vesicles. The interaction between ARF and GLUT4 vesicles was only 
apparent when GTPyS was added to the post-HDM supernatant or homogenisation buffer 
when isolating the vesicles. Inclusion of GTP to the post-HDM supernatant failed to cause an 
association between ARF and GLUT4 vesicles (data not shown). The association of ARF with 
GLUT4 vesicles that occurs in the presence of GTPyS but not GTP or under normal 
conditions, may be explained by the mechanism of ARF binding to membranes (Antonny et 
al., 1997; Losonczi & Prestegard, 1998). In the GDP bound state ARF is mostly soluble but 
interacts transiently with membrane. The N-terminus of ARF is myristoylated and this enables 
it to insert into the bilayer. In addition, some basic residues of the N-terminus interact 
electrostatically with acidic phospholipids of the membrane. The weak interaction of ARF 
with membranes favours the interaction of A R F g d p  with an exchange factor. In the GTP- 
bound state, ARF is tighdy bound to membranes. This longer-lived interaction is due to 
exposure of ARF N-terminal hydrophobic residues. These residues, which are buried in the 
GDP-bound state become available for anchoring ARF to the lipid bilayer when the protein 
switches to the GTP state. They provide the additional binding energy that, in addition to 
non-specific electrostatic interactions and insertion of the myristoyl group, permits a stable 
association of ARF with the membrane. Hence, non-hydrolysable GTPyS is likely to increase 
ARF association with membranes. Since GTP did not increase ARF association with GLUT4 
vesicles then a high level of ARF GTPase activity is suggested. Whilst a small amount of ARF 
was found to bind non-specifically to the S. aureus cells, immunoprecipitation of GLUT4 
vesicles using acrylamide beads instead of S. aureus cells reduced non-specific ARF binding 
(Gillingham et al., 1999).
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Further evidence for ARF association with GLUT4 vesicles is provided by the observations 
that GLUT4 vesicles can associate, with BFA sensitive, adaptor proteins, AP-1 and AP-3 
(Gillingham et al, 1999). Adaptor proteins appear to participate in two crucial events in 
trafficking processes, namely the physical formation of transport intermediates and the 
selection of cargo for transport (Hirst & Robinson, 1998). ARF1 has been shown to regulate 
the recruitment of both AP-1 and AP-3 to membranes (Zhu et al., 1998; Ooi et al., 1998). 
ARF and adaptor proteins are therefore likely to participate in the biogenesis of insulin- 
responsive GSVs.
Recently it has been shown that addition of myristoylated peptides corresponding to the N- 
terminus of ARF5 and ARF6 inhibited insulin-stimulated transferrin receptor and GLUT1 
trafficking to the PM in permeabilised 3T3-L1 adipocytes (Millar et al., 1999). Whilst 
myristoylated N-terminal ARF5 peptides did not significantly affect insulin-stimulated PM 
GLUT4 levels, the ARF6 peptide inhibited GLUT4 translocation to the PM by ~50%. Other 
studies have shown that overexpression of ARF6 can redistribute the transferrin receptor to 
the PM, while a dominant negative mutant of ARF6 was shown to redistribute transferrin 
receptors to intracellular membranes (D’Sou2a-Schorey et al., 1995). Millar et al. (1999) have 
therefore suggested that ARF6 may be involved in insulin-stimulated GLUT4 trafficking to 
the PM, or alternatively ARF6 may be responsible for regulating GLUT4 internalisation from 
the PM. These data provide further evidence for the regulation of GLUT4 endocytosis by 
insulin (section 3.9).
ARF6 has been reported to be localised only to the PM in cultured mammalian cells 
(Cavenagh et al., 1996). Furthermore the ARF-GEF, ARNO (section 1.14.2), has been shown 
to stimulate nucleotide exchange on both ARF1 and ARF6 (Paris et al., 1997; Frank et al., 
1998). Insulin stimulation of 3T3-L1 adipocytes causes the translocation of ARNO to the PM 
(Venkateswarlu et al., 1998). It was therefore suggested that the translocation of ARNO to the 
PM might activate ARF6 and regulate subsequent plasma membrane cycling events. If ARNO 
activates ARF6, and if active ARF6 blocks GLUT4 internalisation (Millar et al., 1999), then 
ARNO translocation to the PM would cause a subsequent reduction of GLUT4 
internalisation. Insulin treatment of adipocytes does inhibit GLUT4 endocytosis, but only to a 
small extent in comparison to the effects of insulin on GLUT4 exocytosis to the PM (Satoh et 
al, 1993; Yang & Holman, 1993; Jhun et al., 1992).
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Insulin appeared to cause a redistribution of ARF from the cytosol to the PM (figure 32). This 
result is in agreement with Kamam et al (1997) who also observed an insulin-stimulated 
translocation of ARF to the PM. Since BFA does not inhibit GLUT4 translocation to the PM, 
then the ARF translocated to the PM is unlikely to be ARF derived from GLUT4 vesicles. 
ARF association with GLUT4 vesicles, was only apparent in the presence of GTPyS and not 
GTP. This latter result suggests that under the conditions used to sub-fractionate the 
adipocytes ARF exhibits a high GTPase activity, probably due to the interaction with GAPs. 
A difference in the levels of PM ARF isolated from basal and insulin-stimulated adipocytes 
may have been detected as the PM was rapidly isolated from the cytosol (<30 min). Therefore 
cytosolic GAP activity associated with the PM may have been reduced thereby increasing the 
levels of GTP-bound ARF and hence a tighter association of ARF with the PM. A 
subfractionation of basal and insulin-stimulated adipocytes in the presence of GTPyS 
increased ARF association with all membrane fractions, with a reduction of ARF in the 
cytosol, however no major differences between basal and insulin-stimulated fractions were 
observed (data not shown). This indicates that since GTPyS increases ARF binding to 
membranes any differences that are due to insulin stimulation are no longer apparent. Both 
GDP and GTP bound to ARF will be exchanged for GTPyS resulting in the active 
conformation of all ARF isoforms. The translocation of ARF5 from the cytosol to the PM 
upon insulin stimulation of 3T3-L1 adipocytes has been observed (Millar et al, 1999). Whether 
the translocation of ARF seen in figure 32 is due to ARF5 is difficult to assess without the use 
of specific ARF isoform antibodies.
In summary, it would appear from the GTP-oxidation and labelling experiments that in 
adipocytes both small Ras-like and heterotrimeric GTP-binding proteins are activated by 
insulin, and that in part these proteins are activated by insulin downstream of PI 3-kinase. 
ARF can associate with GLUT4 vesicles, and by recruiting adaptor proteins it is proposed that 
ARF can regulate the trafficking of GLUT4 from the PM back to the insulin-responsive 
GSVs. ARF was also observed to translocate from the cytosol to the PM upon stimulation of 
the adipocytes with insulin. It is possible that the observed translocation of ARF could be due 
to ARF5, and the ARF isoform associated with GLUT4 vesicles is ARF1. Isoform specific 
ARF antibodies are required to determine which ARF isoform can associate with GLUT4 
vesicles, and which isoform translocates from the cytosol to the PM upon insulin stimulation. 
Further research is required to determine whether any of these events are BFA sensitive.
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CHAPTER 5
PR O T E IN  KINASE B
PART A - The effects of okadaic acid on PKB activity in tat and human adipocytes
Whilst PKB activity has been shown to be dependent upon PI 3-kinase activation, it is still not 
clear whether PKB is necessary for insulin-stimulated GLUT4 translocation. Since the mode 
of activation of PKB is primarily by serine and threonine phosphorylation, the non-specific 
serine/threonine phosphatase inhibitor okadaic acid (OA) (section 1.15) was used to correlate 
the effects of phosphatase inhibition on both PKB activity and GLUT4 translocation in both 
human and rat adipocytes.
5.1 Glucose transport and PKB activity in human adipocytes treated with okadaic acid
Human adipocytes were isolated (section 2.7) and treated either with or without 20 nM insulin 
and/or 1 fiM OA. Adipose cells were then either assayed for 3-OMG transport, or lysed and 
PKB immunoprecipitated for PKB activity measurements. Figure 36A shows that insulin 
stimulation of the human adipose cells produces a 3.5-fold increase in the 3-OMG transport 
rate (0.011 ± 0.001/s in insulin-stimulated cells compared to 0.0033 ± 0.0001/s  in basal cells). 
This was mimicked by the OA, which produced a 3-OMG uptake rate constant of 0.0125 ± 
0.002/s. Unlike experiments by Rondinone & Smith (1996), the 3-OMG transport rate in 
adipose cells treated with both OA and insulin were found not to be additive compared to 
insulin stimulation alone (0.0143 ± 0.008/s for cells treated with insulin and OA compared to 
0.0125 ± 0.002/s for insulin-stimulated cells).
Insulin stimulation of human adipocytes produced a 14-fold increase in PKB activity (figure 
36B) (46.76 ± 10.36 fmol/min/ml 40% cells in insulin-stimulated cells compared to 3.244 ± 
0.908 fmol/min/ml 40% cells in basal cells). By contrast cells treated with OA alone, only 
exhibited a 2-fold increase in PKB activity (7.490 ± 2.520 fmol/min/ml 40% cells). Insulin 
and OA treatment together gave a 10- fold increase in PKB activity (31.17 ± 8.849 
fmol/min/ml 40% cells) compared to basal cells. However PKB stimulation by both insulin 























Figure 36. 3-OMG transport and PKB activity in human adipose cells treated with 
insulin and/or okadaic acid. Human adipocytes were isolated and treated with or without 1 
pM okadaic acid (OA) for 20 min and then with or without 20 nM insulin (I) for 30 min. 
Adipose cells were then either direcdy used in determining the rate of uptake of 50 pM 3- 
OMG (A) or lysed and PKB immunoprecipitated for PKB activity measurements (B). Data 
are means ± SEM for 3 separate experiments. * P < 0.05 vs B, *** P < 0.001 vs B, vp 
significandy different from insulin, P < 0.05.
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5.2 Okadaic acid effects on 3-OMG transport and PKB activity in rat adipocytes
Whereas 1 pM OA stimulated 3-OMG transport in human adipocytes to an extent 
comparable with the insulin stimulation, this was not found for rat adipocytes. In rat 
adipocytes, OA stimulated the 3-OMG transport rate 10-fold above basal levels (from 0.003/s 
in basal cells to 0.030/s in okadaic acid treated cells). However the stimulation produced by 
OA was only 16% of that observed following insulin treatment (0.030/s for OA treated cells 
compared to 0.183/s for insulin treated cells) (figure 37).









Figure 37. 3-OMG transport in rat adipocytes stimulated with 1 pM okadaic acid.
Isolated rat adipocytes were either incubated with either 20 nM insulin (I) or 1 pM okadaic 
acid (OA) for 20 min, or with no additions (B). The rates of uptake of 50 pM 3-OMG were 
then determined. Data is from a single experiment.
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Additionally, treatment of rat adipose cells with OA failed to significantly stimulate PKB. It 
was shown that while insulin stimulated PKB 7-fold over basal cells (88.73 fmol/min/ml 40% 
cells compared to 12.11 fmol/min/ml 40% cells in basal cells), OA only produced an ~ 2-fold 
increase in PKB activity (22.56 fmol/min/ml 40% cells) over basal cells (only 25% of the 
insulin stimulated activation) (figure 38).
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Figure 38. PKB activity in insulin and okadaic acid stimulated rat adipose cells.
Isolated rat adipocytes were stimulated with either 20 nM insulin (I) or 1 pM okadaic acid 
(OA), for 20 min at 37°C, or incubated with no additions (B). Cells were then lysed and PKB 
immunoprecipitated from detergent soluble lysates. The measurements of the PKB activity 
were performed directly on the immunoprecipitates. Results are means from 2 separate 
experiments.
130
PART B - PKB activity in contraction- and insulin-stimulated soleus muscle
In contrast to the insulin-mediated signalling leading to GLUT4 translocation in adipocytes, 
little is known about intracellular signalling mechanisms through which muscle contraction 
elicits glucose transport and GLUT4 translocation. Whilst muscle contraction appears to be 
independent of PI 3-kinase activation (Lund et al, 1995; Yeh et al., 1995), it is conceivable that 
muscle contraction stimulates a pathway that utilises common steps to that of insulin 
signalling. Hence further studies were undertaken to see if PKB may be a candidate for a 
common mediator of insulin- and contraction-stimulated glucose transport.
5.3 PKB activity in isolated rat soleus muscles
To investigate whether muscle contraction and insulin stimulate GLUT4 translocation, via 
PKB, rat soleus muscles were stimulated in vitro with either insulin, insulin following a pre­
treatment with wortmannin (100-1000 nM), or by contraction (5 min at 10 Hz with square- 
wave pulses of 0.5 ms duration and 10 V amplitude). This part of the experiment was carried 
out by Dr Sten Lund (Aarhus, Denmark). Muscles were then frozen. Muscles were 
subsequendy homogenised and solubilised in a 1% (v/v) Triton X-100 buffer (section 2.9). 
PKB was immunoprecipitated from the detergent-soluble lysates and the PKB activity was 
direcdy measured in the immunoprecipitates. Figure 39 shows that insulin stimulated PKB 
activity ~4-fold above basal levels in muscle samples (15.2 ± 0.5 fmole/min/mg compared to
3.9 ± 0.3 fmole/min/mg for basal muscles). Addition of 100 nM or 1 pM wortmannin 
inhibited the insulin-stimulated increase in PKB activity in the soleus muscles. The resulting 
levels of activity were below those of basal muscles (1.1 ± 0.1 and 0.8 ± 0.1 fmole/min/mg 
respectively).
In contrast to insulin stimulation, muscle contraction did not induce activation of PKB 
activity above basal levels (3.9 ± 0.3 fmole/min/mg in basal muscles compared to 4.2 ± 0.5 
fmole/min/mg in contracted muscles). The combined effect of insulin and contraction also 
failed to stimulate PKB activity above that already activated by insulin alone (insulin 15.2 ± 0.5 
fmole/min/mg compared to insulin and contraction 13.55 ±3.1 fmole/min/mg). The PKB 
activity in muscles treated with either insulin or wortmannin corresponded to both 3-OMG 
transport and GLUT4 photolabelling with ATB-pH]BMPA (Lund et al., 1998). However, 
whilst the PKB activity in contraction-stimulated muscles were not higher than basal PKB 
activity levels, muscles stimulated by contraction were observed to have 3-fold higher levels of
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Figure 39 PKB activity in isolated rat soleus muscles. Soleus muscles from Wistar rats 
were either stimulated with insulin and/or by contraction. Some muscles were stimulated by 
insulin following a 10 min pre-treatment with either 100 nM or 1 pM wortmannin. Following 
these treatments, muscle samples were homogenised and the PKB activity was measured in 
PKB immunoprecipitates from detergent-soluble lysates. Data are means ± SEM from six 
separate experiments. * P < 0.001 vs. basal samples.
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5.4 Chapter 5 discussion
PKB and glucose transport in rat and human adipocytes treated with OA. It is unclear as to whether 
PKB activation is necessary for insulin-stimulated GLUT4 translocation to the PM (section 
1.12). The phosphorylation of serine and threonine residues on PKB is required for PKB
activation. The non-specific serine/threonine phosphatase inhibitor, okadaic acid (OA), has
been shown to elicit a partial insulin-like response on glucose transport in rat adipocytes 
(Lawrence et al., 1990; Corvera et al., 1991; Rondinone et al, 1996) and a full insulin response 
on glucose transport in human adipocytes (Rondinone & Smith, 1996). It was therefore 
hypothesised that inhibition of PKB dephosphorylation may elevate PKB activity and possibly 
cause an increase in GLUT4 translocation to the PM.
In both human adipocytes and rat adipocytes, treatment of the adipocytes with OA only
increased PKB activity 2-fold above basal PKB activity. In these studies, the antibody used to 
immunoprecipitate PKB from the adipocytes immunoprecipitates both P K B a and PKBp, but 
not PKBy. PKBy is not activated by insulin in adipocytes (Walker et al., 1998) and is therefore 
an unlikely candidate to be involved in insulin-stimulated GLUT4 translocation to the PM. 
The possibility that OA stimulates PKBy cannot be assessed here, and further work would be 
required to determine whether PKBy is involved in GLUT4 translocation to the PM. OA 
treatment of rat adipocytes gave a 2-fold increase in PKB activity, 14% of the insulin- 
stimulated PKB activity. The OA-stimulated increase in PKB activity corresponded to a 10- 
fold increase in glucose transport (16% of the insulin-stimulated glucose transport). The OA- 
stimulated increase in glucose transport is in complete agreement with data obtained by 
Rondinone et al., (1996).
As discussed in chapter 3, there appears to be spare receptor and signalling capacity in 
adipocytes in the pathway that leads to the elevation of GLUT4 translocation. Only 14% of 
the maximal insulin receptor kinase activity in rat adipocytes, and 10% of the insulin- 
stimulated PI 3-kinase activity in 3T3-L1 adipocytes, is required to activate glucose transport 
maximally (Klein et al. (1991) and unpublished data respectively). Furthermore, the results in 
chapter 3 suggest that a 2-fold increase in PKB activity in rat adipocytes (after a 24 h chronic- 
insulin treatment) can still give rise to a normal rate of GLUT4 exocytosis (compared to 
acutely insulin-stimulated cells). Hence, if PKB is involved in insulin-stimulated GLUT4 
translocation to the PM, then a 2-fold OA-stimulated increase in PKB activity, might be 
expected from data discussed above, to be sufficient to elicit a full insulin-like translocation of
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GLUT4 to the PM. However, the OA-stimulated PKB activity in rat adipocytes only 
corresponds to 16% of the maximal insulin-stimulated glucose uptake. This could suggest that 
PKB activity is not involved in insulin-stimulated GLUT4 trafficking. Alternatively, OA might 
be stimulating PKBy, which is not stimulated by insulin in rat adipocytes, and therefore is 
unlikely to contribute to insulin-stimulated GLUT4 trafficking. Furthermore, platelet-derived 
growth factor can stimulate PI 3-kinase to the same extent as insulin, without a significant 
increase in glucose transport (Wiese et al., 1995). This result suggests that the location of PI 3- 
kinase is critical for determining its role in GLUT4 trafficking. Similarly, the site of action of 
PKB activity may also be a determining parameter in eliciting the insulin-stimulated GLUT4 
translocation to the PM. OA may inhibit cytosolic phosphatases and hence activate PKB at a 
membrane site distinct from that activated by insulin which may act on a specific membrane 
targeted PKB.
It might not be valid to compare the PKB activity in freshly isolated and chronic-insulin 
treated adipocytes. The chronic-insulin treated cells represents a system whereby processes 
downstream of PKB might maintain a high ‘signalling activity’ despite reductions in PKB 
activity. Furthermore, at concentrations of insulin that stimulate maximal glucose transport 
(0.7 nM insulin, Satoh et al., 1993) in rat adipocytes, PKBP activity is 100% of the maximal 
insulin-stimulated PKBP activity, and PKBa is ~55% of the maximal insulin-stimulated 
PKBa activity (Walker et al, 1998), suggesting that PKBP activity and PM GLUT4 levels 
correlate.
In contrast to the rat adipocyte data, the small OA activation of PKB activity in human 
adipocytes was associated with a level of stimulation of 3-OMG uptake that was comparable 
to insulin stimulation. The differences between the rat and human adipocytes may simply be 
explained by differences between the two cell types. In human adipocytes, ATB-BMPA 
studies determined that insulin-stimulated human adipose cells contain approximately 9.9 x 
104 GLUT4 molecules in the plasma membrane, compared to 195 x 104 GLUT4 molecules in 
the plasma membrane of insulin-stimulated rat adipocytes (Simpson et al., 1983). The low 
abundance of GLUT4 can account for the low Vmax for 3-OMG transport in human 
adipocytes compared to rat adipocytes. Additionally, it was shown that in the basal state of 
human adipocytes, approximately 25% of the GLUT4 is at the cell surface (compared to 2% 
for rat adipocytes), whilst in the insulin-stimulated state 50% of the GLUT4 was shown to be 
at the cell surface (as for rat adipocytes) (Kozka et al., 1995). Furthermore, it was shown by
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Kozka et al. (1995) that the Vmax for 3-OMG were very similar in human and rat adipocytes in 
the basal state. It was therefore suggested that the larger human adipocytes have adapted to 
release a greater proportion of the total cellular pool of GLUT4, to provide the basal 
metabolic needs of the adipocyte. Hence, the residual intracellular-pool of GLUT4 that is 
available to respond to insulin is lower in the human than the rat adipocyte. Therefore, 
insulin-stdmulates glucose transport in human adipocytes by only ~3-fold, in comparison to 
the 40-fold increase in rat adipocytes. If the same proportion of the intracellular GLUT4 pool 
were to translocate to the PM upon OA-stimulation in both rat and human adipocytes, then 
the OA-stimulation in human adipocytes would be more insulin-mimetic, since there is a 
smaller intracellular-pool of GLUT4 to respond to the OA.
Without further studies, it is unclear to what extent the activation of PKB by OA contributes 
to OA-stimulated glucose uptake. The 2-fold increase in OA-stimulated PKB activity in both 
human and rat adipocytes is probably not due to increased phosphorylation of PKB and 
therefore an increase in its activity. The increased PKB activity more likely represents a 
situation where activated PKB molecules under basal conditions are prevented from being 
dephosphorylated in the presence of OA. Hence, the low level of PKB activity in basal cells 
becomes slighdy elevated.
If PKB stimulation by OA does not correspond to elevations in OA-induced glucose 
transport, then how can the effects of OA be explained? One interesting scenario that would 
require further investigation, would be the idea that OA stimulates the recycling endosomal 
pool. The recycling endosomal pool contains the transferrin receptor, GLUT1 and a 
proportion of the intracellular GLUT4. In 3T3-L1 adipocytes, the recycling endosomal pool 
contains ~40% of intracellular GLUT4 protein (Livingstone et al., 1996), whereas in rat 
adipocytes ~K)% of the intracellular GLUT4 protein co-localises with the transferrin receptor 
(Gillingham et al1,1999). Assuming that GLUT4 continuously recycles in human adipocytes as 
in rat adipocytes, then since 25% of the GLUT4 is on the cell surface in human adipocytes, 
the recycling endosomal pool may contain a higher proportion of recycling GLUT4 than rat 
adipocytes. The differences in the quantities of GLUT4 in the recycling endosomal pool could 
account for the differences observed between the OA-stimulation of glucose transport in 
human and rat adipocytes. OA stimulation of the rate of exocytosis from the recycling 
endosomal pool would result in an increase in GLUT4 on the cell surface to a small extent in 
rat adipocytes, and perhaps to a greater extent in human adipocytes.
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Evidence that OA may stimulate the recycling endosomal pool is provided by ablation studies 
in 3T3-L1 adipocytes (Livingstone et al, 1996). In insulin-stimulated 3T3-L1 adipocytes, the 
percentage of GLUT1 than can be ablated decreases from 68% to 34% upon insulin 
stimulation (Livingstone et al, 1996). Similarly, when 3T3-L1 adipocytes were treated with 
OA, the GLUT4 ablation was decreased from 40% to 26%. The latter result suggests that less 
GLUT4 is located in the recycling endosomal pool after OA stimulation. This result was 
explained by the idea that OA inhibited GLUT4 endocytosis in the basal state resulting in 
increased GLUT4 levels at the cell surface and an increase in glucose transport (Livingstone et 
al, 1996). However, studies in rat adipocytes have shown that OA stimulates the exocytosis 
rate constant of GLUT4 trafficking to the PM by ~3-fold, but with no significant changes in 
the endocytotic rate constant (Rampal et al, 1995). Hence, an alternative explanation for the 
reduced ablation of GLUT4 upon OA stimulation is that this reagent stimulates the exocytosis 
of GLUT4 from the recycling endosomal pool in a manner similar to insulin. In human 
adipocytes, treatment of the cells with both insulin and okadaic acid, does not give an additive 
effect on glucose transport (figure 36A). This suggests that OA stimulates GLUT4 
translocation from an intracellular GLUT4 pool that is also stimulated by insulin. Whilst 
insulin and OA treatment of human adipocytes does not alter glucose transport in comparison 
to insulin stimulation alone, the OA and insulin treatment reduces PKB activity. This can be 
explained by consideration of the observation that OA induces the phosphorylation of serine 
and threonine residues on IRS-1, and that this reduces insulin-stimulated tyrosine 
phosphorylation of IRS-1 (Tanti et al, 1994). Therefore, the reduced IRS-1 phosphorylation 
(and presumably IRS-2) is likely to reduce downstream signalling, such as PI 3-kinase and 
PKB. In the combined insulin and OA treatment the lowered PKB activity may still be 
sufficient to elicit GLUT4 translocation to the PM from the recycling endosomal pool. 
Alternatively, OA may exert its effects downstream of PKB to cause GLUT4 translocation, or 
the insulin-stimulated translocation of the endosomal recycling pool is a PKB-independent 
process. This last idea has some precedence from a recent study which has indicated that in 
3T3-L1 adipocytes the insulin stimulation of the recycling-endosomal pool does not require 
PKB activity (Foran et al, 1999).
The observation that insulin-stimulated GLUT1 translocation to the PM is inhibited by 
wortmannin (Clarke et al, 1994) suggests that the insulin-stimulation of the exocytosis of 
GLUT1 and GLUT4 from the recycling endosomal pool is dependent upon PI 3-kinase. 
However, in rat adipocytes wortmannin is not inhibitory to the insulin-mimetic effect of OA 
on glucose transport activity (Rondinone et al, 1996). This suggests that since PKB requires
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activation by PI 3-kinase the action of OA is exerted downstream of, or independent of PKB. 
Additional serine/threonine kinases may exist, which can be activated by OA-inhibition of a 
phosphatase activity.
If OA stimulates the exocytosis of GLUT1 and GLUT4 from the recycling endosomal pool 
independently of PKB, then a serine/threonine kinase is likely to regulate the trafficking of 
the recycling endosomes. This could possibly explain the effect of phorbol esters on glucose 
transport. As discussed in the introduction, PMA (an activator of cPKC and nPKC isoforms) 
has only a small effect on increasing glucose transport in rat adipocytes, similar to OA. cPKC 
and nPKC isoforms do not appear to play a major role in insulin-stimulated GLUT4 
trafficking. A PKC isoform might be involved in regulating the recycling of early-endosomes, 
since PMA can stimulate GLUT1 exocytosis to the same extent as insulin (Holman et al., 1990; 
Saltis et al'., 1991). Both OA and PMA can cause phosphorylation of GLUT4 (Gibbs et al., 
1986; Joost et al., 1987; Lawrence et al., 1990). However, insulin alone does not cause GLUT4 
phosphorylation (Gibbs et al., 1986; Joost et al., 1987; Lawrence et al, 1990). GLUT4 
phosphorylation induced by OA and PMA may therefore promote its exocytosis to the PM, 
via a pathway not normally stimulated by insulin.
PKB activity in contraction-stimulated muscle. Although muscle contraction does not stimulate 
glucose transport by a PI 3-kinase-dependent mechanism (Lund et al., 1995; Yeh et al., 1995; 
Lee et al., 1995), there is some evidence that there may be a common pathway downstream of 
PI 3-kinase. For example, polymyxin B, an inhibitor of PKC, inhibits both insulin- and 
contraction-stimulated glucose transport (Henriksen et al. 1989). Furthermore, it was shown 
that the calcium channel blocker verapamil could inhibit both insulin- and contraction- 
stimulated glucose transport (Cartee et al., 1992). It is therefore possible that insulin and 
contraction may share some common signalling step. PKB was appealing since PKB has been 
shown to be activated by cAMP independently of PI 3-kinase (Sable et al., 1997).
Insulin stimulated PKB activity about 4-fold above basal in rat soleus muscles. This is in good 
agreement with published data achieved in rat skeletal muscles after in vivo insulin 
administration (Cross et al., 1997). The increase in PKB activity was shown to correlate with 
the fold increase in glucose transport activity and cell surface GLUT4 content observed after 
insulin stimulation (Lund et al., 1998). Wortmannin treatment of the muscle samples 
completely abolished the insulin-induced PKB activity, confirming previous reports that the 
regulation of PKB is mediated by a wortmannin-sensitive PI 3-kinase. However, maximal
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electrically stimulated muscle contraction, which increased both glucose transport and cell 
surface GLUT4 (Lund et al., 1998), did not induce activation of PKB above basal activity. The 
combined effect of insulin and contraction also failed to affect PKB activity further than that 
already activated by insulin alone. However, the maximal stimulatory effect of both insulin 
and muscle contraction were shown to be completely additive on both glucose transport 
activity and PM GLUT4 content (Lund et al., 1998). These data indicate that at some level in 
the signalling pathways, there are different mechanisms leading to the stimulatory actions of 
insulin and muscle contraction. However, the PKB data clearly demonstrates that insulin- and 
contraction-induced activation pathways do not converge at the level of PKB and that PKB is 
not involved at all in contraction-induced glucose transport and GLUT4 translocation in rat 
soleus muscle (Lund et al., 1998). This conclusion is in precise agreement with a subsequent 
study by Broznick, Jr. & Bimbaum (1998).
138
CHAPTER 6
PHO SPHA TID Y LIN O SITID E- 
BINDING P R O T E IN S
Current evidence suggests that insulin-stimulated PI 3-kinase activity is necessary to stimulate 
GLUT4 translocation to the plasma membrane (section 1.9). It is postulated that the lipid 
products of PI 3-kinase are involved in the route for further downstream processes leading to 
GLUT4 translocation (section 1.11). However, the mechanisms by which PI 3-kinase lipid 
products stimulate glucose transport are still not clear. Therefore, in order to identify targets 
of the PI 3-kinase lipid products, a collaboration was established with Professor G. D. 
Prestwich, University of Utah. The collaboration provided novel photoaffinity probes and 
affinity resins based upon PI(3,4)P2 and PIP3. The aim of the work described in this chapter 
was to utilise these photoaffinity probes and affinity resins to identify PI(3,4)P2 and PIP3 
binding proteins in rat adipocytes.
6.1 Benzophenone based photolabels
The PI(3,4)P2 and PIP3 photoaffinity probes utilise a photoactivatable benzophenone group, 
which is chemically more stable than other photolabelling groups such as diazo esters, aryl 
azides and diazirines. Benzophenone-containing probes also have the advantage of being able 
to be manipulated in ambient light and activated at wavelengths which avoid protein damage. 
Additionally the benzophenone-probes react preferentially with unreactive C-H bonds, even 
in the presence of solvent water and bulk nucleophiles. Incorporation of the photolabel into 
proteins is achieved by photoactivation of the benzophenone group (figure 39). These 
processes, and the use of benzophenone photophores in biochemistry, are reviewed by 
Dorman & Prestwich (1994).
6.2 Synthesis of phosphoinositide-based photolabels and affinity resins
The phosphoinositide based photolabels are formed by a series of chemical syntheses, 
ultimately generating an co-aminopropyl tethered analogue of PIP3, PI(3,4)P2 or PIP2 
(Prestwich, 1996). Reaction of the terminal amine group with 4-benzoyl-[2,3-3H]- 
dihydrocinnamoyl N-hydroxysuccinimide (pH]BZDC-NHS) (Olszewski et al., 1995) results in 
the photolabel (figure 40). By attachment of the photophore via a flexible linker at some 
distance from the ligand recognition site, a photolabel is generated which has ligand-target 
selectivity and a degree of efficiency similar to that of the benzophenone molecule alone. 
Alternatively the phosphoinositide analogue is coupled to Affi-Gel 10 (Bio-Rad), where a 
crosslinked-agarose matrix bearing AT-hydroxysuccinimide (NHS) functional groups is 
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Figure 39. Photochemistry of the benzophenone photophore. Absorption of a photon at 
~350 nm results in the promotion of an electron from a non-bonding n-orbital on the oxygen, 
to an antibonding 7l*-orbital of the carbonyl group. This results in a diradical triplet state (1) in 
which the oxygen n-orbital is electrophilic. The excited state may last 80-120 |is, before 
relaxation back to the ground state and regeneration of the benzophenone moiety. However, 
if in the excited state the geometry pf the electron-deficient oxygen orbital allows interaction 
with a weak C-H CT-bond, such as those found in the backbone of polypeptides (2), then 
hydrogen abstraction can occur, to complete the half-filled n-orbital. The resulting ketyl (3) 
and alkyl (4) radicals that are formed can readily recombine to generate a new C-C bond, 
producing benzpinacol-type compounds (5). Alternatively, if the excited triplet state is 
proximal to an amine or similar heteroatom, then an electron-transfer step can occur (6). This 
is followed by proton abstraction from an adjacent alkyl group and a radical 1,2-shift. Radical 
recombination can then occur as previously described. These reactions are the basic processes 
that follow benzophenone photoactivation, but other radical reaction pathways can exist.
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Figure 40. Structures of phosphoinositide analogues bearing either an agarose matrix 
or [3H]BZDC-photolabelling group. PI(3,4)P2 analogues - Ri = Ra = OPO3'2, R3 = OH. 
PIP3 analogues - Ri = R2 = R3 -  OPO3 '2 PIP2 analogues - Ri = OH, R2 -  R3 = OPO3 '2
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6.3 Photolabelling tat adipocyte whole cell homogenates using [3H]BZDC-
phosphatidylinositides
A whole cell lysate was prepared from rat adipocytes and proteins were photolabelled with the 
PIP2, PIP3 and PI(3,4)P2 [3H]BZDC analogues. After the photolabelling reaction, the 
radiolabelled proteins were subjected to SDS-PAGE and visualised by fluorography (section 
2.26). The fluorograph of photolabelled proteins from a whole cell lysate is shown in figure 
41. Analysis of the fluorograph revealed labelling of numerous proteins with all three 
photolabels, with a greater degree of labelling with the PI(3,4)P2-photolabel. The higher 
degree of photolabelling with the PI(3,4)P2-photolabel probably represents a higher 
concentration of the photolabel, and not an increased affinity for the PI(3,4)P2 analogue itself, 
since an overall higher background labelling was observed. Proteins binding 
phosphatidylinositides phosphorylated at the D-3 position of the inositol ring are proteins of 
interest. Hence, the fluorograph was analysed for proteins that bound the PIP3- and 
PI(3,4)P2-photolabels and not the PIP2-photolabel.
At least three proteins appeared to be selectively photolabelled by the PI(3,4)P2- and PIP3- 
photolabels relative to the PIP2-photolabel (indicated by arrows, figure 41). The proteins 
uniquely photolabelled by the PIP3 photolabel appeared to run as a doublet with an 
approximate molecular mass of 38 kDa (lane 3, figure 41). The PIP3 photolabelled protein 
doublet was therefore termed p38. The proteins uniquely photolabelled by PI(3,4)P2 appeared 
to run as a doublet with an approximate molecular mass of 37 kDa and a single protein at 
approximately 39 kDa (indicated by arrows, lane 5, figure 41). These latter proteins were 
termed p37 and p39.
The photolabelling of p38 was not non-specific labelling since it was reduced by competition 
of the pH]BZDC-photolabel with 100 pM dipalmitoyl-PIP3 included into the photolabelling 
reaction (lane 4, figure 41). Similarly, although dipalmitoyl-PI(3,4)P2 was not available at the 
time of the experiment, dipalmitoyl-PIP3 was also found to reduce the pH]BZDC-PI(3,4)P2 
photolabelling of both p37 and p39 (lane 6, figure 41). This latter result is not wholly 
unexpected, since most proteins which bind PI(3,4)P2 are also found to bind PIP3, albeit with 
varying affinities (section 1.11).
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Overall, the whole cell lysate photolabelling with the pH]BZDC-phosphatidylinositides 
revealed at least three proteins, p37, p38 and p39, which may represent targets of the lipid 
products of PI 3-kinase.
Since the literature generally indicates that proteins which bind PI(3,4)P2 also bind PIP3 
(section 1.1 /), it is possible that due to the additional phosphate group on the PIP3 photolabel 
compared to the PI(3,4)P2 photolabel, then p37 and p38 may be the same protein.
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Figure 41. [3H]BZDC-Phosphatidylinositide photolabelling of an adipocyte whole cell 
homogenate. Basal adipocytes were homogenised and the infranatant removed from the fat. 
50 pg aliquots of the homogenate were then photolabelled with 0.2 pCi of [3H]BZDC-PIP2 
(lanes 1 and 2), pH]BZDC-PIP3 (lanes 3 and 4) or pH]BZDC-PI(3,4)P2 (lanes 5 and 6), in 
the presence of 100 pM dipalmitoyl-PIP2 (lane 2) or 100 pM dipalmitoyl-PIP3 (lanes 4 and 6). 
Radiolabelled proteins were analysed by SDS-PAGE and fluorography.
144
6.4 [3H]BZDC-phosphatidylinositide photolabelling of adipocyte subcellular fractions
Both basal and insulin stimulated rat adipocytes were homogenised and subcellular fractions 
isolated to determine the cellular location of the PI(3,4)P2 and PIP3 binding proteins, p37, 
p38 and p39, and whether or not their cellular distribution altered in insulin stimulated cells.
Labelling by the three photolabels was observed in PM, LDM and HDM fractions. However, 
specific labelling for either PI(3,4)P2 or PIP3 relative to PIP2 was not observed in the PM, 
LDM or HDM fractions. Furthermore, no differences in labelling due to insulin-stimulation 
were detected in these fractions.
In the cytosolic fraction, slight differences in labelling were observed between basal and 
insulin-stimulated samples, but this may have been representative of slight differences in 
protein loading on the gel (noticeable by observation of the Coomassie Blue stained proteins). 
A pattern of photolabelling of proteins specific for the PIP3 and PI(3,4)P2 labels, was found 
in the cytosolic fraction (figure 42) that was similar to that observed in lysates (figure 41). 






Figure 42. [3H]BZDC-Phosphatidylinositide photolabelling of basal and insulin- 
stimulated rat adipocyte cytosol. Rat adipocytes were homogenised and the cytosol 
isolated. 50 pg protein aliquots were photolabelled using 0.2 pCi of [3H]BZDC-PIP2 (lanes 1- 
4), [3H]BZDC-PIP3 (lanes 5-8) or [3H]BZDC-PI(3,4)P2 (lanes 9-12). Non-specific labelling 
was determined by the inclusion of 100 pM dipalmitoyl-PIP2 (lanes 2 and 4) or 100 pM 
dipalmitoyl-PIP3 (lanes 6, 8, 10 and 12) in photolabelling reactions. Radiolabelled proteins 
were analysed by SDS-PAGE and fluorography.
Basal Insulin Basal Insulin Basal Insulin 
1 2 3 4 5 6 7 8 9  10 11 12
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The photolabelling of p39 by [3H]BZDC-PI(3,4)P2 was not totally reduced in the presence of 
cold di-palmitoyl-PIP3 (lanes 10 and 12). This was interpreted as being either due to non­
specific labelling, or due to a significandy lower Km for PI(3,4)P2 compared to PIP3.
6.5 Purification of phosphatidylinositide-binding proteins by heparin-agarose 
chromatography
The pH]BZDC-photolabels and affinity resins have been used in the detection and 
purification of the PIP3 binding protein centaurin-a from rat brain (Hammonds-Odie et al, 
1996), Communication with G. Prestwich and A. Theibert (co-authors on the aforementioned 
publication), suggested that a protocol similar to that used for the identification of centaurin- 
a , would be appropriate to purify the PI(3,4)P2 and PIP3 binding proteins, p37, p38 and p39. 
Such a protocol requires heparin-agarose chromatography followed by affinity 
chromatography.
Heparin-agarose chromatography often yields a rapid, efficient initial purification of 
phosphoinositide-binding proteins (Theibert et al1, 1997), It has been proposed that rather 
than acting as a conventional cation exchange resin (since many of the proteins that interact 
strongly have neutral pi), heparin-agarose, a polysulfated glycosaminoglycan, may act as a 
pseudo-affinity resin.
A 5 fold dilution of the cytosol with 10 mM Tris-HCl, pH 7.2, 5 mM EDTA, and incubation 
with heparin-agarose allowed binding of p37, p38, but not p39 (figure 43) to the heparin- 
agarose. The dilution of the cytosol is required to lower the concentration of endogenous 
inositol or phosphate containing compounds that might interfere with binding to the heparin- 
agarose (personal communication with A. Theibert). Proteins, p37 and p38, were found in the 
heparin eluate fraction (lanes 3 and 6, figure 43) and were more concentrated relative to the 
initial cytosol fraction (comparing equivalent amounts of protein). Furthermore, the heparin- 
agarose step appeared to increase the relative concentration of a protein, designated as p40, 
that photolabelled with the PI(3,4)P2- but not the PIP3-photolabel (lane 6, figure 43).
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Figure 43. Photolabelling of heparin-agarose eluates. Rat basal cytosol was incubated 
with heparin-agarose for 2 h in 10 mM Tris-HCl, pH 7.2, 5 mM EDTA. Unbound proteins 
were removed and bound proteins eluted with 2 M NaCl. Cytosol fraction (lanes 1 and 4), 
unbound proteins (lanes 2 and 5) and eluted proteins (lanes 3 and 6) were photolabelled with 
[3H]BZDC-PIP3 (lanes 1-3) or [3H]BZDC-PI(3,4)P2 (lanes 4-6).
Additionally, it was observed that the majority of PI(3,4)P2 and PIP3 photolabelled proteins 
were in the heparin eluate fraction. Protein measurements indicated that approximately 50% 
of the cytosolic proteins bound to the heparin-agarose column. This indicated a degree of 
non-specific binding to the heparin-agarose, so cytosolic proteins were bound to heparin with 
varying NaCl concentrations (0-250 mM), eluting with 1.5 M NaCl.
Analysis of the profile of binding to the heparin under varying concentrations of NaCl, 
revealed that p37 and p38 eluted between 50-100 mM NaCl, whereas p40 eluted with 150-200 
mM NaCl. A subsequent experiment therefore bound the cytosolic proteins to the heparin in 
the presence of 50 mM NaCl, then proteins were eluted stepwise with 175 mM NaCl, then 
300 mM NaCl. Under these conditions, protein measurements revealed that 90% of the 
cytosolic protein did not bind to the heparin, and the remaining 10 % was eluted from the
147
heparin-agarose using 175 mM and 300 mM NaCl. Figure 44 shows part of a Coomassie Blue 
stained profile of 50 pg of each of these fractions following photolabelling and SDS-PAGE.
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Figure 44. Coomassie Blue stain of cytosolic proteins eluted from heparin-agarose with
175 and 300 mM NaCl. Cytosolic proteins (~ 22 mg) were bound to heparin-agarose in the 
presence of 50 mM NaCl. Proteins were then eluted stepwise using 175 mM NaCl then 300 
mM NaCl. The NaCl was removed from the samples and 50 pg aliquots of cytosol (C), 
proteins not bound to the heparin-agarose (FT), 175 mM NaCl eluate (175) and 300 mM 
NaCl elute (300) were photolabelled with the [3H]BZDC-photolabels. Samples were then 
analysed by SDS-PAGE, stained with Coomassie (as above) and fluorography (figure 45). 
Broad range markers used in most experiments for approximate molecular mass determination 
of proteins is shown (M). The fluorography of the above gel is shown by figure 45.




















Figure 45. Photolabelling of heparin-agarose 175 mM and 300 mM NaCl eluates. The
cytosol was isolated from rat adipocytes. Cytosolic proteins (~ 22 mg) were then bound to 
heparin-agarose in the presence of 50 mM NaCl. Proteins were then eluted stepwise using 175 
mM NaCl then 300 mM NaCl. The NaCl was removed from the samples and 50 pg aliquots 
of cytosol (C), proteins not bound to the heparin-agarose (FI), 175 mM NaCl eluate (175) and 
300 mM NaCl elute (300) were photolabelled with the [3H]BZDC-photolabels (0.1 pCi/ 50pg 
protein). Samples were then analysed by SDS-PAGE and fluorography.
Analysis of the Coomassie stained proteins (figure 44) shows that amongst other differences, 
there is a relative increase in the concentration of at least one protein at ~38 kDa in the 175 
mM NaCl elution, and an increase in the relative concentration of two proteins at ~ 40 and 43 
kDa with the 300 mM NaCl elution (indicated by arrows). The photolabelling of these 
proteins (figure 45) showed that the p38 doublet labelled by the [3H]BZDC-PIP3 photolabel 
was high in both the 175 and 300 mM NaCl eluates, more so in the latter eluate. Therefore, 
the protein seen to increase in its relative concentration by Coomassie Blue staining at ~38 
kDa in the 175 mM NaCl eluate (figure 44), probably does not represent the photolabelled 
protein, p38. Out of the two cytosolic proteins labelled by the [3H]BZDC-PI(3,4)P2
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photolabel, p37 and p39, only p37 was concentrated in the NaCl eluates, again to a higher 
extent in the 300 mM NaCl eluate. The observation that p39 does not bind to the heparin is 
consistent with data shown in figure 43. Additionally, it was observed that two proteins, p40 
and p43, were photolabelled to a greater extent by the [3H]BZDC-PI(3,4)P2 photolabel in the 
300 mM NaCl eluate. This photolabelling may correspond to the increase in the proteins seen 
at these molecular weights by the Coomassie Blue staining of this fraction. Whilst 
photolabelling of these two proteins was also observed with proteins with similar molecular 
weights using the [3H]BZDC-PIP2 photolabel, the photolabelling was greater for the 
pH]BZDC-PI(3,4)P2 photolabel.
In summary, three cytosolic proteins p37, p38 and p39 showed selective photolabelling for D- 
3-phosphorylated phosphatidylinositides relative to PIP2. The relative protein concentration 
of p37 and p38 was increased using a heparin-agarose chromatography step. The heparin- 
agarose chromatography step also increased the relative concentration of two proteins, p40 
and p43, that strongly photolabelled with the PI(3,4)P2-photolabel.
6.6 Purification of phosphatidylinositide-binding proteins by affinity chromatography
To further purify p37, p38, p40 and p43, a phosphoinositide affinity resin based upon 
Ins(l,3,4)P3 was used. Initially 30 mg of cytosolic protein (40 fat pads) was incubated with 
heparin-agarose (as described in section 6.5) and bound proteins were eluted stepwise with 175 
mM NaCl then 300 mM NaCl. The 300 mM NaCl eluate (~ 950 pg protein) was diluted to 
remove the NaCl (section 2.20) then circulated through the Ins(l,3,4)P3 column overnight at 
4°C. The column was then washed with 10 mM Tris-HCl, pH 7.2, 1 mM EDTA, and bound 
proteins were eluted with a NaCl gradient (0 - 2 M NaCl) collecting 30 x 2 ml fractions. The 
280nm absorbance of the column eluate was measured. 100 pi of each 2 ml fraction was 
collected and proteins visualised by SDS-PAGE and silver staining (figure 46).
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Figure 46. Silver staining of proteins after heparin-agarose and Ins(l,3,4)P3 affinity 
chromatography. 30 mg of cytosolic protein was incubated with heparin-agarose and bound 
proteins were eluted stepwise with 175 mM NaCl then 300 mM NaCl. The 300 mM NaCl 
eluate (~ 950 pg protein) was then circulated through an Ins(l,3,4)P3 affinity resin overnight 
at 4°C. The column was then washed with 10 mM Tris-HCl, pH 7.2, 1 mM EDTA, and 
bound proteins eluted with a NaCl gradient (0 - 2 M NaCl) collecting 30 x 2 ml fractions 
(measuring the absorbance at 280 nm). 100 pi of each 2 ml fraction was collected and proteins 
visualised by SDS-PAGE and silver staining. 50 pg of the 300 mM NaCl heparin eluate before 
(A) and after passing through the Ins(l,3,4)P3 affinity column (B) were also included on the 
gel. No proteins were visualised by silver staining from fraction 8 onwards.
Figure 46 showed no obvious depletion of proteins from the heparin-agarose eluate occurred 
after Ins(l,3,4)P3 affinity chromatography (compare lanes A and B, figure 46). Some proteins 
were found to bind to the Ins(l,3,4)P3 column, eluting with a relatively low NaCl 
concentration. One protein in particular which appeared to bind the Ins(l,3,4)P3 affinity resin 
relative to other proteins was a protein at ~40 kDa. The silver staining pattern, would suggest 
that this 40 kDa protein might be p40, identified previously (figure 45). Fractions eluted from 
the Ins(l,3,4)P3 affinity resin and containing more than one protein (determined by silver 
staining) were pooled together (fractions 1-3). Additionally, fractions 5-7 which were 
estimated by silver staining to contain only one protein, ~40 kDa, were also pooled together.
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The two pooled fractions were then photolabelled with the three phosphoinositide 
photolabels. Initially, the pooled fractions which eluted from the Ins(l,3,4)P3 column showed 
no photolabelling, following a 6 week exposure of the fluor impregnated gel to light sensitive 
film. However, the amounts of protein photolabelled were very small. The BCA protein assay 
(sensitive to detecting 20 pg protein /ml) was unable to detect any protein in the pooled 
fractions used for photolabelling. However, a longer exposure of radiography film to the gel 
(>6 months), showed a single protein of ~ 43 kDa (possibly p43, as in figure 45) was 
photolabelled in both of the pooled fractions, but this protein was not the 40 kDa protein 
observed by silver staining (figure 46). The single protein was found to be photolabelled to a 








Figure 47. Photolabelling of Ins(l,3,4)P3 affinity column eluates. 50 pg of adipocyte 
cytosol and a heparin-agarose eluate (300 mM NaCl eluate) were photolabelled with 0.1 pCi 
[3H]BZDC-PI(3,4)P2. The heparin-agarose eluate was diluted and concentrated to remove the 
NaCl before photolabelling (section 2.20). Subsequent to heparin-agarose chromatography and 
Ins(l,3,4)P3 affinity chromatography steps, pooled fractions (1-3) and (5-7) eluted from the 
Ins(l,3,4)P3 affinity column were concentrated to ~200 pi (with NaCl removal by repeated 
concentration and dilution) and 50 pi aliquots photolabelled with 0.2 pCi of either 
[3H]BZDC-PI(3,4)P2,-PIP3 or -PIP2. Samples were then subjected to SDS-PAGE and 
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Although, p43 appeared to bind to the Ins(l,3,4)P3 affinity column, there was not enough 
protein to identify p43 by Edman sequencing. Furthermore, neither p37 nor p40 appeared to 
bind to the Ins(l,3,4)P3 column. Since proteins that bind PI(3,4)P2 are generally found also to 
bind PIP3 with equal of greater affinity, it was decided to use a Ins(l,3,4,5)P4 affinity column. 
It was hoped that the Ins(l,3,4,5)P4 column would bind both PIP3 and PI(3,4)P2 binding- 
proteins. Since only a small quantity of protein bound to the Ins(l,3,4)P3 affinity column, the 
cytosol from 200 fat pads was isolated, to start with a higher amount of phosphatidylinositide— 
binding proteins. The isolated cytosol was sequentially applied to heparin-agarose (as for 
previous experiments), and proteins were eluted with 175 and 300 mM NaCl. The 300 mM 
NaCl eluate was retained, the NaCl was removed (section 2.20) and the eluate applied to a 
Ins(l,3,4,5)P4 affinity column. Proteins were eluted from the Ins(l,3,4,5)P4 affinity column 
with a linear NaCl gradient (0 - 2M NaCl). A flow rate of 0.2 ml /  min was used and 30 x 1 ml 
fractions were collected. Silver staining 100 pi aliquots of each fraction revealed that the 
majority of protein bound to the column eluted at 0.5-1 M NaCl (fractions 9-15). Fractions 9- 
15 were pooled together, the NaCl removed by repeated dilution with 10 mM Tris-HCl, pH 
7.2, 1 mM EDTA, and the proteins concentrated using centrifugal concentrators. From 150 
mg of cytosolic protein, 8.7 mg of protein was applied to the Ins(l,3,4,5)P4 column, the 
pooled proteins eluted from the Ins(l,3,4,5)P4 column gave 280 pg of protein, 0.2% of the 
starting protein. The protein profile of this fraction, as visualised by Coomassie-Blue staining, 
after SDS-PAGE, is shown by figure 48.
The fluorograph of the gel shown in figure 48, is shown in figure 49. Comparison of the 
Coomassie Blue stained proteins eluted from the Ins(l,3,4,5)P4 column (figure 48), and the 
fluorograph (figure 49), revealed that all the proteins eluted from the Ins(l,3,4,5)P4 affinity 
column showed some degree of photolabelling. Proteins eluted from the Ins(l,3,4,5)P4 
column included proteins p37, p38, p40, which all showed strong photolabelling for 
PI(3,4,)P2 relative to PIP3 and PIP2. Weaker photolabelling in comparison to p37/38/40 was 
observed by a protein at ~43 kDa, which may represent p43 (figures 45 & 47).
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Figure 48. Coomassie Blue staining of the Ins(l,3,4,5)P4 affinity column eluate.
Fractions 9-15 which were eluted from the Ins(l,3,4,5)P4 affinity column were pooled and 
concentrated to ~ 600 pi (280 pg protein). 50 pg aliquots of the original cytosol preparation 
(C), 50 pg aliquots of the 300 mM heparin-agarose eluate (H), and 10 pg aliquots of the 
pooled Ins(l,3,4,5)P4 affinity resin eluate (R) were photolabelled with the three 
phosphatidylinositide photolabels (0.1 pCi photolabel/sample). Samples were subjected to 
SDS-PAGE, Coomassie Blue staining and fluorography (figure 49). Broad range molecular 
weight markers (M) are shown on the gel.
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Figure 49. Photolabelling of cytosol, heparin-agarose eluates and Ins(l,3,4,5)P4 affinity 
column eluates. 50 pg aliquots of either adipocyte cytosol (C) or heparin-agarose 300 mM 
NaCl eluates (H) were photolabelled with the three [3H]BZDC-phosphatidylinositides. 
Additionally 10 pg aliquots of Ins(l,3,4,5)P4 affinity resin eluates (R) were photolabelled with 
the three photolabels. All photolabelling reactions contained 0.1 pCi of the appropriate 
photolabel (all at 42.5 Ci/mmol). Samples were then subjected to SDS-PAGE and 
fluorography. The fluorograph represents a 14 day exposure at -70°C.
6.7 Identification of phosphatidylinositide-binding proteins
30 pg of the isolated Ins(l,3,4,5)P4 affinity column eluate fraction was subjected to SDS- 
PAGE and electrophoretic transfer onto PVDF for protein sequencing. Details of the 
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Figure 50. Protein sequencing and identification of Ins(l,3,4,5)P4-binding proteins. 30 pg of Ins(l,3,4,5)P4 protein was subjected to SDS- 
PAGE and electrophoretically transferred onto PVDF. Ponceau-S staining of the membrane is shown by the left hand panel, indicating molecular 
weight markers and the Ins(l,3,4,5)P4-binding proteins. Photolabelling of the proteins is shown (data from figure 51). Proteins were sequenced by a 
variety of methods (see table 5 overleaf).
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plOO The protein band was initially subjected to automated Edman sequencing with an 
Applied Biosystems 477A protein sequencer. There was no determinable sequence 
data, most probably due to a blocked N-terminal residue. Another band was treated 
by trypsin in-blot digestion. The protein fragments were separated by reverse phase 
HPLC. Detection of HPLC fractions indicated that the tryptic digest had digested 
the protein to an unusable state. Further attempts to cleave the protein into 
fragments using CNBr were also unsuccessful.
p52 The protein band was initially subjected to automated Edman sequencing with an 
Applied Biosystems 477A protein sequencer. There was no determinable sequence 
data, most probably due to a blocked N-terminal residue. Another band was treated 
by trypsin in-blot digestion. The protein fragments were separated by reverse phase 
HPLC. HPLC fractions were then subjected to MALDI mass spectroscopy. Six 
peptide fragments were identified by MALDI mass spectroscopy, which gave mass 
data consistent with that of phosphogluconate dehydrogenase. Edman sequencing 
of one HPLC fraction gave the sequence XVSNEIEAGDMQLI, consistent with 
the protein being phosphogluconate dehydrogenase. The molecular weight of 
phosphogluconate dehydrogenases is typically in the range of 52-53 kDa.
p43 The protein band was initially subjected to automated Edman sequencing with an 
Applied Biosystems 477A protein sequencer. There was no determinable sequence 
data, most probably due to a blocked N-terminal residue. Another membrane was 
subjected to a deblocking method to remove an acetylation group from serine and 
threonine residues by adding anhydrous trifluoroacetic acid (TFA) to the membrane 
and incubating for 1 h at 40°C, then allowing the TFA to evaporate then subjecting 
the membrane to sequencing again. This again provided no sequencing data. 
Another band was treated by trypsin in-blot digestion. The protein fragments were 
separated by reverse phase HPLC. HPLC fractions were then subjected to MALDI 
mass spectroscopy. No masses were detected, this could be due to the lack of 
material since the HPLC monitoring at 215 and 280 nm indicated that there was not 
much material. There may have been an over estimation of the amount of protein 
from the staining of the blot, or the losses by the digestion method may have been 
greater than expected.
p40 Automated Edman sequencing of the protein band with an Applied Biosystems 
477A protein sequencer gave the sequence PHRYPALTTEQK. The sequence 
indicates that the protein is aldolase.
p40b The protein band was subjected to automated Edman sequencing with an Applied 
Biosystems 477A protein sequencer. There was no determinable sequence data. No 
further attempts at sequencing were made.
p37/38 Sequencing of the protein doublet by automated Edman sequencing gave the 
sequence AKVAVLGASGGIGQPL for both proteins. This identified the proteins 
as malate dehydrogenase.
p29 The protein band was initially subjected to automated Edman sequencing with an 
Applied Biosystems 477A protein sequencer. There was no determinable sequence 
data, most probably due to a blocked N-terminal residue. Another band was treated 
by trypsin in-blot digestion. The protein fragments were separated by reverse phase 
HPLC. HPLC fractions were then subjected to MALDI mass spectroscopy. A 
partial sequence was obtained. The partial sequence of LQENG did not give 
protein identification.
Table 5. Sequencing methods used to identify phosphatidylinositide-binding proteins.
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6.8 Chapter 6 discussion
Whilst PI 3-kinase activity is necessary to stimulate GLUT4 translocation to the PM (section 
1.9), details of the intracellular signalling pathway downstream of PI 3-kinase are unclear. The 
likely route for the generation of subsequent signalling processes is via the lipid products 
formed by the activated PI 3-kinase. PI(3,4)P2 and PIP3 photolabels and affinity resins were 
therefore employed to identify phosphatidylinositide-binding proteins in rat adipocytes.
Photolabelling experiments indicated that proteins which preferentially bound PI(3,4)P2 and 
PIP3 in preference to PIP2, appeared to be mainly cytosolic. The observation that apparent 
PI(3,4)P2-/PIP3-binding proteins were cytosolic was not wholly unexpected. The recruitment 
of PIP3 binding proteins PKB and PDK1 to membranes upon PIP3 production is well 
described in the literature. It is therefore possible that the cytosol represents the largest 
PI(3,4)P2-/3-binding protein pool. If insulin stimulation targets PI(3,4)P2-/PIP3-binding 
proteins to membranes, then differences in photolabelling between basal and insulin 
membrane fractions would have been observed. However, no differences in photolabelling 
were observed between basal and insulin samples. A lack of observable changes in the 
subcellular distribution of PI(3,4)P2-/PIP3-binding proteins upon insulin treatment, may be 
explained in a number of ways. Firsdy, the photolabelling of proteins may not have been 
sensitive enough to detect small amounts of protein. Each photolabelling reaction used 50 pg 
of protein. It is therefore likely that the proportion of true PI(3,4)P2-/PIP3-binding proteins 
in subcellular fractions such as the PM and LDM would be very small and probably 
undetectable. For example, labelling of aldolase (p40) was only detectable following heparin- 
agarose chromatography when its protein concentration relative to other proteins was 
increased (see figure 45). Hence, these initial experiments may not have identified novel and 
potentially important PI(3,4)P2-/PIP3-binding proteins in subcellular fractions due to the low 
levels of protein. It may be necessary to look at the photolabelling of PM and LDM fractions 
following heparin-agarose chromatography. Secondly, none of the photolabelling experiments 
takes into account the differences in affinity for the three photolabels utilised. For instance, a 
protein with a higher affinity for PIP3 than PI(3,4)P2 and PIP2, may not have been direcdy 
observed, if the single concentration of the photolabels used was too high to be selective. 
Important PI(3,4)P2-/PIP3-binding proteins may therefore have been overlooked. Ideally, the 
experiments would need to be repeated using a concentration range of competitor 
phosphatidylinositides to obtain a more accurate picture of the affinity of proteins for one 
phosphatidylinositide over another. Thirdly, the long exposure times might not necessarily
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distinguish between strong and weakly photolabelled proteins (minimum exposure times were 
generally a month). Any small translocation differences may have been missed. Fourthly, 
phosphatases may have been active in subcellular fractions, and hence any insulin-induced  
targeting of PI(3,4)P2-/PIP3-binding proteins to membranes may have been lost. Finally, any 
important PI(3,4)P2-/PIP3-binding protein < 20 kDa would not have been observed, since 
photolabelled proteins were analysed by 10% SDS-PAGE gels.
Photolabelling of proteins with PI(3,4)P2 and PIP3 analogues therefore has its limitations. 
Despite the limitations, three cytosolic proteins p37, p38 and p39, seemed to be good 
candidate PI(3,4)P2-/PIP3-binding proteins. Sequencing of p37/38 revealed the proteins to 
be malate dehydrogenase, and p52 (figure 50) to be phosphogluconate dehydrogenase. Both 
these bind phosphate containing substrates and this is possibly the reason why they bind to 
both the heparin and Ins(l,3,4,5)P4 columns. Malate dehydrogenase photolabelling did not 
appear to be non-specific (figure 41), it may therefore be necessary to reduce the time of 
photolabelling to reduce possible aberrant labelling.
There is previous research indicating that aldolase binds Ins(l,4,5)P3 , Ins(l,4)P2 and more 
importantly Ins(l,3,4,5)P4 (Thieleczek et al., 1989). Furthermore, Ins(3,4)P2 inhibits the 
binding of Ins(l,4,5)P3 to aldolase (Baron et a l 1995; Baron et al., 1998). It would therefore 
seem that the Ins(l,3,4,5)P4-affinity column has isolated at least one phosphoinositide-binding 
protein. The photolabelling of aldolase with PI(3,4)P2 is greater than the photolabelling with 
PI(4,5)P2 (figure 49). This result is consistent with the reported affinity of aldolase for the 
different phosphoinositides (Baron et al., 1995; Baron et al., 1998). However, to date there has 
been no previous evidence for the binding of aldolase to phosphatidylinositides. The 
specificity of photolabelling of aldolase has not been tested, and further experiments using 
purified aldolase are needed to examine whether aldolase can also specifically bind 
phosphatidylinositides. It is generally thought that proteins that bind PI(3,4)P2 also bind PIP3 
but with an equal or greater affinity (Rameh et a l 1997; Kavran et al., 1998). However, 
aldolase clearly photolabels more efficiently with PI(3,4)P2 than PIP3 (figure 49), giving 
further need for investigating the specificity of phosphatidylinositide binding.
The ability of aldolase to bind F-actin is well documented (Arnold & Pette, 1970; O’Reilly & 
Clarke, 1993). Interestingly, aldolase has recently been found to associate with the C-terminus 
of GLUT4 (Kao et al., 1999). Kao et al. (1999) observed that an anti-aldolase antibody could
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partially inhibit GLUT4 translocation to the PM in 3T3-L1 adipocytes. Additionally, fructose
1,6-bisphosphate can bind to aldolase and disrupt GLUT4/aldolase/F-actin binding. It also 
inhibits GLUT4 translocation to the PM. It was proposed (Kao et al, 1999) that aldolase 
mediates the interaction between GLUT4 and F-actin and that glucose metabolism may 
provide a negative feedback signal for the regulation of glucose transport by insulin. Whilst 
fructose 1,6-bisphosphate can release aldolase from F-actin, Ins(l,3,4,)P3 is also reported to 
release aldolase from F-actin (Thieleczek et al., 1989). An interesting speculation is the 
possibility that PI(3,4)P2 generation may interact with aldolase, thereby releasing GLUT4 
vesicles from the cytoskeleton. A tethering of GLUT4 vesicles to an intracellular structure has 
been proposed by Oatey et al (1997). However destabilisation of actin microfilaments with 
cytochalasin D was reported to have no effect on green-fluorescent protein(GFP)-GLUT4 
translocation to the cell surface. This latter result is in contrast to Wang et al. (1998) who 
observe a 50% decrease in glucose transport and GLUT4 translocation to the PM with 
cytochalasin D treated 3T3-L1 adipocytes. If PI(3,4)P2 does interact with aldolase bound to 
GLUT4, then there would be a rationale for the occurrence of PI 3-kinase activity on GLUT4 
vesicles. The location of PI 3-kinase activity is an important aspect in GLUT4 trafficking, but 
it is likely that more than one intracellular site is involved with PI 3-kinase and GLUT4 
trafficking.
Western blotting of the Ins(l,3,4,5)P4 eluate, revealed that PKBa/P (a PIP3-binding protein), 
did not bind to the Ins(l,3,4,5)P4-affinity column (data not shown). It is therefore possible 
that the Ins(l,3,4,5)P4 moiety of the affinity column is not sufficient to bind 
phosphatidylinositide-binding proteins. The phosphatidylinositide-binding proteins may also 
require the recognition of the glycerol backbone and fatty acids of the phosphatidylinositide. 
Tanaka et al. (1997) and Shirai et al. (1998) have shown that the glycerol backbone and fatty 
acids are important for the binding of proteins to the inositide lipid. Tanaka et al. (1997) used 
an IP3 analogue, similar to the one used here, to isolate PIP3-binding proteins (figure 51). The 
PIP3 analogue used by Tanaka et al. (1997) isolated a 43 kDa protein from bovine brain, 
centaurin-a, which was also isolated by Prestwich and colleagues using the PIP3 analogue 
used here (Hammonds-Odie et al., 1996). However, the Japanese group subsequently went on 
to modify the IP3 analogue to contain both a glycerol group and short fatty acid groups 
(figure 51) (Shirai et al, 1998). Using a protocol identical to the one which identified 
centaurin-a, the new PIP3 analogue additionally isolated the PIP3 binding proteins, Tec 
tyrosine kinase, Gaplm and PKBy (Shirai et al., 1998).
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In addition to a partial purification of phosphatidylinositol-binding proteins, heparin-agarose 
chromatography was used to remove phosphoinositol-phosphatases before these were added 
to a phosphoinositol-phosphatase sensitive affinity column. Interestingly, Shirai et al. (1998) 
state that their PIP3-affinity resin was reusable and hence insensitive to phosphoinositol- 
phosphatases, under the conditions used to isolate PIP3-binding proteins. Since the heparin- 
agarose step led to the loss of p39, it have been worthwhile to add the adipocyte cytosol 
fraction directly to the Ins(l,3,4,5)P4 resin. However, this would likely result in the isolation of 







O - P - O
OH
n/ V
" Y  OH
OPO(NaO)2
Aminopropyl-Ins(l,3,4,5)P4
NH2 Used in this thesis to isolate aldolase and 
other unknown proteins, and by 







\\ // -n h 2
(4-aminophenylbutyryl)-Ins (3,4,5) P3
Isolated centaurin-a (Tanaka et al., 1997).
CH3COO—
OH O—
0 0 0 (0 ^ -




3- (4- aminophenylbutyry 1) ,2- 
acetyl,propyl-Ins (1,3,4,5)P4
Isolated Tec tyrosine kinase, Gaplm, 
PKBy and centaurin-a (Shirai et al., 
1998).
Figure 51. PIP3 analogues used to isolate PIP3 binding proteins. All analogues were 
linked to Affi-Gel 10 (Bio-Rad).
Whilst the binding of phosphogluconate dehydrogenase and malate dehydrogenase to the 
Ins(l,3,4,5)P4 column is thought to be non-specific binding, proteins p i00, p43, p40b, p29 
and p28, which remain unidentified, might represent phosphatidylinositide-binding proteins.
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Proteins of ~29 kDa were always seen to be photolabelled by all three photolabels and hence 
p29 was not considered as a possible PI(3,4)P2-/PIP3-binding protein. However as 
mentioned previously, the photolabelling experiments may not allow discrimination of 
differences in affinity for the photolabels at a single concentration of photolabel. Hence, it is 
possible that p29 may be a true PI(3,4)P2-/PIP3-binding protein and further experiments are 
required to determine whether p29 discriminates between PI(3,4)P2/3 and PIP2 at lower 
ligand concentrations.
p28 was only seen to be photolabelled following the Ins(l,3,4,5)P4 affinity chromatography 
step (figure 49). Again, no discrimination between the three photolabels was observed, and 
further experiments are required to identify whether the photolabelling is specific, and 
whether p28 binds PI(3,4)P2/3 to a greater extent than PI(4,5,)P2.
A protein ~ 43kDa was found to bind to both the Ins(l,3,4)P3 and Ins(l,3,4,5)P4 column. It 
is not known whether the 43kDa protein binding to both affinity columns is the same protein, 
however 43kDa is the molecular mass of centaurin-a, a PIP3 binding protein (Hammonds- 
Odie et al.t 1996; Strieker et al., 1997; Tanaka et al, 1997). The 43 kDa protein was the only 
protein that appeared to be weakly photolabelled following the Ins(l,3,4)P3 affinity 
chromatography step, but only a small amount of protein was applied to the Ins(l,3,4)P3 
column at the time. In contrast, the p43 that eluted from the Ins(l,3,4,5)P4 column showed 
relatively weak photolabelling compared to aldolase, malate dehydrogenase, and p29. It is 
possible, that the adipocyte protein p43, is an isoform of centaurin-a, with a weaker affinity 
for PI(3,4)P2/3, than previously identified brain forms of centaurin-a.
Finally, plOO is of approximately the right molecular weight as Gaplm, an Ins(l,3,4,5)P4 
binding protein (Fukuda & Mikoshiba, 1996), also isolated by Shirai et al (1998). Further work 
is required to determine whether p i00 does represent Gaplm.
In summary, heparin and Ins(l,3,4,5)P4 chromatography have been used to isolate PI(3,4)P2- 
/PIP3-binding proteins from adipocytes. Using an adipocyte cytosol fraction, the 
phosphoinositol-binding protein aldolase was isolated. Aldolase, an actin binding protein, has 
recendy been shown to bind to the C-terminus of GLUT4, and hence it is speculated that PI 
3-kinase can regulate GLUT4 binding to the cytoskeleton via aldolase. Other proteins which 
bound to the Ins(l,3,4,5)P4 affinity column, were malate dehydrogenase, phosphogluconate
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dehydrogenase, and the unidentified proteins p i00, p43, p40b, p29 and p28. It is possible that 
p i00 represents Gaplm and p43 represents centaurin-a, but further work is required to 
identify and characterise these proteins.
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CHAPTER 7
C O N C L U SIO N
Using insulin-resistant adipocytes, research described here has indicated that despite reduced 
activation of early signalling intermediates, a reduction of PM GLUT4 is likely to be a result of 
increased endocytosis of GLUT4, rather than a reduction in GLUT4 exocytosis. The 
mechanisms regulating GLUT4 exocytosis are still unclear, and less is known about how 
insulin may regulate GLUT4 endocytosis. Ultimately, any process that increases PM GLUT4 
in NIDDM patients, albeit by increasing GLUT4 exocytosis or decreasing endocytosis, would 
be of benefit. The work reported here indicates that metformin reduces endocytosis of 
GLUT4 and this may account for its therapeutic action. If NIDDM patients were also found 
to show increased GLUT4 endocytosis, particularly in muscle, then the mechanisms regulating 
GLUT4 endocytosis will be of particular importance, and a shift in current research to study 
such mechanisms may be appropriate.
Research in this thesis has neither supported or disproved whether PKB is necessary for 
insulin-stimulated GLUT4 trafficking to the PM in adipocytes. Conclusive evidence that PKB 
is not required for contraction-stimulated GLUT4 translocation to the PM in muscle is 
described. Studies looking at the relationship between PKB activity and the serine/threonine 
phosphatase inhibitor okadaic acid (OA) suggested that OA may stimulate the exocytosis of 
recycling endosomes in a PKB-independent manner. Whilst this hypothesis needs to be 
further tested, a very recent study has indicated that the insulin stimulation of the recycling- 
endosomal pool does not require PKB (Foran et al, 1999). If both PMA and OA act on the 
recycling of GLUT4 from the recycling-endosomal pool, then it is suggestive of an 
unidentified serine/threonine kinase regulating this endosomal recycling.
Many aspects of the regulation of GLUT4 exocytosis remain unclear. This includes the precise 
role of each IRS molecule in GLUT4 trafficking, the site(s) of PI 3-kinase activation, the 
targets of PIP2/3, whether PKB is involved in GLUT4 trafficking and the precise roles of 
synip and mime 18c in GLUT4 vesicle fusion with the plasma membrane. In an attempt to 
provide further information into the regulation of GLUT4 trafficking, a significant proportion 
of the research in this thesis was aimed into identifying regulators of GLUT4 vesicle 
trafficking, namely GTP- and phosphatidylinositol-binding proteins.
The data using the periodate-oxidised GTP technique indicated that insulin activated GTP- 
binding proteins which were sensitive to the actions of wortmannin. Identification of these 
proteins was problematic. It was found that the GTPase ARF can form a strong association
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with GLUT4 vesicles. Whilst it is not known which isoform of ARF associates with GLUT4 
vesicles, it seems that more than one isoform of ARF regulates GLUT4 trafficking. Since 
GLUT4 vesicles can associate with adaptor proteins, AP-1 and AP-3 .(Gillingham et al.y 1999), 
it is likely that ARF1 associates transiently with GLUT4 vesicles. Hence it is proposed that in 
addition to the proposed role of ARF6 in GLUT4 endocytosis (Millar et al.y 1999) ARF1 can 
regulate the trafficking of GLUT4 from the PM back to the insulin-responsive GSVs.
Techniques used for attempts at identification of PI(3,4)P2-/PIP3-binding proteins from 
adipocytes led to the isolation of aldolase, and other PIP3 binding proteins. These currendy 
remain unidentified but might possibly be centaurin-a and Gaplm. Aldolase has been reported 
to bind phosphoinositides (Thieleczek et al.y 1989), actin (Arnold & Pette, 1970), and the C- 
terminus of GLUT4 (Kao et al.y 1999). Whether PI 3-kinase regulates aldolase binding to 
GLUT4, and hence the cytoskeleton, remains to be determined. The cytoskeleton is likely to 
play an important role in GLUT4 trafficking by possible tethering of GLUT4 vesicles (Oatey 
et al.y 1997), the localisation of PI 3-kinase (Clark et al., 1998) and by directing the movement 
of vesicles (Gonzalez & Scheller, 1999).
GLUT4 trafficking and the related signalling processes, are complex. Many aspects of the 
signalling processes remain unclear. This thesis, has only in part touched upon some of the 
processes. These require further research in order to provide those elusive answers to the 
unique trafficking of glucose transporter 4 that can be applied to the study of NIDDM.
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